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ABSTRACT 
 
AN EXAMINATION OF FACTORS AFFECTING HEMOGLOBIN A1C LEVELS AND 
SELF-CARE BEHAVIORS AMONG TYPE 2 DIABETIC PATIENTS IN PRIMARY CARE 
SETTINGS 
 
 
By 
Courtney Proie 
March 2017 
 
Dissertation supervised by Melanie Turk, PhD, RN 
Despite all of the research that has demonstrated the importance of optimal control of diabetes, 
there are still many people who do not receive adequate care, education, and support in managing their 
diabetes (Barnard, Peyrot, & Holt, 2012; Rossi et al., 2015).  This cross-sectional, descriptive, study 
examined the effects of the components of the Chronic Care Model on the outcomes of self-care 
behaviors and HbA1c levels for Type 2 diabetes patients cared for by nurse practitioners and physicians 
in the primary care setting.  Specifically, this study examined the effects of self-management support, 
conceptualized as patient perceptions of patient activation, participation in decision-making, and 
practitioner facilitation of patient involvement in care. This study also examined the elements of the 
model together (community resources, self-management support, decision support, clinical information 
systems and delivery system design) for their combined and individual effect on patient self-care 
behaviors and HbA1c levels.   
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Participants of this study were diagnosed with type 2 diabetes, 18 years of age or older, and 
currently seeing a physician or nurse practitioner within a primary care setting for the care and 
management of their type 2 diabetes. Participants (N=82) completed a total of 6 questionnaires which 
included a demographics form, the Patient Activation Measure (PAM), the Facilitation of Patient 
Involvement Scale (FPI), the Perceived Involvement in Care Scale (PICS), and Patient Assessment of 
Care for Chronic Conditions (PACIC), and the Summary of Diabetes Self-Care Activities (SDSCA).  
The PACIC was found to have significant associations with General Diet Score (p=.020), Specific 
Diet Score (p=.027), exercise (p=.032), and blood glucose testing (p=.046).  The PAM was found to have 
significant associations with General Diet Score (p=.023) and foot care (p=.006).  The FPI was found to 
have a significant association with blood glucose testing (p=.030).  The PICS was found to have a 
significant association with blood glucose testing (p=.046).   
The results were helpful to address some of the questions related to HbA1c and self-care behavior 
practices. Of notable importance, having no statistical significance in the results when comparing nurse 
practitioner patients and physician patients demonstrates that, in this particular study, there was no 
difference in the standards and variables that were measured comparing nurse practitioners and 
physicians.  The patients who were cared for by both types of providers experienced similar outcomes 
with regard to self-care behaviors, HbA1c, levels of patient activation, participation in decision-making, 
and facilitation of patient involvement in care. Therefore, this is an important finding supporting the 
notion that care received by nurse practitioner patients and physician patients is not different.  
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Chapter 1 
Introduction 
 This chapter is an introduction to the proposed research study.  The background and 
development of the research questions, along with definitions, assumptions, and limitations will 
be discussed.  The evolution, purpose, and significance of this research study will be introduced 
and described.  The problem that will be examined and assessed by this proposed study will be 
explained. The need for this proposed study will be introduced and will continue through the 
review of the literature in chapter 2.   
Type 2 diabetes is currently a significant epidemic in the United States of America; and 
occurs when the body does not produce enough insulin or the cells are not receptive to the 
insulin that is released in the body (RW.ERROR - Unable to find reference:355; American 
Diabetes Association, 2016a; US Department of Health and Human Services, 2014). Type 2 is 
the most common type of diabetes, affecting millions of people, while many others remain 
unaware they are at risk (American Diabetes Association, 2016a).  According to the Centers for 
Disease Control and Prevention, it is estimated that for every 3 people diagnosed with diabetes, 
one person goes undiagnosed (2.68:1 ratio of diagnosed to undiagnosed cases in 2011) (Centers 
for Disease Control and Prevention, 2016).  Without the proper utilization of insulin, 
carbohydrates are converted to glucose and remain in the blood rather than being transported into 
the cells for energy.  The accumulation of glucose in the blood leads to diabetes complications if 
left untreated (American Diabetes Association, 2016a).   
 According to the World Health Organization (WHO), the number of worldwide cases of 
Type 2 diabetes has increased from 170 million in 2000 to 280 million in 2010; and this number 
is expected to increase to 430 million by the year 2030 (Shaw, Sicree, & Zimmet, 2010; Wild, 
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Roglic, Green, Sicree, & King, 2004).  There are currently 25.6 million people ages 20 or older 
who have Type 2 diabetes.  In 2010, there were 1.9 million people with a new diagnosis of Type 
2 diabetes (US Department of Health and Human Services, 2014).   In 2007, diabetes was the 
seventh leading cause of death based on United States (US) death certificates; and this number is 
likely to be underestimated, as death related to diabetes is often underreported (US Department 
of Health and Human Services, 2014). In 2007, a total of 231,404 death certificates listed Type 2 
diabetes as either the underlying or direct contributing factor to death (American Diabetes 
Association, 2016a).  Diabetes remains the seventh leading cause of death based on preliminary 
data for 2011 (Hoyert & Xu, 2012).  Diabetes can lead to other complications including heart 
disease, stroke, high blood pressure, blindness, kidney disease, nervous system disease, 
retinopathy, and amputations (American Diabetes Association, 2016a; Campbell, 2009).  
 Despite improvements in care for patients with Type 2 diabetes, in 2008, less than 20% 
of all diabetes patients reached the desired evidence based goals of management, such as 
engaging in self-care behaviors to promote target glucose levels and achieving the targeted the 
HbA1c levels (O'Connor et al., 2011). A more recent study followed 1,343 patients from 2007 
through 2010, finding that only 52.5% of the patients achieved Hemoglobin A1c (HbA1c) values 
of 7% or less with 77.9% of the population studied achieved 8% or less (Casagrande, Fradkin, 
Saydah, Rust, & Cowie, 2013). The total estimated cost, direct and indirect, related to diabetes in 
2012 was $245 billion, and those with diabetes have medical costs that are 2.3 times higher than 
those without diabetes,  (American Diabetes Association, 2016b; US Department of Health and 
Human Services, 2014). The incidence of Type 2 diabetes has been linked to a variety of 
characteristics such as race, age, socioeconomic status, weight, lifestyle, and metabolic disorders 
(RW.ERROR - Unable to find reference:355; RW.ERROR - Unable to find reference:358; 
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RW.ERROR - Unable to find reference:354; Alberti, Boudriga, & Nabli, 2007).  The prevalence 
of Type 2 diabetes has increased dramatically over the past twenty years, therefore, research 
focused on improving both management and outcomes for patients with Type 2 diabetes is 
needed.   
 Because Type 2 diabetes is a chronic disease, the Chronic Care Model (CCM) will be 
used as a guide for the proposed study. The elements of the CCM include the community, the 
health system, self-management support, delivery system design, decision support, and clinical 
information systems (Robert Wood Johnson Foundation, 2016a).  Through productive 
interactions between informed and activated patients and prepared, proactive practice teams and 
the combination of these elements the end result is improved outcomes for patients with chronic 
conditions. Beneath the surface of the main elements of the CCM are the variables that will be 
examined in this proposed study. These variables include patient activation, patient participation 
in decision-making, and participation in self-care behaviors relate directly to the informed, 
activated patient.  Facilitation of patient involvement and variations in practice among types of 
practitioners relate to the prepared, proactive practice team.  The health system encompasses 
decision support, delivery system design, and clinical information systems. The community 
element includes available community resources and self-management support (Robert Wood 
Johnson Foundation, 2016a). These variables will briefly be introduced in this chapter to explain 
why these variables are important to examine in this proposed study. They will all be explained 
in detail in chapter 2.    
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Figure 1. The Chronic Care Model Operationalized 
 
Background of the Problem 
The Health System: Delivery System Design, Clinical Information Systems, and Decision 
Support 
 Delivery system design, clinical information systems, and decision support are an 
intertwined set of variables that are all individual elements of the CCM (Robert Wood Johnson 
Foundation, 2016a).  These variables are more practitioner focused in terms of how care is 
delivered to the patients.  Characteristics of these variables include evidence-based care, ensuring 
follow-up care, culturally appropriate care, sharing evidence-based guidelines and information to 
encourage patient participation in care, integrating specialist expertise in care, using appropriate 
decision support and reminder tools, facilitating individual care planning, and sharing of 
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information among patients and providers (Robert Wood Johnson Foundation, 2016b; Robert 
Wood Johnson Foundation, 2016c; Robert Wood Johnson Foundation, 2016d).   
 Delivery system design is especially important for patient with Type 2 diabetes who 
require continuing management and occasional involvement from other practitioners or 
specialists. The delivery system design relates to how the patient can access necessary services 
and/or the way they are referred to additional services. Having organized and well managed care 
is important for patients with diabetes, and a team based approach including a dietician and 
certified diabetes educator has been shown to improve outcomes (Dancer & Courtney, 2010; 
National Institutes of Health and the Centers for Disease Control and Prevention, 2011).   
A component of an organized delivery system design involves the use of clinical 
information systems.  The clinical information system should be a readily available database 
relating to each individual patient, such as an electronic health record (EHR).  This type of 
database can remind practitioners to order specific tests or address specific issues for each 
individual patient, based on the information in their individual record.  Having an electronic 
based system can also provide easy access for other practitioners or specialists who are treating 
the patient to access information related to other patient consultations or treatments that have 
been carried out.  This type of documentation and easily accessible electronic information is 
especially important in patients, including those with Type 2 diabetes, because of the complexity 
of care for some of these patients (Dancer & Courtney, 2010; Siminerio, Zgibor, & Solano, 
2004).  
 Decision support and evidence based guidelines can be tied to the use of electronic health 
records.  The use of clinical information systems and electronic decision support tools has been 
shown to improve practitioner performance.  However, research related to patient outcomes and 
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use of decision support systems has been insufficient and the data that has been analyzed has 
been inconsistent.  Measured outcomes, including glycosylated hemoglobin (HbA1c) levels, 
have shown little or no improvement in studies examining the effect of decision support systems 
on patient outcomes (Crosson, Ohman-Strickland, Cohen, Clark, & Crabtree, 2012; Frijling et 
al., 2002; Garg et al., 2005; Hunt, Haynes, Hanna, & Smith, 1998; Jaspers, Smeulers, 
Vermeulen, & Peute, 2011; Keyhani et al., 2008; Lau et al., 2012; McCoy et al., 2012; O'Connor 
et al., 2011; Poon et al., 2010; Romano & Stafford, 2011; Smith et al., 2008).  
The Community: Community Resources and Self-Management Support 
 Effective management of chronic diseases, like Type 2 diabetes, requires the delivery 
system design also be linked to community resources.  Awareness of cultural and ethnic 
backgrounds of patients and their ties to the community can be useful in determining potential 
community resources for patients. There may be disease-specific support groups within 
neighborhoods that may be more appropriate for patients, as they can be engaged in their 
community and a setting in which they are comfortable (Austin, Wagner, Hindmarsh, & Davis, 
2000).  The success of delivery system designs can be improved by establishing links to the 
community resources to support patients in their self-management endeavors.  Resources 
relevant to diabetes management such as peer groups, exercise classes, or home nursing care 
within local communities can be valuable to patients, especially those who have limited access to 
transportation and vulnerable populations such as the elderly, children, low-income, and 
underserved areas (Glasgow, Tracy Orleans, Wagner, Curry, & Solberg, 2001).   
 The CCM is different from traditional models and approaches to management of chronic 
diseases because two of the main foci are self-management training and counseling (Siminerio et 
al., 2004).  Benefits related to Diabetes Self-Management Education have been recognized by the 
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American Diabetes Association and are considered an integral piece of diabetes care to strength 
the ability of patients to self-manage (Siminerio et al., 2006; Siminerio et al., 2004; Wagner, 
1998).  Self-management support prepares patients to take an active role in the management of 
Type 2 diabetes (Glasgow et al., 2001).  Successful self-management and education programs 
help the patient to better understand the goals, priorities, barriers, and potential problems that can 
arise when dealing with Type 2 diabetes (Glasgow & Anderson, 1999; Glasgow et al., 2001; Von 
Korff & Gruman, 1997).  The use of patient education brochures, referrals to other care team 
members, phone support hotlines, group and/or one-on-one counseling, and referrals to diabetes 
education classes can all aid in increasing self-management support for patients with Type 2 
diabetes (RW.ERROR - Unable to find reference:1044; Solberg et al., 2006).   
Informed, Activated Patients: Patient Activation and Participation in Decision-Making 
Patient activation can be defined as “developing experience with question formulation 
and building information-seeking skills that results in increased collaboration with the health 
care provider (Alegria et al., 2008, p. 247).”  Hibbard, Stockard, Mahoney, and Tusler (2004) 
described the process for conceptualizing and operationalizing what it means for a patient to be 
“activated,” and found that this process involves four stages.  The four stages of activation 
include “believing the patient role is important, having the confidence and knowledge necessary 
to take action, actually taking action to maintain and improve one’s health, and staying the 
course, even under stress (Hibbard et al., 2004, p. 1016).”  Research has found that patients who 
are more engaged, informed, activated, and confident are more likely to perform self-care 
behaviors to promote their health (Lorig et al., 1999; Mosen et al., 2007; Remmers et al., 2009; 
Von Korff & Gruman, 1997).  Patients who are found to have higher levels of activation also 
have better outcomes (Hibbard et al., 2004; Hibbard & Tusler, 2007; Mosen et al., 2007).  
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 Patient activation and patient participation in the medical decision-making process have 
many noted benefits and implications related to self-management of diseases.  McEwen et al. 
(RW.ERROR - Unable to find reference:791) asserts that patient participation has many benefits, 
including increased patient responsibility with a commitment to health and health promoting 
behaviors.  Other authors report that increased patient participation enables more effective self-
management of diseases (RW.ERROR - Unable to find reference:796; RW.ERROR - Unable to 
find reference:285; Golin, DiMatteo, & Gelberg, 1996; Heisler, Bouknight, Hayward, Smith, & 
Kerr, 2002).  Patient activation and participation not only encompasses the decision-making 
process, it extends into all aspects of care: compliance with treatment plans, self-medication, 
medication adherence, patient education, information sharing, and taking part in physical care 
(RW.ERROR - Unable to find reference:801; RW.ERROR - Unable to find reference:285; 
RW.ERROR - Unable to find reference:804; RW.ERROR - Unable to find reference:321; 
RW.ERROR - Unable to find reference:802; RW.ERROR - Unable to find reference:803; 
Glasgow et al., 2002; Hibbard et al., 2004; Lorig et al., 1999; Wolpert & Anderson, 2001).   
 Patient activation and participation in the medical decision-making process is important 
for Type 2 diabetes because this particular disease requires the patient to do a significant amount 
of self-management related to individual lifestyles and personal goals of disease management 
(RW.ERROR - Unable to find reference:314).  If patients are to learn to self-manage Type 2 
diabetes, which involves glucose monitoring, diet modification, and exercise habits patients 
should take an active role in their health and participate in the decisions made during 
consultations with a healthcare practitioner related to defining mutually agreeable management 
goals.  
 9 
 
Prepared, Proactive, Practice Team: Facilitation of Patient Involvement in Care and 
Differences among Types of Practitioners 
 The effect of healthcare practitioners on the outcomes and satisfaction for patients with 
Type 2 diabetes is also important.  Current literature remains inconclusive whether patient 
outcomes and/or patient satisfaction is influenced by the type of practitioner a patient sees. One 
study examined patient satisfaction with primary care practitioners for patients with chronic 
diseases, finding that patients were more satisfied with the care they received from nurse 
practitioners, except in the cases of patients with Type 2 diabetes (Roblin, Becker, Adams, 
Howard, & Roberts, 2004).  Those patients preferred the care of a physician.  Other studies, 
looking only at patients with Type 2 diabetes, had varying results in terms of outcomes 
(Horrocks, Anderson, & Salisbury, 2002).  
 There are also variables related to health care practitioners that may impact health 
outcomes.  Health care practitioners can actively facilitate, or encourage, patients to be involved 
in their own healthcare (Martin, DiMatteo, & Lepper, 2001).  Behaviors, such as suggesting the 
patient ask questions, listening to the patient’s concerns, and providing as much information as 
possible to the patient, can facilitate the patient’s involvement in managing their health (Martin 
et al., 2001).  Martin, DiMatteo, and Lepper (2001) have suggested that when patients recognize 
that their health care provider has facilitated their involvement in care; patients tend to be more 
satisfied with care and better adhere to treatment plans. 
Improved Outcomes: HbA1c and Self-Care Behavior Practices 
 The HbA1c test, also known as glycated hemoglobin, glycosylated hemoglobin, 
glycohemoglobin, A1c, or HbA1c, is a way to measure blood glucose management over a two- 
to three-month period.  This blood test should be done every three to six months for patients with 
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diabetes.  The test reflects a patient’s average blood glucose control over the previous 2 or 3 
months and is a very accurate way to monitor overall diabetes control (Joslin Diabetes Center, 
2016; Mayo Clinic, 2016).  A person without diabetes would have a HbA1c level between 4% 
and 6%; and a common target level for patients with Type 2 diabetes is 7% or less (American 
Diabetes Association, 2016a; Joslin Diabetes Center, 2016; Mayo Clinic, 2016).  HbA1c levels 
are directly correlated with blood sugar levels.  Diet, exercise, medication adherence, and regular 
glucose testing all are factors that can contribute to blood sugar control that will also contribute 
to the HbA1c levels (Joslin Diabetes Center, 2016; UK Prospective Diabetes Study (UKPDS) 
Group, 1998).   
The higher the HbA1c result, the more risk a person has of developing complications 
related to diabetes (American Diabetes Association, 2016a; Mayo Clinic, 2016).  The importance 
of the HbA1c levels should not be minimized.  For every percentage point decrease in HbA1c 
levels there is also a 35% reduction in the risk of microvascular complications, a 25% reduction 
in diabetes related deaths, and an 18% reduction in myocardial infarctions (UK Prospective 
Diabetes Study (UKPDS) Group, 1998).  The risk of complications associated with diabetes is 
significantly reduced when the HbA1c values are less than 8%, ideally lower than 7% (Mayo 
Clinic, 2016; UK Prospective Diabetes Study (UKPDS) Group, 1998).  
Self-care behaviors are an important aspect of disease management, specifically with 
Type 2 diabetes.  The concept of self-care behaviors can encompass a variety of activities such 
as glucose monitoring, medication adherence, diet or exercise adherence, and other activities 
such as regularly checking one’s feet for ulcers or signs of neuropathy (Toobert, Hampson, & 
Glasgow, 2000).  Each of these individual activities is an important piece of the overall challenge 
of successful Type 2 diabetes management.  Examining a patient’s overall compliance with these 
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self-care activities can give a broader picture of how well a person can self-manage aspects of 
this disease.  Wolpert and Anderson (2001) addressed behavioral change in diabetes care and 
stressed diabetes is a self-managed condition, models of care should be focused on promoting 
more self-care behaviors while stressing the importance of glycemic control from the patient’s 
perspective. 
Summary  
 With Type 2 diabetes being a complex disease to manage, it would be unlikely that one 
facet of treatment would be the component that makes managing the disease successful. The 
CCM was designed with this complexity in mind (RW.ERROR - Unable to find reference:898; 
Austin et al., 2000; Bodenheimer, Wagner, & Grumbach, 2002a; Dancer & Courtney, 2010; 
Nutting et al., 2007; Robert Wood Johnson Foundation, 2016a). Each element of the CCM 
provides a unique piece of the necessary formula for successful management of chronic diseases, 
including Type 2 diabetes.  Examining the effects of each of these elements related to outcomes 
such as HbA1c levels and self-care behaviors practices will be useful for designing future 
treatment plans for this patient population.   
Purpose and Aims of Study 
 This cross-sectional, descriptive, study will examine the effects of the components of the 
CCM on the outcomes of self-care behaviors and HbA1c levels for Type 2 diabetes patients 
cared for by nurse practitioners and physicians in the primary care setting.  Specifically, this 
study will examine the effects of self-management support, conceptualized as patient perceptions 
of patient activation, participation in decision-making, and practitioner facilitation of patient 
involvement in care. This study will also examine the elements of the model together 
(community resources, self-management support, decision support, clinical information systems 
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and delivery system design for their combined and individual effect on patient self-care 
behaviors (Summary of Diabetes Self-Care Activities) and HbA1c levels.  Current literature has 
not evaluated the relationship of these variables, as they are being conceptualized, on the specific 
diabetic patient outcomes of HbA1c levels and self-care behaviors, and any differences between 
health care providers.   
 The primary aims of this proposed study are to evaluate patient perceptions of patient 
activation, participation in decision-making, and facilitation of involvement in care (Self-
Management Support) for their effect on self-care behaviors and HbA1c values. The combined 
elements of the CCM including decision support, community support, self-management support, 
delivery system design, and clinical information systems will also be assessed for their effect on 
self-care behaviors and HbA1c values. The secondary aim of this proposed study is to explore 
differences among these variables in patients receiving care from physicians compared to nurse 
practitioners. 
Research Questions 
 The research questions were the results of a thorough review of current literature 
examining the management of Type 2 diabetes. Numerous studies examined the desire of 
patients to participate in the decision-making process related to the treatment of Type 2 diabetes 
(RW.ERROR - Unable to find reference:285; Golin et al., 1996; Golin, DiMatteo, Leaks, Duan, 
& Gelberg, 2001; Heisler, Piette, Spencer, Keiffer, & Vijan, 2005; Jahng, Martin, Golin, & 
DiMatteo, 2005); however, no studies evaluated the extent the level of patient activation and 
patient participation in decision-making affect patient outcomes and any potential differences 
among practitioners.  After examining literature, the following questions were formulated: 
 
 13 
 
Primary questions: 
1. Among Type 2 diabetic patients, do levels of patient activation, participation in 
decision-making for treatment planning, and facilitation of patient involvement in 
care affect HbA1c levels and patients’ performance of self-care behaviors?  
2. Based on the CCM, what are the effects of delivery system design and clinical 
information systems, together with patient perceptions of decision support, self-
management support, and community resources on HbA1c levels and 
participation in self-care behaviors for patients with Type 2 diabetes? 
Secondary questions: 
1. Is there a difference in levels of patient activation, participation in decision-
making, and facilitation of patient involvement in care when a nurse practitioner 
treats a patient compared to a physician? 
2. Do patients who see nurse practitioners for management of Type 2 diabetes 
experience higher levels of engagement in self-care behaviors and more 
therapeutic HbA1c levels compared to patients who see a physician? 
Definition of Terms 
 Rigorous research requires that the concepts being studied be defined in order to be 
operationalized.  Based on a review of the current literature, these definitions have been 
developed for the variables presented in the study. 
 Type 2 Diabetes – With Type 2, the body either does not produce enough insulin or the 
cells in the body are resistant to the insulin. If insulin is unable to carry sugar in the blood 
into the cells, then the cells become starved for energy. Over time, high blood glucose 
levels can cause damage to the eyes, kidneys, nerves, and/or heart (American Diabetes 
Association, 2016a).  
 14 
 
 Patient – A patient is defined as someone who is sick with, or being treated for, an illness 
or injury.  A patient is one who is receiving medical care (Patient. 2013, p. 1754).  For 
this proposed study, the patient must have a diagnosis of Type 2 diabetes.  
 Practitioner – A practitioner is one who has met the professional and legal requirements 
necessary to provide a health care service (Practitioner. 2013, p. 1884).   
 Nurse Practitioner (NP) – A nurse practitioner is defined as licensed registered nurse who 
has advanced preparation (master’s or doctoral program) in the area of diagnosis and 
treatment of illnesses. Nurse practitioners may work in collaborative practice with 
physicians or independently in private practice or in nursing clinics.  Depending on state 
laws, NPs may obtain prescriptive authority allowing them to prescriptions for 
medications.  NPs must undergo national certification, periodic peer review, clinical 
outcome evaluations, and adhere to a code of ethical practices. NPs are licensed in all 
states and the District of Columbia, and practice under the rules and regulations of the 
state in which they are licensed.  They provide care in clinics, hospitals, emergency 
rooms, urgent care sites, private practices, nursing homes, schools, colleges, and public 
health departments within rural, urban and suburban settings (Nurse practitioner. 2013, p. 
1646; American Association of Nurse Practitioners, 2013).   
 Primary Care Physician (PCP) – A primary care physician is a generalist physician who 
provides care to the undifferentiated patient at the point of first contact and takes 
continuing responsibility for providing the patient’s care.  This physician assumes 
medical coordination of care with other physicians for the patient with multiple health 
concerns (Primary care physician. 2013, p. 1807; American Academy of Family 
Physicians, 2016).   
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 Decision-making – Decision-making is defined as the process of using adequate 
information to come to a conclusion and make choices (Decision-making. 2013, p. 627).  
For this study, decision-making refers to the decisions made related to treatment and 
management of Type 2 diabetes.  Both practitioners and patients may be involved in 
decision-making.   
 Participation in the decision-making process – Participation in the decision-making 
process is defined as the patient’s involvement and input related to decisions regarding 
treatment and management of Type 2 diabetes.  Patients may be very active in voicing 
their opinions related to which options are most appropriate for their lifestyle, while other 
patients may defer to the practitioner to make the most appropriate choice based on their 
medical expertise (Decision-making. 2013; Merriam-Webster, 2013c).  In this study, 
participation in the decision-making process will be operationalized using the Perceived 
Involvement in Care Scale.  A wide range of participation may exist among patients.  
 Shared decision-making – Shared decision-making is a process by which patients and 
providers consider outcome probabilities and patient preferences and reach a health care 
decision based on mutual agreement (Frosch & Kaplan, 1999, p. 285).   
 Self-care behaviors – Self-care refers to actions that people initiate and perform on their 
own behalf in maintaining life, health, and well-being (Self-care. 2013, p. 2106).  
Diabetes self-care behaviors include a variety of activities, such as checking blood 
glucose levels, medication adherence, eating a particular diet, following an exercise 
regimen, checking feet regularly, smoking/alcohol habits (Toobert et al., 2000).  Self-care 
behaviors will be operationalized using the Summary of Diabetes Self-Care Activities 
assessment.  
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 Chronic condition – A chronic condition is defined as any condition that requires ongoing 
adjustments by the affected person and interactions with the health care system (Robert 
Wood Johnson Foundation, 2016a).   
 Chronic care – Chronic care is defined as long-term medical care (greater than 90 days) 
for individuals with a chronic physical or mental impairment (Merriam-Webster, 2013a). 
 Decision support – In this setting, decision support is designed as the practice of sharing 
evidence-based guidelines and information with patients to encourage their participation 
in the decision-making process related to their treatment plans (Robert Wood Johnson 
Foundation, 2016c).  Decision support will be operationalized using a subscale of the 
Patient Assessment of Care for Chronic Conditions (PACIC) questionnaire. 
 Patient Activation – Patient activation is defined as developing experience with question 
formulation and building information-seeking skills that results in increased collaboration 
with the health care provider (Alegria et al., 2008, p. 247).  Patient activation will be 
operationalized using the Patient Activation Measure (PAM) and the Patient Assessment 
of Care for Chronic Conditions (PACIC). 
 Facilitation of Patient Involvement in Care – To facilitate is to make easier, help bring 
about (Merriam-Webster, 2013b).  Behaviors, such as suggesting the patient ask 
questions, listening to the patient’s concerns, and providing as much information as 
possible to the patient, can facilitate the patient’s involvement in managing their health 
(Martin et al., 2001).  Facilitation will be operationalized using the Facilitation of Patient 
Involvement Scale (FPI) and a subscale of the Perceived Involvement in Care Scale 
(PICS).   
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 Delivery System Design – The CCM defines delivery system design as defining roles and 
distributing tasks among team members, using plan interactions to support evidence-
based care, providing clinical case management services for complex patients, ensuring 
regular follow-up care by the care team, and giving care that patients understand and fits 
with their cultural background (Robert Wood Johnson Foundation, 2016d).  Delivery 
system design will be operationalized through participants self-reporting if follow-up 
appointments were requested by the practitioner and/or patients were referred to an 
endocrinologist, a dietician, optometrist/ophthalmologist (eye doctor), podiatrist (foot 
doctor) and/or a diabetes educator.  
 Clinical Information Systems – The CCM defines clinical information systems as 
providing timely reminders for patients and providers, facilitating individual patient care 
planning, sharing information with patients and providers to coordinate care (Robert 
Wood Johnson Foundation, 2016b).  Clinical information systems will be operationalized 
through the demographic form where patients will be asked to report if they discussed 
goals of treatment with their practitioner and if they were given any printed information 
from the practitioner related to goals of treatment or test results. 
 Community Resources – The CCM defines this as encouraging patients to participate in 
effective community programs (Robert Wood Johnson Foundation, 2016g).  Community 
resources will be operationalized using a subscale of the Patient Assessment of Care for 
Chronic Conditions (PACIC).   
 Self-Management Support – The CCM defines self-management support as emphasizing 
the patient’s central role in managing their health, using effective self-management 
support strategies that include assessment, goal-setting, action planning, problem solving, 
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and follow-up, and organizing internal and community resources to provide ongoing self-
management support to patients (Robert Wood Johnson Foundation, 2016f).  Self-
management support will be operationalized using two subscales of the Patient 
Assessment of Care for Chronic Conditions (PACIC) questionnaire.   
 HbA1c level – The HbA1c level is determined from a HbA1c blood test.  It can also be 
referred to as the glycated hemoglobin, glycosylated hemoglobin, and HbA1c.  This 
blood test can determine both the presence of diabetes mellitus and the degree of 
glycemic control, which is how well a patient is managing his or her blood glucose 
levels.  The HbA1c test reflects the average blood sugar level over the past 2-3 months.  
A normal HbA1c level for a person who does not have diabetes is from 4.5-6 percent.  
Someone with uncontrolled diabetes will have a level above 9 percent.  For most patients 
with Type 2 diabetes, a level of 7 percent or less is considered representative of well-
managed diabetes.  In patients with diabetes mellitus, the HbA1c level will be normal or 
slightly elevated (7% or less) if blood glucose levels are optimally managed over an 8-12 
week period. If glucose levels have not been controlled, the HbA1c levels will be 
elevated (greater than 7%).  HbA1c levels are considered good indicators of long-term 
glycemic control (Hemoglobin, A1c. 2013, p. 1103; American Diabetes Association, 
2016a; Mayo Clinic, 2016).   
Assumptions 
 The assumptions made by the researcher related to this study include: 
1. The participants in this sample are representative of patients with Type 2 diabetes in this 
region, therefore the data will be generalizable to the regional area. 
2. The patients will accurately portray themselves in their demographic data questionnaire. 
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3. The patients will accurately answer the five surveys: Patient Activation Measure Survey 
(PAM), Patient Assessment of Care for Chronic Conditions (PACIC), Summary of 
Diabetes Self-Care Activities, Facilitation of Patient Involvement Scale (FPI), and 
Perceived Involvement in Care Scale (PICS). 
Limitations 
 While every effort will be made to ensure a rigorous study, limitations are an inherent 
piece of all research studies.  Possible foreseen limitations related to this study include: 
1. The relatively small sample size relative to the overall number of patients with Type 2 
diabetes nationally may limit the ability to generalize the results of this study to the entire 
population of patients with Type 2 diabetes. 
2. Due to the concentrated area from which the participants of the study will be recruited, the 
ability to generalize the results beyond Western Pennsylvania might be limited. 
3. The population of patients and providers for this study is being pooled from only one 
health system in the area, thus generalizability may be limited to this healthcare system. 
4. Data on most variables except for HbA1c will be self-reported.  Issues can arise related to 
self-report data when participants do not clearly understand the questions being asked. 
Directions for all questionnaires will be reviewed with each participant to reduce this 
limitation as much as possible. Another disadvantage of self-report data is the social-
desirability bias.  This occurs when participants answer the questions to portray 
themselves as socially acceptable, and answers may not always be truthful.  
5. Another limitation related specifically to descriptive designs is that descriptive designs 
cannot establish causation; they can only describe effects on relationships between 
variables.  
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Significance of the Study to Nursing 
 Throughout the past two decades, the number of people diagnosed with diabetes has risen 
767%, with the majority of those affected residing in the United States and China (RW.ERROR - 
Unable to find reference:361).  Currently, 20% of the populations in the Caribbean and Middle 
East are affected; this number is expected to double within the next twenty years (RW.ERROR - 
Unable to find reference:361).  The cost of treating patients with diabetes is $174 billion 
annually (US Department of Health and Human Services, 2014).  The incidence of Type 2 
diabetes is also increasing at an alarming rate with an estimated 48.3 million people being 
affected by Type 2 diabetes by 2050 (Venkat Narayna, Boyle, Geiss, Saadine, & Thompson, 
2006).  With this shocking rate of new diagnoses, it is necessary to evaluate treatment practices 
to ensure that these patients are receiving optimal care to promote optimal outcomes (Aljasem, 
Peyrot, Wissow, & Rubin, 2001; Anderson & Robins, 1998; Venkat Narayna et al., 2006).  Many 
patients with Type 2 diabetes are managed by primary care offices, with an increase in nurse 
practitioners managing these patients (American Diabetes Association, 2016a). 
 The current literature identifies issues related to management of Type 2 diabetes, 
acknowledging the involvement of nurse practitioners in addition to physicians; however, it is 
lacking in suggestions and recommendations for changes to be implemented to suit this patient 
population.  Gaining an understanding of patient activation, participation in decision-making, 
and facilitation of patient involvement in care for the first primary research question could 
identify important information about the patient/provider relationship related to Type 2 diabetes 
management.  Looking at delivery system design, clinical information systems, self-management 
support, and community resources can also identify meaningful data related to Type 2 diabetes 
from another perspective.  The results from of the data analysis for each research question may 
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identify factors to promote improved management of Type 2 diabetes.  These strategies can be 
used to plan and implement new guidelines related to the manner in which Type 2 diabetes is 
managed.  Currently, there are no studies that have evaluated patient participation levels when 
different healthcare providers treat Type 2 diabetic patients, nor have there been any quantitative 
studies evaluating participation scores and their relationship to overall management outcomes.  
Understanding the effect of the self-management support element of the CCM conceptualized as 
patient activation, participation in decision making, and  practitioner facilitation of patient 
involvement in care, along with the combined elements of the CCM together  on patient self-care 
behaviors and HbA1c can be vital in the future care of Type 2 diabetic patients.  Exploring any 
differences in these variables when patients are cared for by different healthcare providers, i.e., 
primary care physicians and nurse practitioners may also provide information to enhance patient 
outcomes. 
Summary 
   The number of patients with Type 2 diabetes continues to increase at an alarming rate.  It 
is essential that continued research be focused on finding ways to include the patients in the 
treatment process and allow the patients to have a voice in the development of a treatment plan.  
In order for patients to have optimal outcomes related to the treatment of Type 2 diabetes, the 
variables in this study, guided by the CCM, need to be examined to reveal factors that may 
influence the complex treatment of this chronic disease.  The proposed research questions are 
designed to examine the important elements from the CCM to identify how the elements, 
together, have an impact on patient outcomes, specifically HbA1c levels and self-care behavior 
practices. By examining specific variables related to these elements, new information may be 
discovered to improve the way care is delivered for patients with Type 2 diabetes, thereby 
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improving patient outcomes.  Practitioners may become aware of how these variables, including 
differences among physicians and nurse practitioners, impact patients with Type 2 diabetes. 
Assessing the impact of these variables on HbA1c levels and self-care behavior practices will 
provide additional information to improve the care and outcomes of patients with Type 2 
diabetes.   
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Chapter 2 
Review of Literature 
 This chapter discusses the current literature as it relates to the research questions and 
concepts presented in this study.  The direct elements of the Chronic Care Model (CCM) include 
the community, the health system, self-management support, delivery system design, decision 
support, and clinical information systems. These elements combined with productive interactions 
between informed, activated patients and prepared, proactive practice team members are 
designed to promote improved outcomes in patients with chronic conditions.  Variables that will 
be examined in this proposed study include patient activation, patient participation in decision-
making, patient activation, and facilitation of patient involvement. Delivery system design, 
clinical information systems, and decision support systems will also be assessed. Variations in 
practice among types of practitioners and the use of or referral to available community resources 
will be evaluated, in addition to the outcome variables of HbA1c (HbA1c) levels and self-care 
behavior practices.  Appropriate literature will be presented on each of these variables that will 
be assessed in the proposed study.  The information presented in this chapter will outline the 
historical background of the concepts, why they are important in the management of Type 2 
diabetes, and how this study will attempt to fill in any voids, or gaps, in the current literature.  
 
This chapter will be outlined as followed, in concordance with the CCM: 
I. Theoretical Framework, The CCM 
II. Literature Relevant to Research Questions, Underlying Concepts, and CCM Elements 
a. The Health System: Delivery System Design, Clinical Information Systems, and 
Decision Support 
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i. Delivery System Design 
ii. Clinical Information Systems 
iii. Decision Support 
iv. Literature Examining Delivery System Design, Clinical Information 
Systems, and Decision Support 
v. Summary 
b. The Community: Community Resources and Self-Management 
i. Community Resources 
ii. Self-Management Support 
iii. Summary 
c. Informed, Activated Patients: Patient Activation and Participation in Decision-
Making 
i. Patient Activation 
ii. Participation in Decision-Making 
iii. Summary 
d. Prepared, Proactive Practice Team: Facilitation of Patient Involvement in Care 
and Differences among Types of Practitioners 
i. Facilitation of Patient Involvement in Care 
1. Facilitation and Decision-Making Examined Together 
ii. Variations in Care Among Physicians and Nurse Practitioners 
iii. Summary 
e. Improved Outcomes: HbA1c Levels and Self-Care Behavior Practices 
i. HbA1c Levels 
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ii. Self-Care Behavior Practices 
1. Summary 
III. Summary 
Theoretical Framework 
The Chronic Care Model 
 The Chronic Care Model (CCM) defines a “chronic condition” as “any condition that 
requires ongoing adjustments by the affected person and interactions with the health care system 
(Robert Wood Johnson Foundation, 2016a).”  It is estimated that more than 145 million people, 
essentially half of all Americans, are dealing with a chronic condition (Robert Wood Johnson 
Foundation, 2016a) such as diabetes, requiring ongoing adjustments and interactions with the 
health care system.  
 The CCM was developed at the MacColl Center for Health Care Innovation at the Group 
Health Research Institute in the mid-1990s.  The CCM is recognizes the crucial elements of the 
health care system that encourage “high-quality chronic disease care (Robert Wood Johnson 
Foundation, 2016e).”  The elements include “the community, the health system, self-
management support, delivery system design, decision support, and clinical information systems 
(Robert Wood Johnson Foundation, 2016e).”  In 2003, the model was slightly revised and gained 
five additional themes.  These themes are “patient safety, cultural competency, care coordination, 
community policies, and case management (Robert Wood Johnson Foundation, 2016e).”  The 
model synthesizes self-management support, delivery system design, decision support, and 
clinical information systems with productive interactions between informed, activated patients, 
and prepared, proactive practice team members for improved patient outcomes.  The overall goal 
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of applying this model is to have healthier patients, more satisfied providers, and cost savings 
(Robert Wood Johnson Foundation, 2016e).   
 The CCM has been used in research studies, including studies that focused on the 
management of Type 2 diabetes.  A study evaluating use of the CCM in practices treating 
patients with Type 2 diabetes found that when the model was implemented as part of routine 
care, patients had significantly lower values for HbA1c levels and lipid ratios (Nutting et al., 
2007).  Another study also found that utilizing CCM based-care resulted in significantly 
improved HbA1c levels, non-HDL cholesterol levels, and rates of self-monitoring blood glucose 
levels (Piatt et al., 2006).  A third study evaluated 15,687 patient outcomes over the course of 
one year after implementing the CCM in primary care clinics (Siminerio et al., 2004).   
   Over the course of a year, 60% of patients achieved a HbA1c level of <7% and 81.1% of 
patients were less than 8% (Siminerio et al., 2004).  In a rural primary care setting, researchers 
found that after implementation of the CCM, patients had overall improvements in diabetes 
knowledge, patient empowerment, HbA1c levels, and HDL cholesterol levels (Siminerio, Piatt, 
& Zgibor, 2005).  Other studies also found positive outcomes with the implementation of the 
CCM related to the management of chronic obstructive pulmonary disease, depression, asthma, 
and congestive heart failure (RW.ERROR - Unable to find reference:898; Bodenheimer, 
Wagner, & Grumbach, 2002b; Pearson et al., 2005; Solberg et al., 2006; Wagner, Austin, Davis, 
Hindmarsh, & et al, 2001).   
 For the proposed study, the CCM provides a strong theoretical framework because of the 
overall focus on chronic disease management and specific elements of the model are either being 
examined or directly relate to the variables being examined.  The areas of the model that will be 
focused on are the health system, including delivery system design, health care practitioners 
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(NPs and physicians), decision support, and clinical information systems. Referral of community 
resources, especially those related to self-management support will also be examined.  Patient 
activation, participation in decision-making and taking part in self-care behaviors, along with 
practitioner facilitation of patient involvement are also important aspects of the CCM that will be 
evaluated in the proposed study.  The focus of this research study is to examine patient 
activation, facilitation of patient involvement by practitioners, patient participation in the 
decision-making process, and self-care behavior practices; along with decision support, clinical 
information systems, delivery system design, self-management support, and community 
resources related to the management of Type 2 diabetic patients.  The model elements serve as a 
foundation for this study.  
Figure 2. The Chronic Care Model Operationalized 
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Literature Relevant to Research Questions, Underlying Concepts, and Chronic Care Model 
Elements 
The Health System: Delivery System Design, Clinical Information Systems, and Decision 
Support 
Delivery system design refers to the structure of the medical practice, including defined 
roles for care team members, the use of electronic health records, and planned patient visits 
(Austin et al., 2000; Barr et al., 2003; Bodenheimer et al., 2002b; Boville et al., 2007).  Clinical 
information systems are computerized information systems, such as electronic health records, 
that have the ability to provide reminders for practitioners related to standardized care guidelines 
and performance quality indicators (Boville et al., 2007).  Decision support refers to the practice 
of sharing evidence-based guidelines and information with patients to encourage their 
participation in the decision-making process related to their treatment plans (Boville et al., 2007; 
Robert Wood Johnson Foundation, 2016c). These evidence-based guidelines can be integrated 
into daily practice through the reminders and alerts provided by the clinical information system 
(Boville et al., 2007).   
Delivery system design, clinical information systems, and decision support are an 
intertwined set of variables that are all individual elements of the CCM under the Health Systems 
umbrella, directly relating to the organization of health care for patients with chronic diseases 
(Robert Wood Johnson Foundation, 2016a).  These variables are practitioner centered, focusing 
on how care is delivered to the patients.  Characteristics of these variables include evidence-
based care, ensuring follow-up care, culturally appropriate care, sharing evidence-based 
guidelines and information to encourage patient participation in care, integrating specialist 
expertise in care, using appropriate decision support and reminder tools, facilitating individual 
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care planning, and sharing of information among patients and provider (Robert Wood Johnson 
Foundation, 2016b; Robert Wood Johnson Foundation, 2016c; Robert Wood Johnson 
Foundation, 2016d).   
 Delivery system design. Delivery system design is especially important for patients with 
Type 2 diabetes because these patients require continued management and occasional 
involvement from other practitioners or specialists. This does not simply refer to adding more 
tasks into an already busy system, rather streamlining processes and having defined roles for care 
team members to improve the delivery of care to patients (Austin et al., 2000; Barr et al., 2003).  
The use of decision support tools is an important part of delivery system design to improve self-
management support and provide appropriate follow-up care (Austin et al., 2000; Barr et al., 
2003; Bodenheimer et al., 2002b).  Having organized and well managed care is important to 
improve outcomes within this patient population (Dancer & Courtney, 2010).  Team-based care 
has been shown to improve outcomes of patients with diabetes, including a dietician and certified 
diabetes educator as part of the treatment plan (National Institutes of Health and the Centers for 
Disease Control and Prevention, 2011).   
Clinical information systems. A component of an organized delivery system design 
involves the use of clinical information systems.  The clinical information system should be a 
readily available database relating to each individual patient, such as an electronic health record.  
This type of database can remind practitioners to order specific tests or address specific issues 
for each patient, based on the information in their individual record. This type of system should 
also include performance summaries of various aspects of care, such as HbA1c levels over time 
(Glasgow et al., 2001).  Having an electronic based system can also provide easy access for other 
practitioners or specialists who are treating the patient to access information related to other 
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patient consultations or treatments that have been carried out by other members of the care team.  
This type of documentation and easily accessible electronic information is especially important 
in patients with Type 2 diabetes because of the complexity of care required (Dancer & Courtney, 
2010; Siminerio et al., 2004). 
The use of clinical information systems can prompt practitioners and support decisions 
related to planned, preventative care (Barr et al., 2003; Glasgow et al., 2001; Lewis & Dixon, 
2004).  Information within the systems should be regularly updated to provide the most current 
evidence-based recommendations which can directly contribute to the care provided for patients 
needing chronic management (Glasgow et al., 2001).  The use of status summaries, which are 
provided through the clinical information system showing a summary of the patient, including 
trends in lab values and current medication lists, are available and be extremely useful for 
tracking patient progress and preventative care they have received (Solberg et al., 1997).   
Decision support.  Decision support systems (DSS) are computer-based programs that 
can be used to support complex decision making and problem solving in healthcare and other 
disciplines (Shim et al., 2002). Decision support systems were developed in the early 1970s, 
based upon theoretical studies of organizational decision-making at the Carnegie Institute of 
Technology in the late 1950s and technical development at Massachusetts Institute of 
Technology during the 1960s (RW.ERROR - Unable to find reference:1047).  Typical DSS 
characteristics include database management with access to internal and external information, 
modeling functions, and interface designs to allow for queries, reporting, and graphing (Shim et 
al., 2002).   
Decision support systems and the use of evidence based guidelines can be tied to the use 
of electronic health records.  The use of clinical information systems and electronic decision 
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support tools has been shown to improve practitioner performance.  However, research related to 
patient outcomes and use of decision support systems has been insufficient and the data that has 
been analyzed has been inconsistent (Crosson et al., 2012; Frijling et al., 2002; Garg et al., 2005; 
Hunt et al., 1998; Jaspers et al., 2011; Keyhani et al., 2008; Lau et al., 2012; McCoy et al., 2012; 
O'Connor et al., 2011; Poon et al., 2010; Romano & Stafford, 2011; Smith et al., 2008). The 
proposed study will fill in the gap in the literature by examining the use of decision support 
systems in conjunction with other variables that directly relate to the care and management of 
patients with Type 2 diabetes in order to evaluate the impact of the decision support system when 
combined with other aspects of care delivery.   
Literature examining delivery system design, clinical information systems, and 
decision support.  A study tested the CCM components in a clinic treating patients with 
diabetes, using the outcomes of HbA1c levels and low-density lipoprotein (LDL) cholesterol.  
Three leaders from each clinic that participated in the study completed a survey assessing 
components of the CCM in their clinics. These survey scores were correlated with the outcome 
measures for the patients with diabetes.  Delivery system design scores were positively 
correlated with improvements in HbA1c levels and LCL cholesterol test rates at the clinics (r = 
0.49-0.57, p < .05).  Self-management support and clinical information systems were associated 
with outcomes but were not found to be statistically significant (Sperl-Hillen et al., 2004).   
A study by Poon (2010) examined the relationship between the use of electronic health records 
(EHR) and quality of care.  Using a statewide survey of physicians in Massachusetts, questions 
were asked regarding practice organizations, populations served, physician demographics, and 
use of EHR features including laboratory test results, radiology test results, laboratory order 
entry, radiology order entry, electronic visit notes, reminders for care activities, electronic 
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problem list, electronic medication lists, and electronic prescription transmission.  Of the 507 
respondents, only 144 (28.4%) used an EHR.  Examining the overall quality of care when using 
an EHR, improvements in quality of care were found related to women’s health (p = .18), 
depression, (p = .34), colon cancer screening (p = .09), cancer prevention (p = .08), and well 
child care (p = .78). In areas of diabetes (p = .47) and asthma (p = .85), physicians who were not 
using an EHR, had higher quality scores than those using the EHR.  These overall results among 
medical subpopulations did not yield any significant relationships among quality of care and use 
of the EHR; however, further research is necessary to clarify the relationship between EHRs and 
outcomes for patients with Type 2 diabetes (Poon et al., 2010).     
A systematic review of the impact of electronic health records (EHR) in Canada 
examined the impact on prescribing support, disease management, clinical documentation, work 
practice, preventative care, and patient-physician interaction.  Forty-three studies were selected 
for this review; 27 were published between 2005 and 2009.  Overall, 22 of the 43 studies showed 
positive impacts on patient care. The greatest improvements were noted related to preventative 
care (66.7%), work practice (64.3%), disease management (57.1%), and productivity (63.6%). 
Clinical documentation (16.7%) and user satisfaction (18.2%) had the least improvement (Lau et 
al., 2012).   
Keyhani and colleagues (2008) used previously collected data from National Ambulatory 
Medical Care Survey (NAMCS, 2005) and the National Hospital Ambulatory Medical Care 
Survey (NHAMCS, 2005) to examine the use of an EHR on blood pressure control and receipt of 
appropriate therapy for chronic conditions.  The authors found no significant effects of using an 
EHR and appropriate therapy for chronic conditions, except in the case of inhaled steroids for 
asthma therapy (adjusted OR 2.86%, 95% CI, 1.12-7.32).  There were no significant effects of 
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using an EHR for blood pressure control except for the use of angiotensin converting enzyme 
inhibitors or angiotensin receptor blockers in patients with diabetes and hypertension (OR 2.58, 
95% CI, 1.22-5.42 (Keyhani et al., 2008). This study also reflects the need for further research 
related to patient outcomes and the use of EHRs, along with evaluation of the CCM, as the 
results of this particular study directly contrast the premise of the model.  
A different study analyzed survey data related to the use of electronic health records 
(EHR) and clinical decision support systems (CDSS) using a more recent set of data from the 
National Ambulatory Medical Care Survey (NAMCS, 2005-2007) and the National Hospital 
Ambulatory Medical Care Survey (NHAMCS, 2005-2007). Information from 243,478 different 
patient visits was evaluated for 20 different quality indicators.  Among all indicators, only diet 
counseling in high-risk adults showed statistically significant results related to the incorporation 
of this practice when using an EHR or CDSS (28% vs. 20%, adjusted OR 1.65, 95% CI, 1.21-
2.26; p = .002). There were no significant improvements among the remaining 19 indicators 
based on the use of an EHR or CDSS, compared to those not using these types of electronic 
systems (Romano & Stafford, 2011).   
 Garg and colleagues (2005)  performed a review of one hundred studies related to clinical 
decision support systems (CDSS) to identify characteristics of various CDSS that predicted 
benefits.  In 97 of the studies assessing practitioner performance, 62 studies (64%) showed 
positive improvements related to the use of diagnostic systems, reminder systems, disease 
management systems, and drug dosage/prescription systems. The improvements in practitioner 
performance were also associated with CDSSs that provided automatic prompts rather than 
requiring users to activate system prompts on their own.  A 73% improvement in practitioner 
performance was found when the CDSSs had automatic prompts compared to only 47% 
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improvement when the CDSSs required  users to activate systems prompts (p = .02).  Patient 
outcomes were assessed in 52 of the 100 studies, however only 7 (13%) of these studies reported 
improvements related to patient specific outcomes, none of which were related to the 
management of Type 2 diabetes (Garg et al., 2005). This further enforces the need for research 
related to outcomes that relate directly to the patient population that is targeted in this proposed 
study.   
 A more focused study on decision support systems and care of patients with diabetes 
examined a telemedicine intervention for improving care within the context of the CCM (Smith 
et al., 2008).  A group of 97 primary care physicians and 639 patients participated in an 
interventional study using an author-designed, disease-specific, web-form recommendation for 
each patient encounter.  The physicians reported using 49% of the generated summaries they 
received via email. There were no significant effects found for the intervention group related to 
the process of diabetes care (p = .41), HbA1c levels (p = .95), low density lipoprotein cholesterol 
(p = .19), blood pressure levels (systolic, p =.15; diastolic, p = .85) or the estimated 10-year risk 
of coronary artery disease (p = .93), nor were there any significant cost differences among the 
intervention and control group (p = .02) (Smith et al., 2008).   
  Another literature review was synthesized to evaluate the impact of CDSS on 
practitioner performance and patient outcomes.  A total of 17 systematic reviews (SR) were 
included in this analysis, all published between 1994 and 2009.  Twelve of the 17 SRs found 
strong evidence that CDSS significantly impact practitioner performance, mainly noting benefits 
of reminder systems for preventative care.  Sixteen of the 17 SRs examined the use of CDSS and 
patient outcomes. Three of the 16 SRs found strong evidence of positive impacts on patient 
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outcomes related to appropriate drug dosing and preventative care reminders (Jaspers et al., 
2011).   
 A study that included 11 clinics, 41 primary care physicians, and 2,556 patients with 
diabetes focused on the impact of an EHR based decision support system (DSS) called the 
Diabetes Wizard on HbA1c levels, blood pressure, and low-density lipoprotein (LDL) 
cholesterol levels.  This program generated recommendations based on algorithms and 
recommendations based on individual patient data related to specific changes in medication, 
changes in treatment for patients with contraindications to current treatment, overdue laboratory 
tests, and changes in follow-up intervals based on the patient’s current state of diabetes control.  
Patients in the intervention group had significantly greater improvements in HbA1c levels 
(intervention effect -.26%, 95% CI, -.06% to -.47, p = .01).  There were no significant impacts on 
blood pressure (SPB <130mm Hg, intervention effect 5.1%, p = .03; DBP <80mm Hg, 
intervention effect = 3.9%, p = .07) or LDL cholesterol levels (mean LDL levels, intervention 
effect 1.37%, p = .62) (O'Connor et al., 2011). 
 Other authors analyzed data from 16 EHR-using facilities and 26 non-EHR-using 
facilities to assess quality of diabetes care.  The use of the EHR was not associated with better 
adherence to guidelines or more rapid improvement in adherence. Facilities not using an EHR 
were more likely to meet the targeted outcomes for HbA1c levels, LDL cholesterol, and blood 
pressure at the 2-year follow up assessment (OR = 1.76, 95% CI, 1.12-2.51) (Crosson et al., 
2012). While this study shows that targets were more likely to be met when not using an EHR, 
research will need to continue and build upon the previous study with the increasing use of 
EHRs. The proposed study will continue to examine the use of EHRs from a different 
perspective to include use of reminders related to patient outcomes.   
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 Summary.  There is an abundance of literature relating to delivery system design, 
clinical information systems, and decision support. The proposed study will examine how these 
variables impact care provided to patients with Type 2 diabetes and if they have an impact on the 
specific patient outcomes of HbA1c levels and self-care behaviors practices. Patients with Type 
2 diabetes may see a variety of practitioners for various aspects of care; and use of CISs and/or 
DSSs by their primary care practitioner may impact the quality of care for patients related to 
control of their blood sugars.  Examining how care is delivered using aspects of a CIS and/or 
DSS will give insight into whether these techniques of care are beneficial in helping this patient 
population manage their disease.   
The Community: Community Resources and Self-Management Support 
Community resources.  Effective management of chronic diseases, like Type 2 diabetes, 
requires that the delivery system design also be linked to community resources.  Awareness of 
cultural and ethnic backgrounds of patients and their ties to the community can be useful in 
determining potential community resources that can be helpful to patients. There may be disease-
specific support groups within neighborhoods that may be more appropriate for patients, as they 
can be engaged in their community and a setting in which they are comfortable (Austin et al., 
2000).  The success of delivery system designs can be improved by establishing links to the 
community resources to support patients in their self-management endeavors.  Resources 
relevant to diabetes management such as peer groups, exercise classes, or home nursing care 
within local communities can be valuable to patients, especially those who have limited access to 
transportation and vulnerable populations such as the elderly, children, low-income, and 
underserved areas (Glasgow et al., 2001).   
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Literature related to preventative services has identified the importance of community 
resources to promote, support, and maintain healthy behaviors (Curry & McBride, 1994; Irvin, 
Bowers, Dunn, & Wang, 1999; Starfield, Power, & Weiner, 1994).  Community services are 
available in a variety of forms including mobile screening vans, voluntary agencies, community 
centers, and senior centers (Glasgow et al., 2001).  Practitioner awareness of and referral of 
patients to appropriate community resources or other care team members can help to increase the 
patient’s success at self-management of Type 2 diabetes (Barr et al., 2003). 
 Appropriate follow-up care is not only part of delivery system design, but also part 
community resources within the CCM (Glasgow et al., 2001; Lewis & Dixon, 2004).  
Appropriate care that is formulated within the ideals of delivery system design needs to use the 
appropriate community resources to be successful (Austin et al., 2000; Lewis & Dixon, 2004).  
Utilizing not only other care team members such as certified diabetes educators, dieticians, 
and/or  medical specialists such as an endocrinologist, but also using resources within the 
community such as support groups, community exercise programs, and mobile health clinics are 
vital at promoting independence and successful outcomes for patients with Type 2 diabetes (Barr 
et al., 2003; Glasgow et al., 2001; Lewis & Dixon, 2004).  
Examining the referral to and use of community resources for patients with Type 2 
diabetes is an important variable related to the management and support for patients with Type 2 
diabetes. Community resources can be invaluable to patients, especially those with transportation 
difficulties. Becoming aware of how community resources are referred and utilized will help 
with the future development of diabetes treatment standards.  Ensuring that these available 
community resources are utilized will benefit patients by allowing them to work within their own 
communities to manage Type 2 diabetes.   
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Self-management support.  The CCM is different than traditional models and 
approaches to management of chronic diseases because self-management training and counseling 
are a focus (Siminerio et al., 2004).  Benefits related to Diabetes Self-Management Education 
have been recognized by the American Diabetes Association and are considered an integral piece 
of diabetes care to strength the ability of patients to self-manage (Siminerio et al., 2006; 
Siminerio et al., 2004; Wagner, 1998).  Self-management is considered to be a primary goal of 
diabetes education interventions because the cost and complications associated with diabetes are 
often preventable when blood sugar levels are well controlled (Stuckey et al., 2009).  Self-
management support prepares patients to take an active role in the management of Type 2 
diabetes (Glasgow et al., 2001).  Successful self-management and education programs help the 
patient to better understand the goals, priorities, barriers, and potential problems that can arise 
when dealing with Type 2 diabetes (Glasgow & Anderson, 1999; Glasgow et al., 2001; Von 
Korff & Gruman, 1997).  The use of patient education brochures, referrals to other care team 
members, phone support hotlines, group and/or one-on-one counseling, and referrals to diabetes 
education classes can all aid in increasing self-management support for patients with Type 2 
diabetes (RW.ERROR - Unable to find reference:1044; Solberg et al., 2006). 
According to the National Standards for Diabetes Self-Management Education (Funnell 
et al., 2009), patients should have a personalized follow-up plan that should be developed by the 
patient and educator.  Patient outcomes and goals of treatment, as well as a plan for ongoing self-
management support, should be communicated to the primary care provider. In addition to a 
diabetes educator, patients may benefit from working with a nurse case manager for self-
management support. The case manager can provide patient reminders for follow-up care, 
needed tests, answering medication questions, providing supplemental education, working with 
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the patient to modify behaviors and set goals, providing psychosocial support, and supplying the 
patient with information about beneficial community recourses (Funnell et al., 2009).   
Another study among 463 adults with Type 2 diabetes and elevated BMI examined 
psychosocial and social-environmental variables that impact diabetes self-management and 
diabetes control. Participants completed self-report surveys, a baseline consultation, along with 
blood work for HbA1c (HbA1c) levels and lipid profiles.  The findings indicated that self-
efficacy, problem solving, and social-environmental support were independently associated with 
diet and exercise habits. Improvements in lipid levels and HbA1c levels were contributed to 
medication adherence (p = .001, p < .0001, respectively), while healthy eating (p = .0003), and 
exercise habits (p = .0004) were directly related to BMI. The authors concluded that self-
management support interventions should be aimed at promoting self-efficacy, problem solving, 
and social-environment support to improve outcomes in patients with Type 2 diabetes (King et 
al., 2010a).   
Summary.  Self-management support is a key element of the CCM (Robert Wood 
Johnson Foundation, 2016e), yet there is little literature available directly examining different 
strategies for self-management support and the impact of self-management support on patients 
with Type 2 diabetes.  The proposed study will have a unique perspective on self-management 
support by examining referrals for patients to other practitioners or programs and the patients’ 
perspectives related to self-management support. Examining this variable from both perspectives 
will give insight to the most beneficial ways of providing patients with this necessary support.   
Informed, Activated Patients: Patient Activation and Participation in Decision-Making 
Patient activation.  Patient activation can be defined as “developing experience with 
question formulation and building information-seeking skills that results in increased 
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collaboration with the health care provider (Alegria et al., 2008, p. 247).”  Hibbard, Stockard, 
Mahoney, and Tusler (2004) described the process for conceptualizing and operationalizing what 
it means for a patient to be “activated,” and found that this process involves four stages.  The 
four stages of activation include “believing the patient role is important, having the confidence 
and knowledge necessary to take action, actually taking action to maintain and improve one’s 
health, and staying the course, even under stress (Hibbard et al., 2004, p. 1016).”  Research has 
found that patients who are more engaged, informed, activated, and confident are more likely to 
perform self-care behaviors to promote their health (Lorig et al., 1999; Mosen et al., 2007; 
Remmers et al., 2009; Von Korff & Gruman, 1997).  Patients who are found to have higher 
levels of activation also have better outcomes related to quality of life, physical and mental 
function, maintaining an exercise regimen, regularly checking glucose levels, and maintaining an 
appropriate blood pressure level (Hibbard et al., 2004; Hibbard, Mahoney, Stock, & Tusler, 
2007; Mosen et al., 2007).   
 The role of trust in the patient-physician relationship was examined related to levels of 
patient activation.  Data were collected by surveying 2224 participants from different patient 
populations including those with diabetes, those with elevated lipids but without coronary artery 
disease, and a group of low risk patients.  The researchers found a positive association between 
patient-physician trust and patient activation (β = 0.235, p < 0.05) (Becker & Roblin, 2008).     
 Whether patient activation is a changeable personal characteristic and whether changes in 
the level of patient activation correlate with changes in health behavior were examined in a study 
with 479 participants who were divided into intervention and control groups. Survey data were 
collected at the initiation of the study, then again at six weeks and six months. The intervention 
group participated in a weekly discussion workshop comprised of patients with various chronic 
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diseases. The survey data collected was related to self-management behaviors, disease specific 
self-management behaviors (hypertension, diabetes, and arthritis), depression, the health related 
quality of life (HRQoL) measure, the PAM, and the Short Marlowe-Crowne Social Desirability 
Scale.  The data from the intervention group was nearly equal to the control group with results 
showing that patients who were able to increase their activation level were also more likely to 
increase self-management behaviors, such as taking medications as directed, checking glucose 
levels as directed, checking feet for cracks or blisters, reading food labels, and reading about side 
effects related to medications (Hibbard et al., 2007).    
 A different study was conducted to examine whether a patient activation intervention 
resulted in patients becoming more active during consultations with practitioners and improved 
HbA1c levels in patients with Type 2 diabetes over a one year period.  The 197 participants were 
divided into the activation intervention (generating 3-5 care-related questions to ask the 
practitioner) educational intervention groups. Raters reviewed the audiotaped consultations to 
assess patients’ active involvement by using the Active Involvement Scale (AIS), a 7-point 
Likert-type scale ranging from 1(not true at all) to 7 (very true).  The results of the study showed 
that prior to the intervention, rated active involvement was significantly correlated with rated 
active involvement after the intervention (r = .66, p < .001). Rated active involvement was 
significantly correlated with the number of questions asked (r = .39. p <.001, n = 151) and with 
percentage of time speaking (r = .67, p < .001, n = 151). There was a significant effect for 
increasing rated active involvement (β = .65, F (1,148) = 110.48, p < .01) and a significant effect 
for the activation intervention compared to the passive education (β = .13, F (1,148) = 4.54, p < 
.05).  There was also a significant effect for patients in the activation group asking more 
questions (β = .32, F (1,122) = 23.53, p < .01) and speaking a greater percentage of time (β = .18, 
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F (1,122) = 6.80, p < .01) than the patients in the passive education group. The findings did 
indicate that, among the total participants, patients with higher rated activation had greater 
decreases in HbA1c values over the 12 month period (β = -.21, F (1,148), p < .01). Important 
findings in this study noted that patient activation did increase rated active involvement in 
consultations and greater active involvement predicted improvements in HbA1c values 
(Williams et al., 2005).    
In a different study, Patient Activation Measure (PAM) scores were correlated with self-
management behaviors, attitudes, and knowledge related to diabetes in a predominately minority 
and underinsured population of 287 participants.  Remarkably, the majority of patients (62.2%) 
scored in the highest level of activation, which was much higher than previous studies using the 
PAM.  Previous studies found that only 14% to 22% of participants typically have scores in the 
highest level (Ellins & Coulter, 2005; Greene, Hibbard, & Tusler, 2005; Hibbard, Mahoney, 
Stockard, & Tusler, 2005; Rask et al., 2009).  The results also showed that patients with higher 
PAM scores were more likely to perform feet checks (p = .009), receive eye care (p = .009), 
exercise regularly (p = .021), and have overall less difficulty managing diabetes (p = .001).  
However, there was not a correlation between higher PAM scores and HbA1c knowledge (Rask 
et al., 2009).     
 A study by Mosen and colleagues (2007) examined PAM scores in adults with chronic 
conditions.  A total of 6673 patients, including those with asthma, diabetes, heart failure, coronary 
artery disease, chronic pain, and a group that had both coronary artery disease and diabetes, 
responded to the surveys. The results showed that patients with higher PAM scores were 
significantly more likely to perform self-management behaviors, adhere to medications, use 
appropriate self-management service, report higher patient satisfaction scores and higher quality 
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of life scores, and also had higher physical and mental function scores compared to participants 
with lower PAM scores (Mosen et al., 2007).   
 A retrospective study used secondary data to examine the relationship between PAM scores 
and future diabetes related health outcomes.  The PAM scores were predictive for HbA1c testing 
(p < .008), low density lipoprotein cholesterol testing (p < .005), and HbA1c control (p < .01).  
Higher PAM scores were found to have a positive association to an increased likelihood that 
patients had HbA1c and low density lipoprotein cholesterol testing and better control of their blood 
sugars, as evidenced by HbA1c results.  The PAM scores were not found to have a significant 
relationship with lipid lowering drug use and low-density lipoprotein cholesterol control 
(Remmers et al., 2009). 
 A more current study examined the levels of patient activation and relationships with 
physicians in chronically ill patients (Alexander, Hearld, Mittler, & Harvey, 2012).  A cross-
sectional, multivariate analysis was performed from data collected through 8,140 digital surveys 
of chronically ill patients, relating to experiences with their physicians, accessibility and use of 
health information about physicians, demographic information, socioeconomic status, health 
status, and health service utilization. The Patient Activation Measure and the Patient-Physician 
Relationship Scales were used in data collection.  Results of the analysis found that patients who 
reported higher quality interpersonal exchanges with their physicians (β = 9.81, p < .001), 
reported that their physicians treated them more fairly and respectfully (β = 5.55, p < .001), and 
had frequent communication by physicians outside of office visits (β = 4.13, p < .001) had higher 
levels of patient activation.  Treatment goal setting related to patient activation levels was not 
found to be statistically significant (β = .91, p < .10) (Alexander et al., 2012).   
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 African Americans (β = -2.38, p < .001) and Hispanic patients (β = -.43, p < .001) were 
found to have significantly lower patient activation levels in general compared to Caucasians.  
Those who had English as a second language were significantly more likely to have lower 
patient activation levels than those who spoke English as a first language (β = -2.54, p < .001). 
Those who were employed (β = 3.11, p < .001) and those with an income level greater than 
$75,000/year (β = 2.22, p < .001) had higher levels of patient activation than those who were 
unemployed or had an income less than $25,000/year. Patient activation was found to increase as 
a patient gets older, but began to decline after the age of 53.  The health status control variables 
of self-assessed health status (β = 1.75, p < .001) and number of chronic conditions (β = 1.68, p < 
.001) were positively associated with patient activation levels.  There was an negative 
association between patients with a regular physician and patient activation (β = -2.71, p < .001), 
meaning that those patients who regularly saw one physician had higher levels of patient 
activation (Alexander et al., 2012).   
The studies presented related to patient activation examine a variety of variables in 
various combinations related to patient activation. Studies have demonstrated the potential 
connection of patient activation to improved self-management of Type 2 diabetes (Hibbard & 
Tusler, 2007; Mosen et al., 2007; Remmers et al., 2009; Rost, Flavin, Cole, & McGill, 
1991)however examining patient activation in conjunction with the other facets that are involved 
in the management of Type 2 diabetes is lacking.  The data related to activation levels and/or 
PAM scores and HbA1c levels is inconsistent among the literature (Alexander et al., 2012; 
Mosen et al., 2007; Rask et al., 2009; Remmers et al., 2009; Rost et al., 1991; Williams et al., 
2005).  Examining patient activation in conjunction with the other variables presented in this 
study will provide a more comprehensive picture of how patient activation benefits patients with 
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Type 2 diabetes related to the multi-faceted, overall management that is required with this type 
of disease; as well as further clarify the relationship between activation and HbA1c levels.   
Participation in decision-making.  Cahill (RW.ERROR - Unable to find reference:252) 
referred to the term “patient participation” as “over-used and ambiguous” (p. 561) in an in-depth 
concept analysis.  The term “patient participation” is currently a commonly used phrase that is 
employed when discussing decision-making, dignity, and quality of life (RW.ERROR - Unable 
to find reference:252).  The early conceptualization of a shared decision-making relationship 
between the patient and practitioner was identified by Szasz and Hollender (RW.ERROR - 
Unable to find reference:794).  The initial framework from which the patient/practitioner shared 
decision-making process stemmed was developed by Arnstein (RW.ERROR - Unable to find 
reference:795) in her framework related to American citizen participation and citizen power.  
Arnstein discussed the difference between the ritual of participating and the act of participating 
that resulted in change or affected the outcome of a process related to citizen’s participating in 
government.  Arnstein’s definitions and ladder of participation have been used throughout other 
areas to describe and define participation in other activities or situations.  In the 1970s there was 
pressure to promote patient participation related to the belief that patients had a right and 
responsibility to be involved in their health care, which was endorsed and supported by the 
World Health Organization (WHO) (RW.ERROR - Unable to find reference:792).  
 Patient participation not only encompasses the decision-making process,  it extends into 
all aspects of care including, compliance of treatment plans, self-medication, medication 
adherence, patient education, information sharing, and taking part in physical care (RW.ERROR 
- Unable to find reference:801; RW.ERROR - Unable to find reference:285; RW.ERROR - 
Unable to find reference:804; RW.ERROR - Unable to find reference:321; RW.ERROR - 
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Unable to find reference:802; Golin et al., 1996; Wolpert & Anderson, 2001).  McEwen et al. 
(RW.ERROR - Unable to find reference:791) assert that patient participation has many benefits, 
including increased patient responsibility with a commitment to health and health promoting 
behaviors.  Other authors report that increased patient participation enables more effective self-
management of diseases (RW.ERROR - Unable to find reference:796; RW.ERROR - Unable to 
find reference:285; Golin et al., 1996; Heisler et al., 2002).  Patient participation in the decision-
making process is vital to promoting and encouraging self-management of diseases, especially 
among patients who require a significant amount of disease self-management, as is the case with 
Type 2 diabetes.  Because of the increased incidence and prevalence of Type 2 diabetes, it is 
important that practitioners learn how to engage and educate patients to make informed decisions 
about treatment plans and disease management, giving patients the best chance to manage their 
diabetes and improve their quality of life. 
 Charles, Gafni, and Whelan (RW.ERROR - Unable to find reference:379) acknowledge 
that the concept of shared decision-making between physicians and patients has been 
increasingly advocated as the idyllic model of treatment.  The authors further discuss the 
meaning of shared decision-making, recognizing that even when using the paternalistic model, in 
which the patient passively agrees to the physician’s treatment of choice, there is still a required 
type of partnership between the patient and physician (RW.ERROR - Unable to find 
reference:379).  The shared decision-making model requires that the patient and physician share 
all stages of the decision-making process, meaning that both the patient and physician have 
treatment options in mind and both decide on a final action together (RW.ERROR - Unable to 
find reference:379).    
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 Patient participation in the decision-making process is consistently missing in regards to 
medical decisions, thus increasing the potential for noncompliance with diabetes treatment plans 
(RW.ERROR - Unable to find reference:285).  A study by Golin et al. (1996) examining if 
patients wanted to be involved in the decision making process found that 71.9% of patients 
wanted the doctor and patient to make decisions together, equally.  Including the patient in the 
decision-making process can decrease the perceived burden of treatment and increase adherence 
to treatment plans (Vijan, Hayward, Ronis, & Hofer, 2005).  An example would be discussing 
the transition of a patient from oral medications to insulin injections.   Discussing this transition 
in a manner than allows the patient to voice concerns, while also allowing the practitioner to 
provide information to minimize fears can be helpful.   Practitioners can present the transition to 
insulin injections in a less “threating manner”, such as a trying insulin as a “temporary trial” 
(Vijan et al., 2005, p. 481).      
 A diabetes-specific scale to assess the patient’s desire to participate in the medical 
decision making process (DPMD) was developed and tested for internal consistency reliability, 
stability, and validity among 65 patients with Type 2 diabetes.  The tool had high internal 
consistency reliability (Cronbach’s alpha = .90, r = 0.71) and demonstrated good validity 
(Pearson r = 0.23, p =.07).  The results of the initial testing of this tool found that patients who 
received diabetes education by attending a group education session with a diabetes educator had 
a greater desire to participate in the medical decision making process than those without 
education (Golin et al., 2001).   
 In a survey of 2,000 patients, individuals were asked to evaluate physicians’ participatory 
decision-making style, rate the physicians’ communication styles, and report understanding of 
the effects of self-care on self-management of the diabetes.  Higher ratings on provider 
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participatory decision-making style and provider communication were associated with higher 
patient self-management assessments (p < .01 in all models).  Thus, the authors concluded that 
participatory decision-making and provider communication were likely to enhance self-
management by increasing patient understanding and self-confidence (Heisler et al., 2002). 
 Summary.  Patient participation in the decision-making process is discussed in the 
literature in a variety of ways.  There are varying data related to the amount of participation that 
a patient desires and what the ultimate effects of the levels of participation have on patient 
outcomes.  Literature has demonstrated a desire among patients to participate in the decision-
making process related to medical decisions regarding treatment (RW.ERROR - Unable to find 
reference:381; Golin et al., 2001).  It has also been determined that increased patient 
participation in the decision-making process can have positive effects related to a patient’s 
ability to self-manage a disease (RW.ERROR - Unable to find reference:324).  Research is 
lacking which examines levels of patient participation related to patient outcomes, specifically in 
patients with Type 2 diabetes and there is also a lack in research related to patient participation in 
decision-making related to the type of practitioner that patients see. Examining patient 
participation in decision-making with a specific outcome, such as a HbA1c level, can provide a 
unique insight into the importance of patient participation in the decision-making process for the 
treatment and management of Type 2 diabetes.  Also examining which practitioners have higher 
levels of patient participation in decision-making and better patient outcomes can impact which 
type of practitioner a patient may choose see.  
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Prepared, Proactive Practice Team: Facilitation of Patient Involvement in Care and 
Differences among Types of Practitioners 
Facilitation of patient involvement in care.  Facilitating patient involvement in care 
requires that there is open communication between the practitioner and the patient, that the 
practitioner provides information to the patient, and that the practitioner allows the patient to 
express his or her concerns, views, and opinions related to treatment (Martin et al., 2001).  
Research has shown that when patients recognize that their health care provider has facilitated 
their involvement in care, patients in a variety of settings tend to be more satisfied with care and 
better adhere to treatment plans related to the specific diseases or health concerns for which they 
are being treated (Martin et al., 2001).  Health care practitioners can actively facilitate, or 
encourage, patients to be involved in their own healthcare by using behaviors such as  suggesting 
the patient ask questions, listening to the patient’s concerns, and providing as much information 
as possible to the patient (Martin et al., 2001).  Health care practitioners can also facilitate the 
patient’s involvement in decision making by offering the patient choices among treatment 
options; and, by facilitating the patient’s involvement in care, the patients can then maintain a 
sense of control related to disease management and have a sense of responsibility to care for 
oneself (RW.ERROR - Unable to find reference:368).   
  In addition to the benefits already noted, facilitation of involvement in care has been 
related to higher levels of trust in the practitioner and self-efficacy, measured in this particular 
study using Wake Forest Physician Trust Scale (WFPTS) and the Diabetes Management Self-
efficacy scale (DMSES) (RW.ERROR - Unable to find reference:869).  A cross-section study 
examined 268 patients and the relationship between literacy, trust, self-efficacy, and participation 
in medical decision-making in patients with Type 2 diabetes.  Literacy levels were assessed 
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using the Rapid Estimate of Adult Literacy in Medicine (REALM); and the Spoken Knowledge 
in Low Literacy in Diabetes Scale (SKILLD) was used to assess diabetes knowledge which does 
not require a certain level of literacy to be used accurately.  There was no relationship found 
between literacy and trust, self-efficacy, or facilitation of patient involvement. Self-efficacy (p < 
.001, p < .001), trust in the practitioner (p < .003, p < .02), and facilitation of patient involvement 
in care (p < .003, p < .008) were related to diabetes-specific mental and social quality of life 
outcomes and facilitation of patient involvement in care was strongly related to self-efficacy (p < 
.001) and trust (p < .001) (RW.ERROR - Unable to find reference:869).    
 Gotler and colleagues (RW.ERROR - Unable to find reference:868) examined the 
prevalence of physician facilitation of patient involvement in decision-making (PDM facilitation) 
by observing 3,435 patient consultations with family physicians in a community practice.  
Research nurses directly observed the consultations assessing for physician facilitation of patient 
involvement, using a measure of 20 physician practice style behaviors that been tested and 
showed good interrater reliability and time use during the consultation.  At the conclusion of 
each visit, the nurse completed a post observation checklist, measuring specific visit 
characteristics.  The results indicated that PDM facilitation occurred in 25% of the observed 
consultations.  Rates of PDM facilitation varied considerably among individual physicians, 
ranging from 0% to 79%.  The results also showed that patient satisfaction was not associated 
with PDM facilitation in this particular study (RW.ERROR - Unable to find reference:868). 
 A study examined physician facilitation of patient involvement in care and physician 
behaviors related to the patient’s perception that the physician encouraged and facilitated their 
involvement in care (N=128).  The results showed that there was congruence among the patient 
perceptions and observer perceptions related to the physician facilitation of patient involvement 
 51 
 
in care (r =.238, p < .01).  The behavior most closely associated with the patient’s perception of 
the physician’s facilitation of involvement in care was asking open-ended questions (β = .49, p < 
.001).  Consistently responding to patient questions (β = .22, p < .01) and offering fewer, not 
more, alternatives for treatment options (β = .21, p < .01) were also associated with higher 
perceptions related to facilitation of patient involvement (Martin, Jahng, Golin, & DiMatteo, 
2003).   
 Facilitation of patient involvement in care has been examined in a variety of areas, 
including patients with Type 2 diabetes. However, by moving beyond the initial 
acknowledgement of whether or not practitioners facilitate care and by incorporating other 
factors such as the level of patient activation and participation in decision-making, a more 
complete picture can be drawn related to facilitation of patient involvement in care and how 
other variables can change based on practitioner facilitation.  Examining only whether 
practitioner-facilitated involvement in care effects outcomes is not encompassing of the 
multifarious process involved in the management of Type 2 diabetes. There is also a significant 
gap in the literature related to facilitation of patient involvement in care and the effect it has on 
HbA1c levels and self-care behaviors.  This proposed study will explore the effect of facilitation 
of involvement, participation in decision-making, and patient activation on participation in self-
care behaviors and HbA1c values to examine a complete picture of Type 2 diabetes care and 
management, in addition to also examining the differences in facilitation of patient involvement 
in care among physicians and nurse practitioners. This proposed study will also begin to fill the 
gap related to facilitation of patient involvement in care and diabetes specific outcomes, such as 
HbA1c levels and self-care behavior practices.    
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 Facilitation and decision-making examined together. Facilitation of patient involvement 
in care and patient involvement in decision-making overlap in many studies (RW.ERROR - 
Unable to find reference:868; RW.ERROR - Unable to find reference:946; Martin et al., 2003).  
Participation in decision-making is often considered to be part of the concept of facilitation of 
patient involvement in care.  Facilitation of involvement can take place in a variety of ways.  
Greenfield, Kaplan, and Ware (RW.ERROR - Unable to find reference:946) acknowledge that 
there are two main lines of research related to facilitation of patient involvement in care.  The 
first focuses on the patient’s willingness and ability to participate in medical decision-making.  
The second line focuses on physician-patient interactions related to outcomes such as 
satisfaction, knowledge, and compliance.  After completing the study related to facilitating 
involvement in care by coaching patients to ask questions and negotiate medical decisions with 
their practitioners, the authors suggest that further research should continue to examine how both 
lines of research affect each other and patient outcomes (RW.ERROR - Unable to find 
reference:946).  The proposed study will examine both the amount of patient participation in the 
decision-making process and the practitioner’s facilitation of patient involvement in care.  
Examining this relationship among Type 2 diabetic patients will help close the gap in the 
literature related to these variables.   
Variations in care among physicians and nurse practitioners.  The advanced practice 
role of nurse practitioners (NPs) began in 1956 (Mundinger, 2002).  In order to provide primary 
care to homebound patients, the nurse practitioner program was designed by Lee Ford, who was 
a nurse with a doctoral degree, and a physician named Henry Silver (Mundinger, 2002).  
Mundinger (2002) described nurse practitioner care, saying that nurse practitioners approach care 
in a unique fashion. Characteristics of a patient they treat include one who is more informed 
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about care, more empowered with self-care, and more confident that all health issues are being 
addressed regularly.  This type of approach is called “differentiated practice (Mundinger, 2002, 
p. 799).”  While many physicians approach patient care in a comprehensive fashion, according to 
Mundinger (2002), nurse practitioners are the only clinicians trained specifically in this manner.   
The nurse practitioner has a crucial role in the care of patients with chronic diseases (Dancer & 
Courtney, 2010).  As the role of the NP continues to expand with increased autonomy, 
reimbursements rates for NPs have increased, and the overhead costs for employing NPs are 
lower than employing physicians, NPs are in a unique position to increase their presence in 
managing care for patients with chronic illness, including Type 2 diabetes (Boville et al., 2007; 
Mundinger et al., 2000; Mundinger, 2002).   
 Varied data exist related to satisfaction and patient outcomes of NPs and physicians.  
While there tends to be a general consensus that patients are more satisfied with care provided by 
NPs, data related to patient outcomes tends to be more inconsistent (Chang et al., 2007; Fain & 
Melkus, 1994; Kinnersley, Anderson, Parry, Clement, & et al, 2000; Roblin et al., 2004; Rudy, 
Davidson, Daly, Clochesy, & et al, 1998; Salisbury & Tettersell, 1998; ter Bogt et al., 2011; 
Venning, Durie, Roland, Roberts, & Leese, 2000).  One study discovered that in patients with 
Type 2 diabetes, physician care was preferred over NP care and a few other studies found patient 
satisfaction and/or patient outcomes in NP groups to be very similar to those seeing physicians 
(Horrocks et al., 2002; Lenz, Mundinger, Hopkins, Lin, & Smolowitz, 2002; Mundinger et al., 
2000; Roblin et al., 2004; Rudy et al., 1998; Salisbury & Tettersell, 1998; ter Bogt et al., 2011; 
Venning et al., 2000).  There is data to show that nurses and NPs can improve patient outcomes 
through various interventions and programs in conjunction with physicians in patients with 
diabetes, however little data exists to show a significant difference in patient outcomes for 
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patients strictly seeing NPs instead of physicians (Chang et al., 2007; Hoffman, Tasota, Zullo, 
Scharfenberg, & Donahoe, 2005; Litaker et al., 2003; Renders et al., 2001; Taylor et al., 2003; 
ter Bogt et al., 2011).  In general, the data related to the variations in care from NPs and 
physicians do not have a clear advantage of one practitioner over another. The studies have 
shown positive, negative, and neutral results related to measured outcomes for patients who see 
NPs compared to patients who see physicians.  
 A health system in Ohio used the CCM to guide the development of a new model that 
incorporated NPs into the delivery of care for patients with chronic illnesses (Boville et al., 
2007).  The goal of this project was to promote interdisciplinary models of care for patients with 
chronic illnesses and to promote training of this interdisciplinary system in other academic 
medical centers.  The role of the nurse practitioner was carried out through planned patient visits, 
which included medication assessments and algorithms for care with the main goals being to 
ensure the patients received all recommended screenings and assessments per disease guidelines 
and to improve patient outcomes through medication changes (if needed) and assisting the 
patient with goal setting for self-management. Team consultations with NPs, primary care 
physicians, medical residents, and various other, as-needed, care team members were conducted 
to present patient cases and use group problem solving strategies.  Success of this model has 
been noted, with improved clinical outcomes in glycemic control, lipid management, and blood 
pressure control (Boville et al., 2007).  
 A systematic review of whether NPs could provide care at the first point of contact as 
effectively as physicians in a primary care setting found 11 trials and 23 observational studies 
that met all inclusion criteria.  Overall, patients were more satisfied with NPs (standardized mean 
difference 0.27, 95% CI 0.07 to 0.47); however, no differences in health status were found.  
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Health status was assessed using different measures including physical function, emotional 
function, social function, and a satisfaction questionnaire incorporating a health status measure.  
Nurse practitioners were found to have longer consultations (weighted mean difference 3.67 
minutes, 95% CI 2.05 to 5.29).  Quality of care by NPs was found to be better in a variety of 
ways, such as identifying physical abnormalities more often, providing more information to 
patients, and offering more advice related to self-care, management of illnesses, and having more 
complete medical records and higher communication scores than the physicians (Horrocks et al., 
2002).  
 An examination of the cost effectiveness among physicians and NPs in a primary care 
setting among 1292 patients (651 from physicians and 641 from NPs) looked at the consultation 
process, patient satisfaction, health status, return visits over a two week period, and costs.  
Results indicated that NPs had consultations that were significantly longer (11.57 v 7.28 min, 
adjusted difference 4.20, 95% CI 2.98 to 5.41), carried out more tests (8.7% v 5.6% of patients, 
OR= 1.66, 95% CI 1.04 to 2.66), and asked patients to return more frequently than physicians 
did (37.2% v 24.8%, OR= 1.93, 95% CI 1.36 to 2.73).  Patients were more satisfied with care 
provided by NPs (mean score 4.40 v 4.24, adjusted difference 0.18, 95% CI 0.092 to 0.257).  
There was no significant difference in costs among NPs and physicians.  Based on these results, 
if NPs could decrease their consultation time while maintaining the benefits of their care, NPs 
could become more cost effective than general practice physicians in primary care settings 
(Venning et al., 2000). 
 A study by Mundinger et al. (2000) examined patient outcomes among physicians and 
NPs for primary care visits and follow-ups related to emergency room or urgent care visits.  The 
study was conducted over a two-year period, interviewing 1316 patients immediately following 
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the consultation and then again at six months and one year after the initial appointments to gather 
various data.  There were no significant differences found in the patients’ health status between 
the NP group and the physician group at the six month interview (p =.92).  Patients with 
hypertension were found to have statistically significantly decreased diastolic values in the NP 
group (82 v 85 mm Hg, p =.04).  There were no differences in satisfaction among groups after 
the initial consultations; however, at the six month interview (p =.88), scores for physicians were 
significantly higher than NPs related to “provider attributes” specifically related to patient 
satisfaction (4.2 v 4.1 on a scale where 5 = excellent, p =.05) (Mundinger et al., 2000).   
 Condosta (2012) examined if care by NPs in a free diabetic clinic exceeded that of the 
physicians.  Outcome measures included HbA1c levels, LDL and HDL levels, ophthalmology 
and podiatry referrals, foot inspection, and microfilament-sensation testing.  The results showed 
that NP care had higher odds (yet statistically insignificant) of foot inspection (adjusted OR 5.98, 
p = .01), podiatry referral (adjusted OR = 1.90, p = .04), and filament sensation testing (adjusted 
OR 1.60, p = .0002).  There was no indication that patients of NPs had better LDL levels, 
HbA1c levels, and ophthalmology referrals (Condosta, 2012). 
 The differences among NP and physicians care were examined in patients seeking “same 
day” primary care consultations.  Outcome measures included patient satisfaction, resolution of 
symptoms and concerns, care provided, information provided, and patients’ intentions for 
seeking care in the future.  The findings indicated that in adult consultations, patients were more 
satisfied with the care received from the NPs (e.g. practice 1 OR -8.79 (95% CI -13.59 to -3.98); 
practice 5 -5.92 (-15.70 to 3.86); practice 10 -5.90 (-12.11 to .31). Resolution of symptoms and 
concerns and care provided were similar between the groups (OR 1.23 (95% CI .87 to 1.73)).  
Patients seeing NPs did report receiving significantly more information related to their illness 
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(cause of illness: OR .58(95% CI .44 to.76); relief of symptoms: OR .32(95% CI .24 to .43); 
duration of illness: OR .34(95% CI .14 to .84) to 2.38(.79 to 7.14); how to reduce recurrence: OR 
.19(95% CI .09 to .38) to OR 1.57(95% CI .46 to 5.23); what to do if problem persists: OR  
.61(95% CI .41 to .90) and all NP consultations except for one practice were significantly longer 
than those with an physician (physician median range of 6 minutes with a range of 4-8 minutes; 
NP median range of 10 minutes with a range of 7-14 minutes) (Kinnersley et al., 2000).   
 Patient satisfaction among physicians and NPs was examined in a managed care setting 
by surveying 41,209 patients from 1997 through 2000.  Findings indicated that patients were 
significantly more satisfied with NP consultations than physician consultations (p < 0.05).  
Patient satisfaction with access to care did not differ significantly by practitioner.  Only in 
consultations specifically related to diabetes management were patients more satisfied with the 
care provided by the physician than the NP for practitioner interaction (p < 0.05), care access (p 
< 0.01), and overall experience (p < 0.05) (Roblin et al., 2004).   
 Another study examined NPs and physicians specifically related to quality of care for 
patients with diabetes among practices with NPs, PAs, or physicians and to assess if the type of 
practitioner contributed to difference in care.  A total of 846 patients from 46 different family 
medicine practices participated in chart audits related to diabetes care and adherence to 
American Diabetes Association (ADA) guidelines.  The findings indicated that practices 
employing NPs had overall better adherence to ADA guidelines, however the reasons for these 
differences were not clear.  The authors were not hypothesizing that the NPs specifically had 
better adherence to ADA guidelines, simply that practices employing NPs had overall better 
compliance with ADA guidelines among all practitioners than practices who did not have any 
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NPs on staff (Ohman-Strickland et al., 2008) ; however, this finding suggests that NPs played a 
role in the overall better compliance.   
 A third study related to Type 2 diabetes examined care processes and patient outcomes 
among NP and physician patients.  The findings indicated that NPs were more likely to 
document diabetes education, height, urinalyses results, and HbA1c values.  There were no 
differences among NPs and physicians when documenting medications, drug/alcohol/tobacco 
use, depression, weight, blood pressure, foot exams, cardiovascular exams, blood glucose testing, 
creatinine testing, and referrals to ophthalmologists.  There were no differences found in patient 
outcomes (HbA1c values, SF-36 results, and improvements in diabetes specific symptoms 
including blurred vision, drowsiness, polyuria, and nocturia) between the two groups (Lenz et al., 
2002).  
 Summary.  The variations among physicians and NPs are an important part of examining 
outcomes related to Type 2 diabetes.  Understanding the differences between NPs and physicians 
and how those differences relate to patients, goals of treatment, and outcomes can influence 
management styles when caring for patients with Type 2 diabetes.  The inconsistency in the 
literature related to outcomes and aspects of practice among physicians and NPs is also an 
important gap in knowledge that will be addressed in the proposed study.  HbA1c values and 
self-care behavior practices among patients from each type of practitioner will be evaluated, in 
addition to looking at referral and follow-up practices.  Physicians and NPs may have patterns of 
practice related to the other variables being examined in this study.  Looking at  these variables 
and outcomes for patients among the physician and NP groups may also provide new insights 
related to patterns of practice that benefit this specific patient population.   
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Improved Outcomes: HbA1c levels and Self-Care Behavior Practices 
 HbA1c levels.  The HbA1c test, also known as glycated hemoglobin, glycosylated 
hemoglobin, glycohemoglobin, A1c, or HbA1c, is a way to measure blood glucose management 
over a two- to three-month period.  This blood test should be done every three to six months for 
patients with diabetes.  The test reflects a patient’s average blood glucose control over the 
previous two or three months and is a very accurate way to monitor overall diabetes control 
(Joslin Diabetes Center, 2016; Mayo Clinic, 2016).  
 A person without diabetes would have a HbA1c level between 4% and 6% (Joslin 
Diabetes Center, 2016).  A common recommended target level is 7% or less for patients with 
diabetes (American Diabetes Association, 2013; Joslin Diabetes Center, 2016; Mayo Clinic, 
2016).  A level of 7% would correlate with an estimated average glucose (eAG) of 154mg/dL 
(American Diabetes Association, 2016c). Based on these recommendations, patients should 
strive to achieve an eAG of 154 or less; or an HbA1c level of 7% or less.  The higher the HbA1c 
result, the more risk a person has of developing complications related to diabetes (Mayo Clinic, 
2016).  The importance of the HbA1c levels should not be minimized.  For every percentage 
point decrease in HbA1c levels, there is also a 35% reduction in the risk of microvascular 
complication for patients with Type 2 diabetes, a 25% reduction in diabetes related deaths, and 
an 18% reduction in myocardial infarctions (UK Prospective Diabetes Study (UKPDS) Group, 
1998).  The risk of complications associated with diabetes is significantly reduced when the 
HbA1c values are less than 8%, ideally lower than 7% (Mayo Clinic, 2016; UK Prospective 
Diabetes Study (UKPDS) Group, 1998).  HbA1c levels are directly correlated with blood sugar 
levels.  Therefore, higher blood sugar levels, no matter what the higher levels are caused by, will 
result in higher HbA1c levels.  Diet, exercise, medication adherence, and regular glucose testing 
 60 
 
all are factors that can contribute to blood sugar control that will also contribute to the HbA1c 
levels (Joslin Diabetes Center, 2016; UK Prospective Diabetes Study (UKPDS) Group, 1998).  
 The proposed study will contribute to the limited literature that has examined all areas of 
the CCM to provide a comprehensive picture of how a patient’s actions and involvement in care 
can directly affect HbA1c levels. Using HbA1c levels as an outcome measure is a reliable way to 
examine blood glucose control that can provide a long-term picture of a patient’s ability to 
manage their diabetes.    
 Self-care behavior practices.  Self-care refers to a significant set of activities that are 
important to patient-centered chronic illness management (Song & Lipman, 2008).  Effective 
management of diabetes requires complex, continual, and demanding self-care behaviors 
including  recognizing signs and symptoms of the disease, diet control, exercise, blood glucose 
monitoring, managing physical and emotional distress, foot care, smoking cessation, limiting 
alcohol consumption, medication regimens, and utilizing family support and community 
resources (American Diabetes Association, 2016a; Arar, Hunt, & Larme, 1998; National 
Institutes of Health and the Centers for Disease Control and Prevention, 2011; Song & Lipman, 
2008).  Managing Type 2 diabetes has proven to be very challenging because of the difficulty 
and complexity involved in making the necessary life-style changes.  Vigilant self-care for 
patients with Type 2 diabetes is particularly important because it can help to delay the 
progression of the disease and onset of complications (Song & Lipman, 2008).   There is much 
literature discussing patient involvement in the medical decision-making process, self-care 
behaviors, and goals of self-management related to diabetes treatment plans.   
Effective self-management is necessary to improve outcomes, specifically HbA1c levels, 
for patients with Type 2 diabetes (Funnell et al., 2009).  Self-care behaviors, such as checking 
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blood glucose levels, medication adherence, eating a particular diet, following an exercise 
regimen, checking feet regularly, smoking cessation, and reducing alcohol intake are necessary 
to prevent morbidity and mortality in patients with Type 2 diabetes (Toobert et al., 2000; Wang 
& Fenske, 1996; Weinger, Butler, Welch, & La Greca, 2005).  Incorporating self-care behaviors 
related to the management of Type 2 diabetes is key to living a long, healthy life and decreasing 
the risk of developing complications (Aljasem et al., 2001).  Patients with Type 2 diabetes are 
expected to make complex, life-long changes in everyday behaviors in order to manage this 
disease; these patients cannot simply take a pill to manage the disease (RW.ERROR - Unable to 
find reference:884; McNabb, 1997).  Diabetes requires lifestyle management in addition to 
medication adherence.   
 Patients have reported that learning to manage self-care behaviors and incorporate these 
changes into their lifestyles is more difficult than accepting the initial diagnosis of Type 2 
diabetes (Hurley & Shea, 1992).  Self-management and the incorporation of self-care behaviors 
are conceptually different than many other health behaviors because these changes are more 
complex, restrictive, and sometimes expensive (Jones et al., 2003).  Diet and exercise have been 
found to be the most difficult self-care behaviors for patients to incorporate in their management 
of Type 2 diabetes (Goodall & Halford, 1991).   
 A study by Sousa and colleagues (2005) examined whether self-care management and 
affects blood sugar control and addressed the relationship between self-efficacy and self-care 
agency.  A cross-sectional study using previously collected data and a convenience sample of 
141 adults with  type 1 or Type 2 diabetes and used the Demographic Questions of the Diabetes 
Care Profile, Appraisal of Self-Care Agency scale, Insulin Management Diabetes Self-Efficacy 
Scale (IMDSES), and the Insulin Management Diabetes Self-Care Scale to examine their 
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association with HbA1c levels. Diabetes self-care management was a significant predictor of 
blood sugar control (β = -.18, t (136) = -2.219, p < .05).  Self-efficacy was found to strongly 
affect diabetes self-care management (β = .61, t (136) = 9.197, p < .001).  However, upon further 
analysis, diabetes self-care management did not strongly affect blood sugar control (β = -.12, p > 
.05), when controlling for demographics, self-rated health, and self-care agency (Sousa et al., 
2005).  
 A study with 1,032 patients from Veterans’ Affairs facilities examined patients’ own 
assessments of self-management with blood sugar control and high-quality diabetes care.  Higher 
evaluations of self-management were significantly associated with lower HbA1c levels (β = -
0.13, p < .001).  Participants in the 95th percentile for self-management had mean HbA1c levels 
of 7.3 (95% CI, 6.4-8.3).  Those in the 5th percentile had mean HbA1c levels of 8.3 (95% CI, 7.4-
9.2). The analysis revealed that for every 10-point increase in patient evaluations of their self-
management practices the odds of receiving HbA1c tests increased by 15% (4-27%), receiving 
an eye examination increased by 16% (7-27%), and receiving a nephropathy screening increased 
by 13% (2-26%) (Heisler, Smith, Hayward, Krein, & Kerr, 2003).   
 A study examining the burden of Type 2 diabetes found that adherence to self-
management goals was independently correlated with a patient’s views about the burdens of 
treatment (Vijan et al., 2005).  Including the patient in the decision-making process can decrease 
the perceived burden of treatment and increase adherence to treatment plans (Vijan et al., 2005).  
Physicians cannot assume that patients will be compliant to a specific treatment plan; rather, the 
patients will often tailor the treatment plan to better fit into their personal lifestyles.
 Management of Type 2 diabetes requires behavioral changes on the part of the patient to 
meet the goals of therapy (RW.ERROR - Unable to find reference:321; Wolpert & Anderson, 
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2001).  Wolpert and Anderson (2001) stressed that because diabetes is a self-managed condition, 
models of care should be focused on promoting more self-care behaviors while stressing the 
importance of glycemic control from the patient’s perspective.  Researchers have acknowledged 
that while the long-term benefits of tight glycemic control are well published, this desired control 
is rarely achieved in the general clinical practice arena.  In order for practitioners to be to achieve 
desired outcomes with their patients, the importance of blood sugar control must be evaluated 
from the patient’s perspective, and the patient’s goals must be incorporated into treatment 
(Wolpert & Anderson, 2001).  
 The effectiveness of self-management training in 72 patients with Type 2 diabetes was 
examined, noting positive effects of self-management training on knowledge, frequency and 
accuracy of self-monitoring of blood glucose, self-reported dietary habits, and glycemic control.  
Educational interventions were found to be more effective than didactic interventions in relation 
to glycemic control, weight control, and lipid profile results.  The authors summarized that self-
management training was effective in the short term for patients with Type 2 diabetes 
(RW.ERROR - Unable to find reference:324).   
 A study by Toljamo and Hentinen (2001) examined self-care behaviors, metabolic 
control, and social support in 213 patients with diabetes.  Of the total sample, 36% of 
participants had a HbA1c level under 7.5%, and 12% of participants had a HbA1c level above 
10%.  Participants living alone had a mean HbA1c value of 8.7%, compared to those living with 
a family member of partner (mean HbA1c level 8.0%, p < .05).  The authors discovered four 
different categories relating to self-care behavior practices: flexible self-care (46%), strictly 
regimen-adherent self-care (16%), self-planned self-care (19%), and neglect of self-care (19%).  
Participants with poorer metabolic control were found to be smokers, living alone, and a higher 
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than average risk of neglect of self-care, with mean HbA1c values of 9.1% (F = 11.8, p < .001) 
compared to those who adhered to self-care (Toljamo & Hentinen, 2001).    
 A study by Daly and colleagues (2009) examined patient self-care behaviors, barriers 
associated with problem behaviors and diabetes control.  A randomly selected sample of 458 
patients completed a mail survey consisting of 141 questions adopted from a variety of 
previously validated instruments.  Cost (p = .005) was found to be the most common barrier 
related to self-care practices. Respondents who viewed Type 2 diabetes as a serious problem (p = 
.006) and those who had depression (p = .007) were strongly associated with higher HbA1c 
levels. Lower HbA1c levels were associated with participants who were married (p = .026) and 
reported greater adherence satisfaction with taking medications and checking blood glucose 
levels (p < .001 for all) (Daly et al., 2009).    
 Another study examined relationship between diabetes treatment barriers and self-
efficacy related to self-care behaviors.  The study used a self-report questionnaire focusing on 
diet, exercise, medication practices, blood glucose testing, and insulin and diet adjustments in 
patients with Type 2 diabetes.  The patients reported barriers related to carrying out diet and 
exercise but less difficulty with blood glucose testing and medication adherence (Aljasem et al., 
2001).  
A literature analysis was completed to examine patient decision-making and non-routine 
behaviors in their personal working concept of self-care (Song, 2010).  Articles chosen were 
published between 1999 and 2009 and targeted adult populations with diabetes mellitus.  The 
authors then set out to address how existing studies examine health outcomes for patients with 
diabetes, how negative health outcomes can be minimized, and the results of the current 
literature on the relationship between self-care in patients with diabetes and health outcomes. 
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The health risks for patients with diabetes include microvascular (blindness and kidney disease) 
and macrovascular (cardiovascular disease and coronary heart disease) complications, 
nontraumatic extremity amputations, pregnancy complications, and death related to flu and 
pneumonia.  The current literature demonstrated that glycemic control helps to prevent both 
microvascular and macrovascular complications in patients with diabetes (Song, 2010).   
 Typical research related to self-care behaviors involves monitoring for signs/symptoms of 
diabetes, managing diet, exercise, testing blood glucose levels, medication compliance, regular 
feet checks, smoking cessation, and limiting alcohol consumption.  Newer research is beginning 
to examine the role of patient decision-making in response to individual disease process 
responses and the need for additional non-routine behaviors to self-manage.  The literature and 
research is beginning to recognize the importance of other factors on self-care behaviors 
including personal experiences, values, and culture (Song, 2010).  
 Another systematic literature review summarized existing knowledge regarding barriers 
to Type 2 diabetes management from both the patient and practitioner perspectives using 
literature published between 1990 and 2009.  The author summarizes that patients’ adherence, 
attitudes, beliefs and knowledge related to diabetes can affect the way individuals manage their 
disease.  Other factors such as culture, language, health beliefs, financial resources, co-
morbidities, and social support also impact individual self-management. Practitioners’ attitudes, 
beliefs, and knowledge can affect how they choose to treat patients with Type 2 diabetes.  
Practitioners may further influence patient perceptions through effective communication and by 
identifying barriers with the patients that directly affect them. Awareness of these factors can aid 
in the development of treatment plans and goals of treatment to enhance the success that a patient 
has at self-managing Type 2 diabetes (Nam, Chesla, Stotts, Kroon, & Janson, 2011).   
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 Summary.  The literature related to self-care behaviors in patients with Type 2 diabetes 
is vast.  However, most of the literature examines why patients do or do not adhere to 
recommendations related to self-care behaviors. Multiple studies have examined patient 
activation and self-care behaviors (Hibbard & Tusler, 2007; Mosen et al., 2007; Rask et al., 
2009; Remmers et al., 2009).  While all of the studies noted that there was some positive impact 
on self-care behaviors in patients with higher activation levels, there were also limitations and 
areas for further research.  Three of the studies noted that having a cross-sectional design was a 
limitation (Mosen et al., 2007; Rask et al., 2009; Remmers et al., 2009).  Mosen et al (2007) also 
noted that from their research, it could not be concluded if patient activation leads to increased 
self-management, or if those patients who engage in self-management behaviors increased their 
activation levels.  The proposed study will have a unique perspective in that it will examine the 
effects of levels of patient activation, participation in decision-making, and facilitation of 
involvement in care on self-care behaviors and HbA1c levels.  Examining variables such as 
patient activation together with and participation in decision-making and facilitation of 
involvement in care will provide information as to whether these factors affect a patient’s ability 
to follow through with self-care recommendations.   
Summary 
The variables in this proposed study can impact self-management of chronic disease and 
achieving desired outcomes related to chronic diseases, including Type 2 diabetes.   Higher 
levels of activation and participation in decision-making have been shown to increase self-
management behaviors such as adhering to self-care behaviors and having improvements in 
HbA1c levels (Golin et al., 1996; Hibbard et al., 2004; Hibbard et al., 2007; Lorig et al., 1999; 
Mosen et al., 2007; M. L. Parchman, Zeber, & Palmer, 2010; Remmers et al., 2009; Von Korff & 
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Gruman, 1997).  Parchman, Zeber, and Palmer (2010) found that participation in decision-
making was associated with patient activation levels, which then increased the medication 
adherence among patients with Type 2 diabetes.  The literature suggests that the amount of 
patient participation in the decision-making process related to the treatment plan can have a 
direct effect on adherence to self-care behaviors related to management of diabetes (RW.ERROR 
- Unable to find reference:364; RW.ERROR - Unable to find reference:285; RW.ERROR - 
Unable to find reference:365; RW.ERROR - Unable to find reference:366; RW.ERROR - 
Unable to find reference:368; RW.ERROR - Unable to find reference:369; Golin et al., 1996; 
Golin et al., 2001; Heisler et al., 2005; Jahng et al., 2005; Montori, Gafni, & Charles, 2006; 
Muhlhauser & Bergert, 2000; Pooley, Gerrard, Hollis, Morton, & Astbury, 2001).  Brashers, 
Haas, and Neidig (RW.ERROR - Unable to find reference:871) found that patients who were 
more assertive, or more activated, were more likely to receive more information from their 
physicians and received more treatment options. Facilitation of patient involvement in care has 
been associated with greater patient satisfaction with care, better patient adherence to treatment 
plans, higher levels of patient trust in practitioners, and increased self-efficacy (RW.ERROR - 
Unable to find reference:869; Martin et al., 2001).  While focusing on treatment from a 
pathophysiological standpoint is important, it is equally important to include patients in deciding 
on the goals related to self-management of the disease, such as diet and exercise (Arar et al., 
1998).  Practitioners should explain rationales behind treatment plans, become aware of the 
patient’s perception related to treatment, and address any concerns related to how the treatment 
plans will be incorporated into the patient’s lifestyle (Wilson et al., 1986). 
 Delivery system design, clinical information systems, decision support, self-management 
support, and community resources are also important aspects related to the management of Type 
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2 diabetes. The use of clinical information systems and electronic decision support tools has been 
shown to improve practitioner performance.  However, research related to patient outcomes and 
use of decision support systems has been insufficient and the data that has been analyzed has 
been inconsistent (Crosson et al., 2012; Frijling et al., 2002; Garg et al., 2005; Hunt et al., 1998; 
Jaspers et al., 2011; Keyhani et al., 2008; Lau et al., 2012; McCoy et al., 2012; O'Connor et al., 
2011; Poon et al., 2010; Romano & Stafford, 2011; Smith et al., 2008).  
Studies specifically examining patients with Type 2 diabetes found conflicting results 
related to blood glucose control, HbA1c monitoring, HbA1c values, overall quality of care, and 
adherence to evidence-based guidelines (RW.ERROR - Unable to find reference:1040; Crosson 
et al., 2012; O'Connor et al., 2011).  Effective management of chronic diseases, like Type 2 
diabetes, requires that the delivery system design also be linked to community resources.  The 
success of delivery system designs can be improved by establishing links to the community 
resources to support patients in their self-management endeavors (Austin et al., 2000; Barr et al., 
2003; Bodenheimer et al., 2002b; Dancer & Courtney, 2010; National Institutes of Health and 
the Centers for Disease Control and Prevention, 2011; Robert Wood Johnson Foundation, 2016b; 
Robert Wood Johnson Foundation, 2016c; Robert Wood Johnson Foundation, 2016d). 
 Self-care behaviors and self-management support are integral parts of managing Type 2 
diabetes in order to delay the progression of the disease, reduce the risk of complications, and 
promote optimal quality of life (Aljasem et al., 2001; Song & Lipman, 2008; Stuckey et al., 
2009).  Increasing patient participation in the decision-making process and providing self-
management support has been shown to directly affect patients’ likelihood of adhering to self-
care behaviors (RW.ERROR - Unable to find reference:379; RW.ERROR - Unable to find 
reference:285; RW.ERROR - Unable to find reference:365; RW.ERROR - Unable to find 
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reference:366; RW.ERROR - Unable to find reference:368; RW.ERROR - Unable to find 
reference:369; Golin et al., 1996; Golin et al., 2001; Heisler et al., 2005; Jahng et al., 2005; 
Montori et al., 2006; Muhlhauser & Bergert, 2000; Pooley et al., 2001).  Ensuring that the 
available community resources are appropriately referred to and utilized by patients is also 
important related to the self-management of Type 2 diabetes. Examining follow-up care and 
referral procedures is important in order to assess whether patients with less desirable HbA1c 
values are being adequately treated and given appropriate resources for support.   Finding 
successful techniques for teaching patients the importance of self-care behaviors and supporting 
them beyond the consultation office is important to increase the patient’s ability to effectively 
manage blood sugars on a daily basis. Because of the personal choices that patients may make, 
the importance of self-care should be stressed to the patient in order to promote as much 
successful self-management as possible (RW.ERROR - Unable to find reference:285). 
 Further examining the differences among practitioners is important with the ever 
evolving and expanding role of the nurse practitioner.  NPs are continuing to increase their 
presence in the treatment of chronically ill patients, including those with Type 2 diabetes 
(Boville et al., 2007; Mundinger, 2002).  Continuing the research examining outcomes for 
patients seeing NPs compared to Physicians is important to ensure that patients are receiving 
optimal care and achieving the desired outcomes related blood glucose management, as 
measured in HbA1c values. Examining the patient outcomes of HbA1c values and self-care 
behavior practices among these two groups, in addition to examining referrals and use of 
generated prompts in the EHRs, will help to fill the current gaps in the literature.   
 Examining all of these variables together can provide a more comprehensive view of 
diabetes management through the eyes of the patient. If patient activation, facilitation of patient 
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involvement, and participation in decision-making are all lacking, there is a potential that there 
will be mismatched goals between the patient and practitioner related to diabetes management, 
which can ultimately lead to overall poor management of diabetes (Heisler et al., 2002; Hibbard 
& Tusler, 2007; Martin et al., 2003; Mosen et al., 2007; Rask et al., 2009; Vermeire, Van Royen, 
Coenen, Wens, & Denekens, 2003; Wolpert & Anderson, 2001).  Also, if delivery system 
designs, clinical information systems, decision support tools are not being utilized as 
appropriately designed, there is a potential to miss important aspects of care for patients 
requirement continual, complex management as those patients with Type 2 diabetes.   The gaps 
in the literature show a need for all of the variables and outcome measures presented in this 
chapter to be examined together to obtain a better understanding of the complexities involved in 
the management of Type 2 diabetes.  Current literature as presented data showing that diabetes 
has been found to be poorly controlled throughout the United States (Li et al., 2004) and the 
CCM has been shown to be a beneficial framework for providing care to patients with Type 2 
diabetes (Bodenheimer et al., 2002a; Dancer & Courtney, 2010; National Institutes of Health and 
the Centers for Disease Control and Prevention, 2011; Nutting et al., 2007; Parchman, Michael 
L,MD, MPH, Pugh, Wang, & Romero, Raquel L,MD, MPH, 2007; Robert Wood Johnson 
Foundation, 2016a; Siminerio et al., 2006; Siminerio et al., 2004; Smith et al., 2008).  Therefore, 
the results of this proposed study that was developed using a successful model for managing 
chronic diseases can offer information to improve outcomes and provide a comprehensive 
picture of current Type 2 diabetes patients to see where future research efforts need to be 
focused.  
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Chapter 3 
Methods 
 While a variety of literature has examined multiple combinations of the variables in this 
study, no study to date has examined the variables in the comprehensive fashion presented here 
based upon the CCM.  Also, no study has examined the patient participation in decision-making 
related to HbA1c values.  Participants for this study are patients who have a medical diagnosis of 
Type 2 diabetes prior to taking part in this study.  The tools that will be used for data collection 
will be completed by the participants, a review of the medical record will be completed by the 
primary investigator (PI), and a blood draw will be collected from each participant to obtain the 
HbA1c level within two months prior to or following the consultation.  The methodology 
presented in this chapter will describe the procedures for this study to recruit participants and 
gather the data to examine the variables of patient activation, facilitation of patient involvement, 
participation in decision-making, decision support, delivery system design, clinical information 
systems, community resources, self-management support, and differences between physicians 
and nurse practitioners in relation to HbA1c values and self-care behaviors as outcomes.  
Research Questions 
The research questions were the results of a thorough review of current literature 
examining the management of Type 2 diabetes presented in chapter two.   
Primary questions: 
1. Among Type 2 diabetic patients, do levels of patient activation, participation in 
decision-making for treatment planning, and facilitation of patient involvement in 
care affect HbA1c levels and patients’ performance of self-care behaviors?  
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2. Based on the CCM, what are the effects of delivery system design and clinical 
information systems, together with patient perceptions of decision support, self-
management support, and community resources on HbA1c levels and participation in 
self-care behaviors for patients with Type 2 diabetes? 
Secondary questions: 
3. Is there a difference in levels of patient activation, participation in decision-making, 
and facilitation of patient involvement in care when a nurse practitioner treats a 
patient compared to a physician? 
 
4. Do patients who see nurse practitioners for management of Type 2 diabetes 
experience higher levels of engagement in self-care behaviors and more therapeutic 
HbA1c levels compared to patients who see a physician? 
Research Procedures 
Design  
 This cross-sectional, descriptive study will examine patient activation, facilitation of 
patient involvement, participation in the decision-making process, decision support, delivery 
system design, clinical information systems, referral to community resources, and self-
management support related to the management of Type 2 diabetes for patients seen by nurse 
practitioners and physicians in the primary care setting.  This study will examine the effects of 
patient activation (Patient Activation Measure), participation in decision-making (Perceived 
Involvement in Care Scale), and practitioner facilitation of patient involvement (Facilitation of 
Patient Involvement Scale and Perceived Involvement in Care Scale) and how these variables 
impact self-care behavior practices (Summary of Diabetes Self-Care Activities) and HbA1c 
levels on patients with Type 2 diabetes.  Delivery system design (Patient Assessment of Care for 
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Chronic Conditions and demographic form), clinical information systems (demographic form), 
decision support (Patient Assessment of Care for Chronic Conditions), self-management support 
(Patient Assessment of Care for Chronic Conditions and demographic form), and referral to 
community resources (Patient Assessment of Care for Chronic Conditions and demographic 
form) will also be assessed for their impacts on the same outcomes, self-care behaviors 
(Summary of Diabetes Self-Care Activities) and HbA1c levels. Secondary aims are to examine 
the variables for patients seen by a nurse practitioner compared to a physician. Patients will 
complete instruments for the independent variables and the outcome of patient self-care 
behaviors at one time point after consultation with a physician or NP, and HbA1c values will be 
examined within two months prior to or immediately following the scheduled consultation. 
Setting 
 Data collection for this study will be completed in five primary care offices throughout a 
health system in Western Pennsylvania.  Literature has shown that many Type 2 diabetes patients 
are managed through their primary care provider at least in the early stages of treatment (Prijatel, 
2011).  There are a total of seven NPs and 18 physicians among the five locations.     
 Participants and Sampling 
 Participants of this study will be required to be diagnosed with Type 2 diabetes and be 18 
years of age or older. Patients must be seeing a physician or nurse practitioner for treatment.  
Patients using medication such as oral agents and/or insulin will be included, and medication 
usage will be categorized as 1) oral agents, 2) insulin, 3) combination oral/insulin, and 4) no 
medication, and controlled for in the data analysis.  Participants must be able to speak, read, and 
write in English.  Patients with dementia and mental illness will be excluded if they are unable to 
make independent decisions, have a surrogate decision maker, a designated care giver.   
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Patients at the designated primary care offices with Type 2 diabetes will be made aware 
that they can have the option of learning about a research study that they may qualify to 
participate in when they are called by phone from the office administration to be reminded of 
their upcoming appointment.  Flyers will be hung in the waiting rooms and exam rooms in the 
participating primary care offices providing a study overview and contact information for the  
principle investigator (PI).  The PI will contact the administration teams at the offices three times 
per week to obtain the number of patients who will be coming to the office with a diagnosis of 
Type 2 diabetes. No identifying information will be given at that time.   If patients with a 
diagnosis of Type 2 diabetes are scheduled for an appointment, the PI will be available at the 
primary care offices for potential meetings with those patients regarding enrollment in the study 
after an office staff person has introduced the study to the patient, and they agree to speak to the 
PI.  Patients must sign a consent form to participate in the study, which includes giving 
permission for the PI to access the patient’s medical records to obtain a HbA1c value. The care 
providers will also need to sign a confidentiality statement of their agreement to participate in the 
study and to keep the patients participating in the study confidential. 
The PI will gain approval and support for the study from the primary care providers and 
will be given written information related to the recruitment of potential participants and 
inclusion/exclusion criteria prior to the initiation of the study.  Patients who are interested in 
participating in the study will meet with the PI at the conclusion of the consultation with their 
care provider in order to be formally enrolled in the study. At this time, potential participants will 
be assessed by the PI using an eligibility checklist. Once the potential participants are deemed 
eligible, the PI will discuss the processes of the proposed study, review the consent form, and 
answer any questions they may have.  The participant will then be asked to sign a consent form 
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to participate in the study.  After a consent form is signed, the participants will be given a packet 
of questionnaires to complete. The packet will include a copy of the Patient Activation Measure, 
Facilitation of Patient Involvement Scale, Perceived Involvement in Care Scale, Patient 
Assessment of Care for Chronic Conditions and the Summary of Diabetes Self-Care Activities, 
and a demographics form. The patients may complete the questionnaires immediately after their 
consultation with their practitioner or they may take the packet home and will also be given a 
stamped, addressed envelope to send the questionnaires to the PI.  If the patients wish to take the 
packet home, the PI will request a contact phone number to follow-up with participants if the 
packets are not returned within one month of the office visit.  If the questionnaires are not 
returned within this time frame, the PI will follow up with the participants via a telephone call.  
If the questionnaires are still not returned within another week, the PI will follow up with one 
additional telephone call. 
 Power analysis.  In a multiple regression analysis, a standard formula of N > 50 + 8k is 
used to determine sample size, with  N being the sample size and k being the number of 
predictors.  A minimal sample size of 91 patients (k = 5) will be necessary to achieve statistical 
significance based on the number of variables. However, using Cohen’s guidelines of effect size, 
an a priori power analysis could be performed to ensure the sample size is large enough to have a 
power of .80.  In this case, R2 = .10 (small to moderate effect) would be used to determine a 
sample size of 112 participants would be necessary to ensure the study had a power of .80 (Polit, 
2010c). 
Instruments Used for Data Collection for Independent Variables 
 Demographic form.  Participants will be asked to complete a 17-item, researcher 
developed demographics tool that will take approximately 3-4 minutes to complete. In addition 
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to describing the population of this proposed study, the tool will also be used to assess delivery 
system design and use of clinical information systems.    The tool will require the patient to 
circle the correct response, with a few handwritten responses required.  The tool will request 
information including name, age, sex, race/ethnicity, level of education completed, marital 
status, and employment status.  The patient will also be asked what type of practitioner they are 
seeing on the day of the consultation (NP or physician).  The patient will be asked the length of 
time the patient has had a relationship with his or her practitioner, the number of visits to the 
primary care provider in the previous 12 months related to diabetes care, the number of visits to 
care team members or community services in the previous12 months that related to diabetes care, 
and length of time since initial diagnosis of Type 2 diabetes.  The patient will also be asked to 
identify if they have seen only physicians or NPs, or if the patient has seen both physicians and 
NPs within the previous 12 months and how frequently they have seen each.   
To assess delivery system design, use of clinical information systems, self-management 
support and referral to community services, the patients will be asked yes or no to whether they 
were asked to make a follow-up appointment, yes or no to whether they were referred to any 
other practitioners or services. If referred to other practitioners or services, the patients will be 
asked to circle which other services they were referred to (i.e.: endocrinologist, dietician, foot 
specialist, eye doctor, certified diabetes educator) and/or write on the form any other services 
they were referred to that are not listed. The patients will also be asked if they discussed goals of 
treatment with their practitioner and if they were given any printed information from the 
practitioner related to goals of treatment or test results.  
 Patient Activation Measure (PAM).  The PAM will be used to measure patient 
activation. The PAM is a 22-item questionnaire to be completed by the participant.  There are 
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four subscales that include: Believes Action Role Important (2 items), Confidence and 
Knowledge to Take Action (10 items), Taking Action (6 items), and Staying the Course Under 
Stress (4 items). Scores range from 1 (disagree strongly) to 4 (agree strongly), allowing for total 
scores to range from 13-52. Higher scores are associated with higher levels of patient activation.  
The PAM should take approximately 5-7 minutes to complete.  The PAM was purchased for 
doctoral dissertation use through the Insignia Health Website (Insignia Health LLC, 2012) 
The PAM was developed in four stages by Hibbard, Stockard, Mahoney, and Tusler (2004).  The 
first stage involved conceptually defining activation through a literature review, consultations 
with experts using the “consensus method,” and focus groups with individuals who have chronic 
diseases.  The domains identified in this stage related to the importance of self-management, 
collaboration with health care providers, maintaining function/preventing declines in health 
status, and having access to appropriate and high quality care (Hibbard et al., 2004).   
 The second stage involved a preliminary scale development using the domains that were 
identified during the first stage.  Rasch psychometric methods were used to develop the scale and 
test the psychometric properties.  Rasch measurement can be used to create interval-like, one-
dimensional, probabilistic Guttman-like scales from ordinal data, and the analysis indicated the 
PAM worked in this manner.  In the case of the PAM, a person’s score on the scale, indicates 
how activated the person is.  The Rasch Person reliability for the 21-item measure was between 
.85 and .87.  The Cronbach’s alpha was .87.  A test-retest reliability assessment was measured by 
the standard error of measurement (SEM) for each person’s estimated activation at each testing.  
A confidence interval (CI) of 95% was calculated for each participant.  Of the 30 participants, 28 
retested within the bounds of the 95% CI.  Criterion validity was assessed using interviews of the 
five highest scorers and five lowest scorers from the initial study.  Using transcribed semi-
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structured interviews and three independent judges, the interviews were categorized by the 
judges as being from a person of “high” or “low” activation.  The judges’ classifications matched 
the participants activation level as measured on the PAM in 83% of the classifications (25 out of 
30 were correct).  Cohen’s kappa for measured activation and the individual judge’s 
classification were .80, .90, and .90 (p < .001 for all kappas) (Hibbard et al., 2004).   
 The third stage involved exploring the idea of extending the range of measure to see if 
this measure could be used on patients who did not have any chronic diseases.  A 22-item PAM 
was used based on the Rasch rating scale model for this stage.  The authors did find that the scale 
could translate to patients without chronic diseases.  Reliability statistics for those with and 
without chronic conditions were comparable (Hibbard et al., 2004).     
 The fourth stage used a national probability sample to assess the measure against 
different subsamples throughout the population and to assess the construct validity.  There was a 
high-level reliability of the PAM across the national sample with infit values ranging from .71 to 
.144.  The 22-item PAM was tested for construct and criterion validity.  The authors tested the 
PAM (activation) with the SF 8 (self-reported health status) and found that those with higher 
activation reported significantly better health (r = .38, p < .001) and had significantly lower rates 
of doctor office visits, emergency room visits, and hospital stays (r = -.07, p < .01) (Hibbard et 
al., 2004).    
 Facilitation of Patient Involvement (FPI) Scale.  The FPI scale will be used to measure 
facilitation of patient involvement in care.  The FPI scale is a 9-item questionnaire that is 
completed by the participant and estimated to take two to four minutes to complete.  Each item is 
scored using a range of 1(none of the time) to 6 (all of the time), with overall scores ranging 
from 9-54.  Higher scores are related to increased patient perception of facilitation of 
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involvement of the patient by the practitioner.   The FPI was developed by Martin, DiMatteo, 
and Lepper (2001) as a self-report scale for patients to be used to assess perceptions of 
physicians’ facilitative behaviors.  The authors developed a preliminary 18-item tool that was 
reviewed by a group of seventeen psychologists for feedback on face validity, content overlap, 
and ambiguity.  After review, 9 items were removed, 7 of the remaining 9 items were modified 
for clarity and specificity.  The response format is similar to that of a Likert scale.  Respondents 
are asked to circle the response that best indicates their answer (Martin et al., 2001).  Permission 
to use the FPI scale was granted by Dr. Leslie Martin via email.  
 Cronbach’s alpha was used to establish internal consistency reliability with a cutoff point 
of .85.  Pearson’s r was used to assess test-retest reliability with a cutoff point of .80.  The 
authors conducted five separate studies to assess consistency reliability and test-retest reliability.  
The Cronbach’s alpha values to establish internal consistency reliability were .93 (N=236), .90 
(N=338), .91 (N=333), .93 (N=44), and .89 (N=84). All values were above the predetermined 
cutoff value of .85.  The test-retest results were .89 (N=44), and .85 (N=84), both also above the 
predetermined cutoff value of .80 (Martin et al., 2001).   
 Construct validity was tested using patient age, gender, level of education (discriminant), 
physician gender, patient’s preferred communication style, and information seeking 
(convergent).  The authors tested the hypothesis that individuals will seek medical information 
and communicate more effectively if the physicians behave in a manner that facilitates their 
involvement.  Validity was determined when communication style and self-reported adherence 
both positively correlated with FPI scores.  The results for communication style were r= .28 
(N=338, p < .001), r= .38 (N=333, p < .001), r= .35 (N=44, p < .10), and r=.46 (N=84, p < .05).  
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The results for self-reported adherence were r=.31 (N=338, p < .001), r=.32 (N=333, p < .001), 
r=.32 (N=44, p < .10), and r= .42 (N=84, p < .05) (Martin et al., 2001).   
 Perceived Involvement in Care Scale (PICS).  The PICS will be used to measure 
facilitation of patient involvement and patient participation in decision-making.  The PICS is a 
13-item questionnaire that will be completed by the patient in 2-5 minutes.  The PICS includes 
three subscale that are Provider Facilitation Scale (5 items), Patient Information Scale (4 items), 
and Patient Decision-Making Scale (4 items). The patient answers agree (1 point) or disagree (0 
points) to each question for a minimum score of 0 and a maximum score of 13. Higher scores are 
associated with an increased patient perception that their practitioner is involving them in in the 
decision-making process (Lerman et al., 1990).  Permission to use a copy of the PICS was 
granted by Dr. Lerman through email. 
The PICS was developed by Lerman and colleagues (1990) and can be used to assess 
patients’ perceptions of physician and patient behaviors that occur during routine medical visits, 
regarding patient attitudes towards illness and the management of illness.  The initial 
questionnaire was comprised of 25 agree/disagree questions.  Scoring was determined by 
awarding one point for every agree answer and 0 points for every disagree answer.  After item 
analysis was completed, the final PICS version was finalized with 13 agree/disagree questions. 
Internal consistency was measured using Cronbach’s alpha with a result of .73 (N=131).  Factor 
analysis resulted in three relatively independent factors labeled provider facilitation (PF), patient-
physician information exchange (PI), and patient decision-making (PDM) (Lerman et al., 1990).   
 Patient Assessment of Care for Chronic Conditions (PACIC).  The PACIC will 
measure decision support, patient activation, delivery system design, referral to community 
resources, and self-management support. The PACIC is a 20-item, self-report questionnaire that 
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will be completed by the patient in two to five minutes.   Each item is scored on a 5-point scale 
ranging from 1 (no or never) to 5 (yes or always).  The 20 items are arranged into 5 subscales 
including Patient Activation (3 items), Delivery System Design/Decision Support (3 items), and 
Follow-up/Coordination (5 items), Goal Setting (5 items) and Problem-solving/Contextual 
Counseling (4 items) subscales; these latter two scales assess self-management support.  Higher 
scores are associated with increased decision support. The PACIC should take approximately 
two to five minutes to complete (Glasgow et al., 2005).  The PACIC is available in the public 
domain and can be found on the Improving Chronic Illness Care website (Robert Wood Johnson 
Foundation, 2016h).   
 The PACIC was developed by Glasgow and colleagues (2005).  Internal consistency for 
the PACIC was evaluated using coefficient alpha.  A confirmatory factor analysis was used to 
evaluate item loading with almost all of the items highly loaded on the proposed scales.  Only 
three items had factor loadings less than .70.  Ten of the twenty items had factor loadings of .80 
or greater.  Item reliability was greater than .50 for 75% of the items, which the authors deemed 
to be acceptable.  Overall test-retest reliability was .58 and individual scale reliabilities ranged 
from .47 to .68.  Validity for the PACIC was correlated moderately to strong (.42-.60) with four 
of the convergent validity measures and r = .32 (Glasgow et al., 2005).  
Instruments Used for Data Collection for Dependent Variables 
Summary of Diabetes Self-Care Activities (SDSCA).  The SDSCA will measure the 
dependent variable self-care behaviors.  The SDSCA is an 11-question, self-report measure 
related to the frequency of patients completing various self-management activities over the 
preceding seven days. The SDSCA is divided into five subscales that include Diet (4 items), 
Exercise (2 items), Blood Sugar Testing (2 items), Foot Care (3 items), and Smoking Habits (1 
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item).  The SDSCA can be completed in 5-7 minutes.  The self-management behaviors assessed 
include diet, exercise, glucose testing, medication adherence, foot care, and smoking habits.  The 
first 10 items are related to how frequently in the previous seven days a patient performed these 
activities. Each item can be scored 0-7 to correspond with the number of days patients report 
engaging in these activities.  Item 11 is a question regarding smoking habits with in the last 
seven days. The patient will answer yes or no. If yes, the patient is asked to report how many 
cigarettes are smoked on an average day.  For items 1-10, the number of days per week (0-7) for 
each question is used as the score. For the general diet score, the mean number of days for items 
one and two is the score. For the specific diet score, the mean number of days for items three and 
four are the score, however the score for item four is to be reversed, (0=7 days, 1=6 days, etc.). 
The exercise score is the mean number of days for items five and six.  The blood glucose testing 
score is the mean number of days for items seven and eight.  The foot care score is the mean 
number of days for items 9 and 10.  The smoking status score is “0” for “nonsmoker” or “1” for 
“smoker.”  Higher scores correspond to participating in self-care behaviors more frequently, with 
the exception of the scoring for item 11 (Toobert & Glasgow, 1994; Toobert et al., 2000)  The 
SDSCA was available in the public domain and permission for use was also provided by Dr. 
Toobert.   
The SDSCA was developed by Toobert and Glasgow (1994).  Three different studies 
were conducted to perform a factor analysis and test the validity and reliability of the SDSCA on 
various sample populations (Toobert & Glasgow, 1994).  Factor analysis was used to assess the 
overall structure of the tool. Three factors were assessed including self-care/adherence, exercise, 
and glucose testing.  All items loaded highly on their intended factor in all three studies.  Based 
on the results of the factor analysis, the SDSCA questionnaire was broken down into three 
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subscales of diet, exercise, and glucose testing.  The average inter-item correlations within each 
SDSCA subscale exceeded .50.  For test-retest reliability the 127 participants in the first study 
we retested six months later, with results ranging from .43 to .58 (Toobert & Glasgow, 1994).     
Face, content, concurrent, and predictive validity were also assessed. The content of the 
SDSCA was collected by a group of experts assembled by the RAND Corporation in an effort to 
study self-care activities in people with diabetes.  The authors note that the SDSCA has face 
validity because it “inquires only about diabetes-related information and specifically about the 
areas of the diabetes regimen for which most patients have daily recommended activities 
(Toobert & Glasgow, 1994, p. 363).”  Concurrent validity was assessed through analysis using 
correlations of SDSCA subscale scores with relevant self-monitoring, behavior inventories, 
interviews, and/or reflective meter measures.  For all of the subscales, concurrent validity was 
determined through statistically significant correlations.  The predictive validity was not 
determined, as the authors attempted to predict HbA1c values using the SDSCA subscales, 
however no significant associations were found.  The authors determined that based on the data 
collected, the SDSCA is a valid and reliable tool for assessing self-care practices among patients 
with diabetes (Toobert & Glasgow, 1994).    
 HbA1c values.  The HbA1c value is a result from HbA1c blood test.  It can also be 
referred to as the glycated hemoglobin, glycosylated hemoglobin, and HbA1c.  This blood test 
can determine both the presence of diabetes mellitus and the degree of glycemic control, which is 
how well a patient is managing his or her blood glucose levels.  The HbA1c test reflects the 
average blood sugar level over the past 2-3 months.  A normal HbA1c level for a person who 
does not have diabetes is from 4.5-6 percent.  Someone with uncontrolled diabetes will have a 
level above 9 percent.  For most patients with Type 2 diabetes, a level of 7 percent or less is 
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considered representative of well-managed diabetes (American Diabetes Association, 2013).  In 
patients with diabetes mellitus, the HbA1c level will be normal or slightly elevated (7% or less) 
if blood glucose levels are optimally managed over an 8-12 week period.  If glucose levels have 
not been controlled, the HbA1c levels will be elevated (greater than 7%).  HbA1c levels are 
considered good indicators of long-term glycemic control (Joslin Diabetes Center, 2016; Mayo 
Clinic, 2016). 
 If not drawn within the two months prior to the consultation, the care provider will give 
the patient a new laboratory order for a HbA1c test. The patient will need to go to an appropriate 
laboratory, as designated by their insurance, to have their HbA1c level drawn within the next two 
months, in addition to any other lab work that is ordered by their care provider. The patient will 
register at the laboratory and the phlebotomist will draw blood from the patient to collect the 
HbA1c level.  The blood samples will be analyzed and reported back to the care provider, 
according to laboratory policy.  The HbA1c level will need to be drawn either within two months 
following the consultation, or if there has been a value drawn within the previous two months 
prior to the consultation, that value can be used.  HbA1c results will also be accepted from rapid 
test machine that may or may not be available at the primary care offices.   
Procedures for Data Collection 
 Only data related to the variables of this study will be collected from the patient.  All 
information related to the patient will be obtained directly from the patient with the exception of 
HbA1c values. The HbA1c values will be obtained via the electronic health record, only after a 
consent form has been signed by the patient.  The PI has extensive training using the electronic 
health record program that will be used to obtain the HbA1c values. The PI will complete a 
HIPPA agreement with the health system and will be granted access to the HbA1c values for the 
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purpose of this study.   All written data pertaining to the patients will be kept in a locked file 
cabinet at the PI’s home of which only the PI will access.  The written data obtained from the 
patients will be de-identified and entered into a password protected, computerized database. Each 
participant will be given a random identification number as part of the data collection process.  
Only the PI will know the patient identification codes.  Patient names with corresponding code 
numbers will be kept on a master list that will be stored in a locked file that is separate from the 
data.  Hard copies of the demographics forms and questionnaires will be number coded to allow 
the PI to identify the data appropriately. No patient identifiers will be entered into the computer 
database.  Only the identification numbers will be entered into the database.   There will be no 
identifying information on the patient questionnaires.   
  All raw data will be checked for errors by the PI by reviewing each individual form to 
ensure the responses are within the limits of the appropriate responses, as designated by the 
directions provided for each instrument used in this proposed study.   The PI will then enter the 
data in to the database and check the entered data against the written data for accuracy.   
Data Analysis 
  The SPSS software package version 20.0 will be used to analyze the data.  The data will 
first be screened to ensure accuracy of the values and assess for any missing values.  Univariate 
normality will be assessed among each of the variables.  Histograms, skewness, kurtosis, means, 
SDs, and frequencies will be evaluated for each of the variables.  Outliers will be identified by 
examining standardized residuals.  Mahalanobis distance (D2) can also be used to evaluate 
outliers by comparing individual values to a standardized value table.  The underlying 
assumptions for each statistical analysis will then be examined.   
 86 
 
 For ease of understanding, the types of data for each tool are as follows. The PAM scores 
range from 0-100, meaning they are ratio data.  The PACIC scores are based on a Likert-type 
scale. Therefore the data is interval.  The SDSCA scores are based on the total number of days 
reported by the patient, meaning this is ratio because there can be zero days reported.  The FPI 
scale scoring is also a Likert-type scale. This data is interval.  The PICS tool is scored using “0” 
if the patient disagrees with the statement or “1” if the patient agrees, and a total score out of 13 
is derived. This type of scoring requires the data to be interval. The HbA1c levels are measured 
on a ratio scale.  Values can range anywhere from 0 and beyond.  A level of 7 or less is 
considered optimal for a person with Type 2 diabetes.  Levels in excess of 7 are associated with 
poor control (Joslin Diabetes Center, 2016; Mayo Clinic, 2016).  Type of care provider will have 
to be coded for each respective group, NP or physician, making this nominal data. Referrals will 
be coded yes or no, making this nominal data.   
 Research Question 1.  Among Type 2 diabetic patients, do levels of patient activation, 
participation in decision-making for treatment planning, and facilitation of patient involvement 
in care affect HbA1c levels and patients’ performance of self-care behaviors?   A multiple 
regression will be used to analyze the data with an alpha set at .05.  Assumptions for multiple 
regression will first be assessed. The first assumption requires ratio or interval level data for the 
dependent variable. Both HbA1c levels and SDSCA scores are ratio level data. The PAM, PICS, 
and FPI scores are all either ratio or interval level data, and do not require any special coding as 
part of the analysis. The second assumption is that the data is randomly and independently 
sampled. Participation in this research study is strictly on a volunteer basis and at a variety of 
different primary care offices, therefore the data is randomly and independently sampled.  The 
fourth assumption is related to homoscedasticity of the data, which is for each value of X, the 
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variability of Y scores must be about the same, and vice versa. The assumption of equal 
variances will be examined by examining the standardized residual plots against the standardized 
predicted values.  The shape should be approximately rectangular to satisfy the assumption. The 
next assumption is that variables being correlated are assumed to have an underlying distribution 
that is bivariate normal, meaning scores on variable X are assumed to be normally distributed for 
each value of variable Y, and vice versa.  This assumption will be tested by examining scatter 
plots for each of variables against HbA1c levels and against SDSCA scores.  Data needs to 
appear linear to satisfy assumption.  Correlations among variables will also need to be assessed 
to ensure that none of the pairs are too highly correlated. Tolerance will be evaluated for each 
predictor variable.  Tolerance values fall between 0 and 1.0, with higher values being more 
desirable (Polit, 2010c).    
 Using the SPSS output, inferences will be made from the data.  After controlling for the 
type of medication used by the patient and the length of time each patient has been diagnosed as 
having Type 2 diabetes, the R2 in the model summary will indicate the percentage of variability 
in HbA1c scores and percentage of variability in SDSCA scores that can be accounted for based 
on the PAM, PICS, and FPI scores.  To evaluate the overall fit of the model, the F values and p 
values from the ANOVA table will be examined.  A p value < .05 would indicate significant 
findings.  The b-weights and standard errors of the predictor variables will be evaluated.  Larger 
standard error values are considered to be unreliable.  The standardized β value will represent the 
correlation between PAM, PICS, and FPI scores and SDSCA and HbA1c levels, while 
controlling for other variables, with the statistical significance (p < .05) based on the t 
distribution.  These values will be presented in the tables as each predictor variable is entered 
into the model.  The 95% confidence interval (CI) will also be evaluated; this is the 95% 
 88 
 
likelihood that the β value for PAM, PICS, and FPI scores in the population fall between the 
lower and upper portion of the 95% CI.  The zero-order, part, and partial correlations for each 
predictor variable will also be evaluated.  Zero-order correlations will look at the bivariate 
correlations.  Partial correlations will give values while controlling for other variables.  Semi-
partial correlations will look at the unique contributions of each variable.  All of these will be 
examined to determine the specific ways the variables affect the SDSCA scores and HbA1c 
levels in patients with Type 2 diabetes.  Using Cohen’s guidelines of effect size, an a priori 
power analysis could be performed. In this case, R2 = .10 (small to moderate effect) would be 
used to determine a sample size of 112 participants would be necessary to ensure the study had a 
power of .80 (Polit, 2010c).  If the results of the multiple regression analysis are insignificant, 
post hoc testing can be performed using the calculated R2 to test if the sample size is too small or 
to verify that there truly is no relationship between the variables (Polit, 2010c).   
Research question 2. Based on the CCM, what are the effects of Delivery System Design 
and Clinical Information Systems, together with patient perceptions of Decision Support, Self-
Management Support, and Community Resources on HbA1c levels and participation in self-care 
behaviors for patients with Type 2 diabetes?  A multiple regression will be used to analyze the 
data with an alpha set at .05.  Assumptions for multiple regression will first be assessed. The first 
assumption requires ratio or interval level data for the dependent variable. Both HbA1c levels 
and SDSCA scores are ratio level data. The PACIC subscale scores for decision support, self-
management support, and community resources are interval data. The data related to the patient 
referrals (REF), whether patient goals were discussed (PG), and if any printouts (PO) were given 
to the patient related to goals of treatment or test results for patient care will need to be dummy 
coded for appropriate use in the multiple regression analysis. The REF responses will be either 
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yes or no. Yes will be coded “1” and No will be coded “0”.  The discussion of goals will also be 
a yes/no response and will be coded “1” for Yes and “0” for No.  Whether the patient received 
any printouts from the care providers will also be dummy coded “1” for Yes and “0” for No.  
The second assumption is that the data is randomly and independently sampled. Participation in 
this research study is strictly on a volunteer basis and at a variety of different primary care 
offices, therefore the data is randomly and independently sampled.  The fourth assumption is 
related to homoscedasticity of the data, which is for each value of X, the variability of Y scores 
must be about the same, and vice versa. The assumption of equal variances will be examined by 
examining the standardized residual plots against the standardized predicted values.  The shape 
should be approximately rectangular to satisfy the assumption.  The next assumption is that 
variables being correlated are assumed to have an underlying distribution that is bivariate 
normal, meaning scores on variable X are assumed to be normally distributed for each value of 
variable Y, and vice versa.  This assumption will be tested by examining scatter plots for each of 
variables against HbA1c levels and against SDSCA scores.  Data needs to appear linear to satisfy 
assumption.  Correlations among variables will also need to be assessed to ensure that none of 
the pairs are too highly correlated. Tolerance will be evaluated for each predictor variable.  
Tolerance values fall between 0 and 1.0, with higher values being more desirable (Polit, 2010c).     
Using the SPSS output, inferences will be made from the data.  After controlling for the 
type of medication used by the patient and the length of time each patient has been diagnosed as 
having Type 2 diabetes, the R2 in the model summary will indicate the percentage of variability 
in HbA1c scores and percentage of variability in SDSCA scores that can be accounted for based 
on the PACIC scores and the presence of chart documented referrals (REF), discussion of patient 
goals (PG), and whether any printouts were given to the patient (PO) (which will be dummy 
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coded, 0-No, 1-Yes for REF, PG, and PO).  To evaluate the overall fit of the model, the F values 
and p values from the ANOVA table will be examined.  A p value <.05 would indicate 
significant findings.  The b-weights and standard errors of the predictor variables will be 
evaluated.  Larger standard error values are considered to be unreliable.  The standardized β 
value will represent the correlation between PACIC scores, REF, PG, PO and SDSCA and 
HbA1c levels, while controlling for other variables, with the statistical significance (p<.05) 
based on the t distribution.  These values will be presented in the tables as each predictor variable 
is entered into the model.  The 95% confidence interval (CI) will also be evaluated; this is the 
95% likelihood that the β value for PACIC scores, REF, PG, and PO in the population fall 
between the lower and upper portion of the 95% CI.  The zero-order, part, and partial 
correlations for each predictor variable will also be evaluated.  Zero-order correlations will look 
at the bivariate correlations.  Partial correlations will give values while controlling for other 
variables.  Semi-partial correlations will look at the unique contributions of each variable.  All of 
these will be examined to determine the specific ways the variables affect the SDSCA scores and 
HbA1c levels in patients with Type 2 diabetes.  Using Cohen’s guidelines of effect size, an a 
priori power analysis could be performed. In this case, R2 = .10 (small to moderate effect) would 
be used to determine a sample size of 112 participants would be necessary to ensure the study 
had a power of .80 (Polit, 2010c).  If the results of the multiple regression analysis are 
insignificant, post hoc testing can be performed using the calculated R2 to test if the sample size 
is too small or to verify that there truly is no relationship between the variables (Polit, 2010c).    
Research question 3.  Is there a difference in levels of patient activation, participation in 
decision-making, and facilitation of patient involvement in care when a nurse practitioner treats 
a patient compared to a physician? To answer this question, an ANCOVA analysis will be 
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completed.  There will be three ANCOVA models. The first model will use PAM scores as the 
dependent variable, the second model will use the PICS scores as the dependent variable, and the 
third model will use the FPI scores as the dependent variable.   
The data will first be screened to ensure the assumptions for ANCOVA are met. The first 
and second assumptions are related to data level. Covariates are usually continuous interval or 
ratio level variables. The covariate of length of time for patients since being diagnosed as having 
Type 2 diabetes is ratio data.  The PAM scores are ratio data. The PICS and FPI scores are 
interval data.  The type of care provider, being a nurse practitioner or a physician, will be coded 
as nominal data because the independent variable in ANCOVA is always nominal (Polit, 2010a).    
The third assumption requires that there is random selection of subjects.  The selection of 
participants will be on a volunteer basis and random to ensure this assumption is met.  The fourth 
assumption requires that the dependent variable be normally distributed.  A visual examination 
of histograms will ensure that this assumption is not violated (Polit, 2010a).     
The fifth assumption is that there is homogeneity of variance. This will be examined 
using Levene’s test for equality of variance.  A non-significant Levene’s test indicates the 
variance between the groups is most likely equal.  The sixth assumption is that the relationship 
between the dependent variable and covariates is linear. Scatterplots will be evaluated, assessing 
for any curvilinearity.  If a covariate is found to have curvilinear relationship with the dependent 
variable, the variable could be transformed as appropriate.  The seventh assumption is that 
relationships between all pairs of covariates are linear. Scatterplots will again be examined to 
assure this assumption is not violated. The eighth and final assumption is that there is 
homogeneity of regression across groups. The covariate should have the same relationship with 
the dependent variable in every group.  Regression lines will be examined and should be parallel 
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to each other to prevent any violation of this assumption and any increased risk of type II errors. 
The assumption of homogeneity of regression across groups can also be tested in SPSS using an 
interaction term in the analysis.  If the interaction term is statistically significant, ANCOVA 
should not be used.  The researcher will also be mindful of cases of multicollinearity.  
Independent variables and covariates that are too highly correlated (.85 or greater) will not be 
included in the analysis (Polit, 2010a).   
The ANCOVA table for each model from the SPSS output will be evaluated.  After 
controlling for the length of time each patient has been diagnosed as having Type 2 diabetes,  the 
researcher will be looking for F values that are statistically significant (p<.05) in order to reject 
the null hypothesis that the adjusted group means are equal.  Parameter estimates will also be 
examined, including b weights, standard errors, t statistics, and significant levels for each 
component in both models.  CIs around the b weights will also be examined. If 0.00 is included 
in the CI range, then the results are not significant.  The partial eta2 will be evaluated for net 
effect size in each respective model. The partial eta2 will indicate the percentage of variance 
accounted for by PAM, PICS, and FPI scores.   Adjusted means will be examined along with the 
95% CI’s around them.  Post hoc tests for pairwise comparisons using the Bonferroni multiple 
comparison procedure, which adjusts for the inflated risk of a Type I error with multiple 
comparisons will be evaluated (Polit, 2010a).   
Research question 4. Do patients who see nurse practitioners for management of Type 2 
diabetes experience higher levels of engagement in self-care behaviors and more therapeutic 
HbA1c levels compared to patients who see a physician?  To answer this question, an ANCOVA 
analysis will be completed.  There will be two ANCOVA models. The first model will use 
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HbA1c levels as the dependent variable and the second model will use the SDSCA scores as the 
dependent variable.   
The data will first be screened to ensure the assumptions for ANCOVA are met. The first 
and second assumptions are related to data level. Covariates are usually continuous interval or 
ratio level variables. The covariates of type of medication used by the patient is categorical data 
and the length of time each patient has been diagnosed as having Type 2 diabetes is continuous 
interval data. The HbA1c levels and the SDSCA scores will be ratio data. The type of care 
provider, being a nurse practitioner or a physician, will be coded as nominal data because the 
independent variable in ANCOVA is always nominal (Polit, 2010a).     
The third assumption requires that there is random selection of subjects.  The selection of 
participants will be on a volunteer basis and random to ensure this assumption is met.  The fourth 
assumption requires that the dependent variable be normally distributed.  A visual examination 
of histograms will ensure that this assumption is not violated (Polit, 2010a).    
The fifth assumption is that there is homogeneity of variance. This will be examined 
using Levene’s test for equality of variance.  A non-significant Levene’s test indicates the 
variance between the groups is most likely equal.  The sixth assumption is that the relationship 
between the dependent variable and covariates is linear. Scatterplots will be evaluated, assessing 
for any curvilinearity.  If a covariate is found to have curvilinear relationship with the dependent 
variable, it is best to eliminate it from the analysis.  The seventh assumption is that relationships 
between all pairs of covariates are linear. Scatterplots will again be examined to assure this 
assumption is not violated. The eighth and final assumption is that there is homogeneity of 
regression across groups. The covariate should have the same relationship with the dependent 
variable in every group.  Regression lines will be examined and should be parallel to each other 
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to prevent any violation of this assumption and any increased risk of type II errors. The 
assumption of homogeneity of regression across groups can also be tested in SPSS using an 
interaction term in the analysis.  If the interaction term is statistically significant, ANCOVA 
should not be used.  The researcher will also be mindful of cases of multicollinearity.  
Independent variables and covariates that are too highly correlated (.85 or greater) will not be 
included in the analysis (Polit, 2010a).    
The ANCOVA table for each model from the SPSS output will be evaluated. The 
researcher will be looking for F values that are statistically significant (p<.05) in order to reject 
the null hypothesis that the adjusted group means are equal.  Parameter estimates will also be 
examined, including b weights, standard errors, t statistics, and significant levels for each 
component in both models.  CIs around the b weights will also be examined. If 0.00 is included 
in the CI range, then the results are not significant.  The partial eta2 will be evaluated for net 
effect size in each respective model.  Adjusted means will be examined along with the 95% CI’s 
around them.  Post hoc tests for pairwise comparisons using the Bonferroni multiple comparison 
procedure, which adjusts for the inflated risk of a Type I error with multiple comparisons will be 
evaluated (Polit, 2010a). 
Human Participants and Ethics Precautions 
 The study will be reviewed and approved by Duquesne University Institutional Review 
Board (IRB) and the Allegheny-Singer Research Institute at Allegheny General Hospital, the 
research review body for primary care practices of Allegheny Health Network.  Office staff or 
care providers who will have knowledge of the study and a direct relationship with potential 
participants will obtain verbal consent from the potential participants to permit the Primary 
Investigator (PI) to discuss the study with those patients.  Once a verbal consent is to approach 
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the patient about participation, the PI will explain the study in detail and answer any questions 
from the potential participant before beginning any data collection.  Participants will only 
approached by the PI after verbal consent has been obtained.   After the study is thoroughly 
explained, the consent form is reviewed with each participant, and the participant verbally agrees 
to proceed with the study, a written consent will be then obtained from the participant.   
After obtaining written consent, a packet of five questionnaires and a demographics form will be 
given to the participant.  The questionnaires and demographics form will be explained to the 
participants by the PI to clarify any questions or confusion that the participants may have.  The 
participants can complete the form and questionnaires immediately following the office visit, 
they can return the forms at the following visit, or they can complete the packet at home and mail 
the information directly to the PI (each packet will contain a stamped, addressed envelope for the 
convenience of the participant).  The participants will be reminded to get their prescribed 
laboratory work, which will include a HbA1c level, if they have not had this lab work drawn 
prior to the consultation visit at which they were enrolled in the study.   
 The consent form will be reviewed with the participants and a copy of the consent will be 
given to each participant.  All participants will be made aware that the risk of participating in the 
study is minimal.  The patients will be receiving no extra treatment or invasive procedures, other 
than the normal recommended blood tests they would be getting as part of their usual care 
regardless of whether they participated in the study.  The participants will be made aware that a 
small amount of time (at most 30 minutes) is required to complete the necessary questionnaires.  
Participants will be informed that their electronic health record will be accessed by the PI to 
obtain the HbA1c level results.  No other information in the EHR will be accessed. A consent 
form will be signed, allowing the PI to gain access to the electronic health record.  There will be 
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a minimal risk of breach of confidentiality related to the written information and access of the 
electronic health records.  The information will be stored in a secure manner and the PI will be 
the sole possessor of the data.  Collected data will only be shared with limited personnel and no 
patient identifiers will ever be shared.  Each participant will be given a random identification 
number as part of the data collection process.  Only the PI will know the patient codes.  Hard 
copies of the demographics forms and questionnaires will be number coded to allow the PI to 
identify the data appropriately. No patient identifiers will be entered into the database, which will 
be stored on a password-protected computer.  Only the identification numbers will be entered 
into the database.  Patient names with corresponding code numbers will be kept on a master list 
that will be stored in a locked file that is separate from the data.  Hard copies of the 
questionnaires will be kept in a locked file cabinet that only the PI will have access to, and will 
be kept separate from the master list containing patient names and numeric codes.  
In order to reduce as much risk as possible, several precautions will be taken to ensure 
the participants’ confidentiality is not breached.  No unique identifiers related to the patient will 
be obtained, such as address, phone number (except in the case of patients taking packet of 
questionnaires home to return via mail), social security number, insurance information, medical 
record number, etc.  The PIs electronic database will be secure and password protected.  The 
paper and electronic data will be destroyed as soon as possible after academic requirements have 
been fulfilled and research findings have been disseminated.   
 The participants in this study will not gain any immediate benefit by taking part in this 
study.  The potential benefits that could be derived from this proposed study for future Type 2 
diabetic patients are related to the types of care providers that patients may benefit from seeing. 
Additional possible benefits are related to how care providers encourage, or facilitate, the 
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involvement of patients in care and decision-making related to the management of Type 2 
diabetes.  The results of this proposed study could have an effect on the approaches that are 
taken, by both care providers and patients, when working to manage blood sugars in patients 
dealing with Type 2 diabetes.  The risks encountered are not greater than those encountered in 
everyday life. 
Conclusion 
 This chapter provides the details of how this proposed study will be carried out and what 
instruments will be used to collect data. The instruments have been thoroughly evaluated and 
analyzed in the literature, allowing for confidence when using these instruments in the proposed 
study.  The proposed data analysis process will provide a thorough and accurate analysis of the 
information collected from the participants in this proposed study.  The results of this proposed 
study could be beneficial to future patients dealing with Type 2 diabetes, including benefits by 
selecting a type of care provider, and may provide information that can promote more patient 
involvement and collaborative approaches to the management of Type 2 diabetes.  
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Chapter 4 
Data Analysis and Results 
Background and Significance of this Study  
Type 2 diabetes is currently a significant epidemic in the United States (US), and was the 
seventh leading cause of death based on US death certificates (Centers for Disease Control and 
Prevention, 2015).  The Centers for Disease Control and Prevention estimates that one out of 
three people will develop type 2 diabetes, and current statistics report that 25.6 million people 
ages 20 and older currently have type 2 diabetes (Centers for Disease Control and Prevention, 
2015; National Institutes of Health and the Centers for Disease Control and Prevention, 2011).  
In 2012, there were 1.7 million people with new diagnoses of type 2 diabetes, and it is projected 
that by the year 2050, one out of every three individuals will develop type 2 diabetes (Centers for 
Disease Control and Prevention, 2015; Venkat Narayna et al., 2006).  The total estimated costs, 
both direct and indirect, related to diabetes in 2013 was $254 billion, and those with diabetes 
have medical costs that are 2.3 times higher than those without diabetes (Centers for Disease 
Control and Prevention, 2015). Evidence shows that diabetes is poorly controlled throughout the 
United States (Fisher, Thorpe, McEvoy Devellis, & DeVellis, 2007; Lynch & Egede, 2011).  
Despite all of the research that has demonstrated the importance of optimal control of diabetes, 
there are still many people who do not receive adequate care, education, and support in 
managing their diabetes (Barnard et al., 2012; Rossi et al., 2015).   
Because Type 2 diabetes is a chronic disease, the Chronic Care Model (CCM) was used 
as a guide for this study. The CCM was developed at the MacColl Center for Health Care 
Innovation at the Group Health Research Institute in the mid-1990s and recognizes the crucial 
elements of the health care system that encourage “high-quality chronic disease care.”  These 
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elements include “the community, the health system, self-management support, delivery system 
design, decision support, clinical information systems, patient safety, cultural competency, care 
coordination, community policies, and case management” (Robert Wood Johnson Foundation, 
2016a; Robert Wood Johnson Foundation, 2016e).  The model synthesizes self-management 
support, delivery system design, decision support, and clinical information systems with 
productive interactions between informed, activated patients, and prepared, proactive practice 
team members for improved patient outcomes.  The overall goal of applying this model is to 
have healthier patients, more satisfied health care providers, and cost saving.  The CCM has been 
used in research studies, including studies that focused on the management of Type 2 diabetes 
and has shown to be a beneficial framework for providing care to patients with Type 2 diabetes 
(Bodenheimer et al., 2002b; Dancer & Courtney, 2010; Frei et al., 2014; Koh, Brach, Harris, & 
Parchman, 2013; National Institutes of Health and the Centers for Disease Control and 
Prevention, 2011; Parchman, Michael L,MD, MPH et al., 2007; Peterson, Blackburn, Phillips, & 
Puffer, 2014; Robert Wood Johnson Foundation, 2016a; Siminerio et al., 2006; Stellefson, 
Dipnarine, & Stopka, 2013).  Studies evaluating the incorporation of the CCM into care for 
patients with Type 2 diabetes found improved HbA1c levels, improved lipid ratios, improved 
blood pressure, higher rates of smoking cessation, and higher rates of self-monitoring of blood 
glucose levels (Frei et al., 2014; Koh et al., 2013; Nutting et al., 2007; Peterson et al., 2014; Piatt 
et al., 2006; Siminerio et al., 2005; Stellefson et al., 2013).  
The CCM is different from traditional models and approaches to management of chronic 
diseases because the main foci are self-management training, counseling, and tracking patient 
care (Stellefson et al., 2013).  Self-management support and counseling prepares patients to take 
an active role in the management of Type 2 diabetes (Glasgow et al., 2001; Stellefson et al., 
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2013).  By having a system that tracks patient appointments, laboratory studies, and upcoming 
recommendations for patient care, the continuity of care becomes more effective and has an 
increased likelihood of improved patient outcomes (Stellefson et al., 2013).   
Figure 3. The Chronic Care Model Operationalized 
 
There are two overarching umbrellas that make up the CCM (figure 3), the health system 
and the community. Under the health system umbrella, delivery system design, clinical 
information systems, and decision support are an intertwined set of variables that directly relate 
to the organization of health care for patients with chronic diseases (Robert Wood Johnson 
Foundation, 2016a).  These variables are health care providers centered, focusing on how care is 
delivered to the patients, and include evidence-based care, ensuring follow-up care, culturally 
appropriate care, sharing evidence-based guidelines and information to encourage patient 
participation in care, integrating specialist expertise in care, using appropriate decision support 
and reminder tools, facilitating individual care planning, and sharing of information among 
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patients and provider (Robert Wood Johnson Foundation, 2016a; Robert Wood Johnson 
Foundation, 2016d; Robert Wood Johnson Foundation, 2016e; Robert Wood Johnson 
Foundation, 2016f; Robert Wood Johnson Foundation, 2016g).    
Under the community umbrella, there is community resources and self-management 
support. Self-management focuses on the concept of the patient having the prominent role in 
managing their personal health (Robert Wood Johnson Foundation, 2016g).  Self-management 
support refers to the activities that help to prepare the patient to manage their health such as  
checking blood glucose levels, medication adherence, eating a particular diet, following an 
exercise regimen, checking feet regularly, smoking cessation, and reducing alcohol intake, which 
are necessary to improve outcomes, specifically HbA1c levels among patients with Type 2 
diabetes (Funnell et al., 2009; Robert Wood Johnson Foundation, 2016f; Toobert et al., 2000; 
Wang & Fenske, 1996; Weinger et al., 2005).  According to the National Standards for Diabetes 
Self-Management Education (Funnell et al., 2009), patients should have a personalized follow-up 
plan that should be developed by the patient and educator addressing  desired outcomes and 
goals of treatment, as well as a plan for ongoing self-management support and reminders for 
follow-up care.   Benefits related to Diabetes Self-Management Education have been recognized 
by the American Diabetes Association and are considered an integral piece of diabetes care to 
strengthen the ability of patients to self-manage (Siminerio et al., 2006; Siminerio et al., 2004; 
Stellefson et al., 2013; Wagner, 1998).  Successful self-management and education programs 
help the patient to better understand the goals, priorities, barriers, and potential problems that can 
arise when dealing with Type 2 diabetes, especially because the cost and complications 
associated with diabetes are often preventable when blood sugar levels are well controlled 
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(Glasgow & Anderson, 1999; Glasgow et al., 2001; Glasgow, Toobert, & Gillette, 2001; Koh et 
al., 2013; Stuckey et al., 2009; Von Korff & Gruman, 1997).   
The CCM builds on the Community and Health System elements, combining them with 
productive interactions between patients and health care providers (Robert Wood Johnson 
Foundation, 2016e).  Combining these elements together, is what ultimately leads to improved 
outcomes for patients with type 2 diabetes (Robert Wood Johnson Foundation, 2016e).  
Informed, activated patients are those patients who have the ability and desire to actively engage 
in their health care and participate in the decision-making related to their treatment (Hibbard & 
Greene, 2013).   Prepared, proactive care providers actively engage in a shared decision making 
process, and facilitate the patient’s involvement in their care (Hibbard & Greene, 2013).  
Many patients with type 2 diabetes are managed by primary care offices, with an increase 
in nurse practitioners managing the care of these patients (American Diabetes Association, 
2013a).  Varied data exist comparing patient outcomes for nurse practitioners and physicians 
(Chang et al., 2007; Fain & Melkus, 1994; Kinnersley et al., 2000; Roblin et al., 2004; Rudy et 
al., 1998; Salisbury & Tettersell, 1998; ter Bogt et al., 2011; Venning et al., 2000).  The literature 
is inconsistent related to patient provider preferences (Horrocks et al., 2002; Lenz et al., 2002; 
Mundinger et al., 2000; Roblin et al., 2004; Rudy et al., 1998; Salisbury & Tettersell, 1998; ter 
Bogt et al., 2011; Venning et al., 2000).  In patients with diabetes, there are data to show that 
nurses and nurse practitioners can improve patient outcomes through various interventions and 
programs in conjunction with physicians; however, little data exist to show a significant 
difference in patient outcomes for patients strictly seeing nurse practitioners rather than 
physicians (Chang et al., 2007; Hoffman et al., 2005; Litaker et al., 2003; Renders et al., 2001; 
Taylor et al., 2003; ter Bogt et al., 2011).  In general, the data related to the variations in care 
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from nurse practitioners and physicians do not show a clear advantage of one health care 
provider over another. The studies have shown positive, negative, and neutral results related to 
measured outcomes for patients who see nurse practitioners rather than physicians (Eisenstat, 
Ulman, Siegel, & Carlson, 2013; C. Everett et al., 2013; C. M. Everett et al., 2013; Fain & 
Melkus, 1994; Horrocks et al., 2002; Kinnersley et al., 2000; Lenz et al., 2002; Litaker et al., 
2003; Mundinger et al., 2000; Ohman-Strickland et al., 2008; Roblin et al., 2004; Rudy et al., 
1998; Salisbury & Tettersell, 1998; Stanik-Hutt et al., 2013; Venning et al., 2000).  Further 
exploring patient outcomes when comparing health care providers (physicians and nurse 
practitioners) was a main goal of this study.   
Health care providers’ actions and approaches to patient care may impact health 
outcomes for patients with type 2 diabetes.  Health care providers can shift their focus from 
personal perceptions and managing lab values to actively facilitating, or encouraging, patients to 
be involved in their own healthcare (Freeman & Loewe, 2000; Martin et al., 2001).  Provider 
behavior can facilitate the patient’s involvement in managing their health (Martin et al., 2001).  
When health care providers  take into account the patients’ perspectives to provide a more 
personal approach to management, patients recognize that their health care provider has 
facilitated their involvement in care, thus leaving patients more satisfied with care and  more 
adherent to treatment plans (Martin et al., 2001; Vijan et al., 2005). 
Guided by the CCM, the focus of this research study was to examine the elements of the 
CCM, which include community resources, self-management support, delivery system design, 
decision support, clinical information systems, along with patient activation, facilitation of 
patient involvement by health care providers, and patient participation in the decision-making 
process, for their effect on patient hemoglobin A1c levels and participation in self-care 
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behaviors.  This study also explored if type of heath care provider caring for the patient impacted 
components of the CCM or type 2 diabetes-specific outcome measures. The results of this study 
can offer information to improve patient outcomes by providing a comprehensive picture of the 
needs of patients with type 2 diabetes based on the CCM.  
Research Questions 
1. Based on the Chronic Care Model, what are the effects of delivery system design and 
clinical information systems, together with patient perceptions of decision support, self-
management support, and community resources on hemoglobin A1c levels and participation 
in self-care behaviors for patients with type 2 diabetes? 
2. Among Type 2 diabetic patients, do levels of patient activation, participation in decision-
making for treatment planning, and facilitation of patient involvement in care affect HbA1c 
levels and patients’ performance of self-care behaviors?  
3. Do patients who see nurse practitioners for management of type 2 diabetes experience 
higher levels of engagement in self-care behaviors and more therapeutic HbA1c levels 
compared to patients who see a physician? 
4. Is there a difference in levels of patient activation, participation in decision-making, and 
facilitation of patient involvement in care when a nurse practitioner treats a patient 
compared to a physician? 
Methods 
Research Design and Procedures 
Using the comprehensive structure of the CCM, this cross-sectional, descriptive study 
examined patient activation, facilitation of patient involvement, participation in the decision-
making process, decision support, delivery system design, clinical information systems, referral 
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to community resources, and self-management support for their effect on self-care behaviors and 
HbA1c levels among patients with Type 2 diabetes seen by nurse practitioners and physicians in 
the primary care setting.  Patients completed six instruments to measure demographic variables, 
the independent variables, and the outcome of patient self-care behaviors at one time point after a 
routine consultation with their physician or nurse practitioner. HbA1c values were examined 
within six months prior to or two months following the data collection visit. 
Data collection for this study was completed in five primary care offices throughout 
Western Pennsylvania and Eastern Ohio. Two of the offices cared for underserved members of 
the community and did not require health insurance for provision of services.  The study was 
approved by a university Institutional Review Board, and all participants signed a consent form 
to participate in the study, which included completing six questionnaires and giving permission 
for the nurse in the office to provide the researcher with their HbA1c value.   
Instruments- Independent Variables 
 Instruments used to collect data related to the independent variables include a 
demographic form, Patient Activation Measure, Facilitation of Patient Involvement Scale, 
Perceived Involvement in Care Scale, and Patient Assessment of Care for Chronic Conditions.   
The dependent variables were measured using the Summary of Diabetes Self-Care Activities 
Scale and a Hemoglobin A1c level.    
 Demographic Form. Participants completed a 17-item, researcher developed 
demographics tool. In addition to describing the sample of this proposed study, the tool was used 
to assess delivery system design and the use of clinical information systems. Delivery system 
design was assessed by asking patients to report about follow-up appointments, referrals to other 
health care providers/specialists, and they length of time they have had a relationship with their 
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health care provider. Clinical information systems was assessed with questions related to follow-
up appointments, discussion of goals during the appointment, and receipt of any printouts related 
to the patient’s summary of care at the visit.    
 Patient Activation and the Patient Activation Measure (PAM).  Patient activation can 
be defined as the “patient’s willingness and ability to take independent actions to manage their 
health and care” (Hibbard & Greene, 2013).  A variety of studies have examined patient 
activation using the Patient Activation Measure (PAM) and found that patients who have higher 
PAM scores are more likely to participate in preventative health care and healthy self-care 
behaviors (Becker & Roblin, 2008; Fowles et al., 2009; Greene & Hibbard, 2012; Hibbard et al., 
2004; Hibbard et al., 2005; Hibbard et al., 2007; Mosen et al., 2007).  Along with increased 
participation in preventative care and health behaviors, studies have also shown a link between 
increased patient activation and improved patient outcomes, more specifically, improvements in 
Hemoglobin A1c, blood pressure, and cholesterol levels (Greene & Hibbard, 2012; Hibbard & 
Greene, 2013; Remmers et al., 2009).  Research also suggests that patients who have higher 
levels of patient activation are more satisfied with the care they receive from their provider, and 
also have lower costs associated with their health care, such has less hospitalizations and 
emergency department visits than those with lower activation scores (Greene & Hibbard, 2012; 
Hibbard & Greene, 2013; Remmers et al., 2009).  
The PAM is a 13-item questionnaire and was the instrument used to measure the level of 
patient activation.   Each question is answered by the patient using a scale of 
agreement/disagreement (0-4). The scores range from Not Applicable (0), Disagree Strongly, 
Disagree, Agree, and Strongly Agree (4). Higher PAM scores correlate with higher levels of 
patient activation.  The Rasch Person reliability for the 13-item measure was between .85 and 
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.87; the Cronbach’s alpha was .87 (Hibbard et al., 2004). The Cronbach’s alpha for this study 
was .876.   
 Facilitation of Patient Involvement and the Facilitation of Patient Involvement (FPI) 
Scale. Wolpert and Anderson (2001) stressed that diabetes is a self-managed condition, models 
of care should be focused on promoting more self-care behaviors while stressing the importance 
of glycemic control from the patient’s perspective. While the benefits of tight glycemic control 
are well-established, this is rarely achieved in the general clinical practice arena (Wolpert & 
Anderson, 2001).  In order for health care providers to help their patients achieve well-controlled 
glucose levels, the importance of blood sugar control must be evaluated from the patient’s 
perspective, and the patient’s goals must be incorporated into treatment (Wolpert & Anderson, 
2001).  Moreover, providers and patients have been noted to agree on treatment options when 
patients have more education related to diabetes, stronger beliefs in the efficacy of the prescribed 
treatment program, and share the decision making process with the physician (Heisler et al., 
2003).  
Facilitation of patient involvement was measured by the FPI scale, a 9-item self-report 
questionnaire that measures to what degree patients perceive that their health care provider 
encourages them to be involved in their own healthcare (Martin et al., 2001).    Each item is 
scored using a range of 1 (none of the time) to 6 (all of the time), with total scores ranging from 
9-54.  Higher scores indicate increased patient perception of facilitation of involvement of the 
patient by the health care provider.   The Cronbach’s alpha values to establish internal 
consistency reliability ranged from .89 to .93, and test-retest results were r =.89 (N=44), and r 
=.85 (N=84).  (Martin et al., 2001).  The Cronbach’s alpha for this study was .303.   
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 Participation in Decision-Making and the Involvement in Care Scale (PICS).  
Participation in decision making refers to a patient-centered process by which patient and the 
health care provider share information related to decisions that needs to be made (Barry & 
Edgman-Levitan, 2012; Branda et al., 2013; Wilkinson, Whitehead, & Ritchie, 2014). The 
healthcare provider presents the benefits and risks of possible choices and the patient presents 
their personal values and feelings related to the options (Barry & Edgman-Levitan, 2012; Branda 
et al., 2013; Wilkinson et al., 2014).  A meta-aggregation study examined factors that influence 
the ability of patients to successfully self-manage type 2 diabetes (Wilkinson et al., 2014). 
Patients were found to be more successful at self-management when their health care providers 
showed consideration for the patient’s “feelings, rights, wishes, or traditions” (Wilkinson et al., 
2014), and acknowledgement that both parties had valuable opinions. It was also found that 
patients who reported higher ratings on health care provider participatory decision-making and 
health care provider communication were also found to have higher ratings on self-management 
assessments (Heisler et al., 2003; Heisler et al., 2002; Heisler et al., 2003).   
The PICS measured patient involvement in care and is a 13-item questionnaire that 
assesses patients’ attitudes related to the management of their chronic illness (Lerman et al., 
1990).  Each question is answered with Agree (1) or Disagree (0).  Higher scores are associated 
with an increased patient perception that their health care provider is involving them in the 
decision-making process.  Internal consistency was measured using Cronbach’s alpha with a 
result of α=.73 (N=131) (Lerman et al., 1990).  Cronbach alpha for this study was .76.   
 Patient Assessment of Care for Chronic Conditions (PACIC).  The PACIC is a 20-
item, self-report questionnaire that measures various aspects of the CCM.  The 20 items are 
arranged into 5 subscales including Patient Activation (3 items), Delivery System 
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Design/Decision Support (3 items), Follow-up/Coordination (5 items), Goal Setting (5 items) 
and Problem-solving/Contextual Counseling (4 items) subscales; these latter two scales assess 
self-management support (Robert Wood Johnson Foundation, 2016h).  Each item is answered on 
a scale of 1-5 by the patient choosing how often the items occurred during the course of the 
relationship with their health care provider. Responses range from None of the time (1), A little 
of the time, Some of the time, Most of the time, and Always (5).  Higher scores are associated 
with the patient’s perception that their care is congruent with the goals of the Chronic Care 
Model.  Internal consistency for the PACIC was evaluated using coefficient alpha (α=.93).  
Overall test-retest reliability was r= .58, and individual scale reliabilities ranged from r=.47 to 
.68 (n=52-57).  Validity for the PACIC was correlated moderately to strongly (r=.42-.60) with 
four of the convergent validity measures (Glasgow et al., 2005). Cronbach alpha for this study 
was .948.   
Type of Health Care Provider.  The nurse practitioner has a crucial role in the care of 
patients with chronic diseases (Dancer & Courtney, 2010).  Varied data exist related to 
satisfaction and patient outcomes of nurse practitioners and physicians.  In general, many studies 
that examine generalized patient populations present data that shows patients are more satisfied 
with care and outcomes are improved when being treated by nurse practitioners (Chang et al., 
2007; Condosta, 2012; Eisenstat et al., 2013; C. Everett et al., 2013; C. M. Everett et al., 2013; 
Fain & Melkus, 1994; Kinnersley et al., 2000; Roblin et al., 2004; Rudy et al., 1998; Salisbury & 
Tettersell, 1998; Stanik-Hutt et al., 2013; ter Bogt et al., 2011; Venning et al., 2000).    
Identifying significant differences in patient outcomes and how those differences relate to goals 
of treatment, may influence management styles among physicians and nurse practitioners when 
caring for patients with Type 2 diabetes.  HbA1c values and self-care behavior practices among 
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patients from each type of health care provider (physicians and nurse practitioners) were 
evaluated, in addition to looking at referral and follow-up practices.   
Instruments- Dependent Variables 
Self-Care Behaviors and the Summary of Diabetes Self-Care Activities (SDSCA). 
Self-care refers to a significant set of activities that are important to patient-centered chronic 
illness management (Song & Lipman, 2008).  Effective management of diabetes requires 
complex, continual, and demanding self-care behaviors including  recognizing signs and 
symptoms of the disease, diet control, exercise, blood glucose monitoring, managing physical 
and emotional distress, foot care, smoking cessation, limiting alcohol consumption, medication 
regimens, and utilizing family support and community resources (American Diabetes 
Association, 2016a; Nam et al., 2011; National Institutes of Health and the Centers for Disease 
Control and Prevention, 2011; Song & Lipman, 2008; Wolpert & Anderson, 2001).  Managing 
Type 2 diabetes has proven to be very challenging because of the difficulty and complexity 
involved in making the necessary life-style changes.  Vigilant self-care for patients with Type 2 
diabetes is particularly important because it can help to delay the progression of the disease and 
onset of complications and increases the likelihood that the patient will live a longer, healthier 
life  (Aljasem et al., 2001; Booth, Lowis, Dean, Hunter, & McKinley, 2013; Haas et al., 2013; 
King et al., 2010b; Nam et al., 2011; Nouwen et al., 2011; Powers et al., 2015; Rise, Pellerud, 
Rygg, & Steinsbekk, 2013; Song, 2010; Song & Lipman, 2008; Svenningsson, Marklund, 
Attvall, & Gedda, 2011; Wilkinson et al., 2014).  
The SDSCA is an 11-question, self-report measure about the frequency in which patients 
completed various self-management activities over the preceding seven days. For example, the 
patient reports how many days in the last week they followed a specific diet, checked their blood 
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sugar as directed, and exercised. Based on the results of a factor analysis, three subscales were 
derived:  diet, exercise, and glucose testing (Toobert & Glasgow, 1994).  Two scores are 
obtained from the diet subscale, the general diet score (GDS) and the specific diet score (SDS). 
For the general diet score (GDS), which looks at the patient’s overall diet, the mean number of 
days for items one and two is the score. For the specific diet score (SDS), which looks at the 
frequency of which patients eat specific food groups, the mean number of days for items three 
and four are the score. The exercise score, which captures how many days per week the patient 
participates in exercise, is the mean number of days for items five and six.  The blood glucose 
testing score, which captures how many days a patient checks their blood sugar in relation to 
how many times per day they are ordered by their health care provider to do so, is the mean 
number of days for items seven and eight.  The foot care score is the mean number of days for 
items 9 and 10.  The smoking status score is “0” for “nonsmoker” or “1” for “smoker.” The 
number of days per week one may smoke is not assessed.  Higher scores correspond to 
participating in self-care behaviors more frequently (Toobert & Glasgow, 1994; Toobert et al., 
2000).  The mean scores are added together, along with the inverse scores related to smoking, for 
a total score. The average inter-item correlations within each SDSCA subscale exceeded .50; for 
test-retest reliability, results ranged from .43 to .58 (Toobert & Glasgow, 1994). The Cronbach 
Alpha for this study is .690, and .70 is considered an acceptable value (Polit, 2010b) .    
Hemoglobin A1c Values.  The Hemoglobin A1c test, also known as glycated 
hemoglobin, glycosylated hemoglobin, glycohemoglobin, A1c, or HbA1c, is a way to measure 
longer-term blood glucose management and reflects a patient’s average blood glucose control 
over the previous 2 or 3 months (Joslin Diabetes Center, 2016; Mayo Clinic, 2016).  A common 
recommended target level is 7% or less for patients with diabetes (American Diabetes 
 112 
 
Association, 2013; Joslin Diabetes Center, 2016; Mayo Clinic, 2016).  The importance of the 
HbA1c levels should not be minimized.  The risk of complications associated with diabetes is 
significantly reduced when the HbA1c values are less than 8%, ideally lower than 7% (Mayo 
Clinic, 2016; UK Prospective Diabetes Study (UKPDS) Group, 1998).  In this study, the HbA1c 
levels were checked via routine bloodwork results from a lab or by a rapid check machine that 
uses a finger stick blood sample that was available in some offices.  Patients using medications 
for glucose control, such as oral agents and/or insulin were included in the sample, and 
medication usage was categorized as 1) oral agents, 2) insulin, 3) combination oral/insulin, and 
4) no medication.  
Sample Selection and Size 
Participants of this study were diagnosed with type 2 diabetes, 18 years of age or older, 
and currently seeing a physician or nurse practitioner within a primary care setting for the care 
and management of their type 2 diabetes. A total of 83 patients consented to participate in this 
study. Eighty-two participants completed all required questionnaires.  Forty patients were being 
seen by a physician, and forty-three patients were being seen by a nurse practitioner. To 
compensate them for their time, the participants received a $15.00 gift card to Giant Eagle or 
Wal-Mart upon completion of the questionnaires. 
In a multiple regression analysis, a standard formula of N > 50 + 8k is used to determine 
sample size, with  N being the sample size and k being the number of predictors.  A minimal 
sample size of 91 patients (k = 5) will be necessary to achieve statistical significance based on 
the number of variables. However, using Cohen’s guidelines of effect size, an a priori power 
analysis could be performed to ensure the sample size is large enough to have a power of .80.  In 
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this case, R2 = .10 (small to moderate effect) would be used to determine a sample size of 112 
participants would be necessary to ensure the study had a power of .80 (Polit, 2010c). 
Collection of Data  
When the patients arrived at their scheduled office visit, they were asked by the staff if 
they would be interested in participating in a brief study for patients with type 2 diabetes. If the 
patients were interested, they were then directed to meet with the primary investigator who was 
present in the waiting room. After obtaining written consent, a packet of six questionnaires was 
given to the participants.  The questionnaires and demographics form were explained to the 
participants by the researcher, and any questions that the participants had were answered.  Each 
participant completed all questionnaires immediately following their office visit with their health 
care provider either in the exam room or in the waiting room. All of the participants had 
Hemoglobin A1c values tested within the last 6 months, either at an outside lab, or on the day of 
the visit via a rapid test machine. Those values were on file in the patients’ charts. An office 
nurse provided the primary investigator with the value for each patient who participated in the 
study.   All data were de-identified, and participants were each assigned a random identification 
number.   
Data Analysis  
The SPSS (IBM, SPSS, Inc, Chicago, Illinois, USA, Version 24) software package was 
used to analyze the data.  The data were entered into the database by the primary investigator. 
Descriptive statistics including, age, sex, race, education, marital status, employment, and length 
of diagnosis were used to examine and describe the sample. The data were screened to ensure 
accuracy of the values and assess for any missing values.  Univariate normality was assessed 
among each of the variables.  Histograms, skewness, kurtosis, means, SDs, and frequencies were 
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evaluated for each of the variables.  An alpha was set at .05 for all analyses.  Variables that were 
controlled for in all models include type of health care provider, length of time under the care of 
that health care provider, length of time since diagnosis, sex, age, marital status, education, race, 
and employment status.  In the models that examined HbA1c values as an outcome, medication 
usage was also controlled for. On the demographics form, patients designated whether they were 
not on any medication, oral medication, insulin, or both oral medication and insulin. These 
responses were coded into the data and used as covariates in the analysis.   
The types of data for each tool are as follows. The PAM scores are ratio-level data and 
range from 0-100.  The PACIC scores are based on a Likert-type scale, making them interval 
level.  The SDSCA scores are ratio-level data and based on the total number of days reported by 
the patient.  The average score for each SDSCA subscale and the inverse score of their smoking 
response are added together for a total score. The FPI scale uses a Likert-type scale, producing 
interval-level data.  The PICS tool is scored using “0” if the patient disagrees with the statement 
or “1” if the patient agrees, and a total score out of 13 is derived. This type of scoring requires 
the data to be interval. The HbA1c levels are measured on a ratio scale.  Type of health care 
provider was coded for each respective group, nurse practitioner or physician, making this 
nominal data. Referrals were coded yes or no, making this nominal data.   
Research question 1. Based on the CCM, what are the effects of Delivery System Design 
and Clinical Information Systems, together with patient perceptions of Decision Support, Self-
Management Support, and Community Resources on HbA1c levels and participation in self-care 
behaviors for patients with Type 2 diabetes? Multiple regression models were used to analyze 
the data.  Assumptions for multiple linear regression were assessed and met. The first assumption 
required ratio or interval level data for the dependent variable (Polit, 2010c).  The first model 
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used the PACIC as the independent variable and the HbA1c values as the dependent variable. 
The other five models used the PACIC as the independent variable and each of the self-care 
behaviors measured by the SDSCA (GDS, SDS, exercise, blood glucose testing, and foot care) as 
the dependent variables.   A logistic regression model was used when analyzing smoking 
(yes/no) as a dependent variable. 
Research Question 2.  Among Type 2 diabetic patients, do levels of patient activation 
(PAM), participation in decision-making for treatment planning (PICS), and facilitation of 
patient involvement in care (FPI) affect HbA1c levels and patients’ performance of self-care 
behaviors?   Multiple linear regression models were used to analyze the data.   Assumptions for 
multiple regression were assessed. The first assumption, requiring ratio or interval level data for 
the dependent variable, was met with both HbA1c levels and SDSCA scores. The second 
assumption that the data were randomly and independently sampled was met. The fourth 
assumption, related to homoscedasticity of the data, was examined and met. The assumption of 
equal variances was examined and met. The next assumption is that variables being correlated 
are assumed to have an underlying distribution that is bivariate normal, meaning scores on 
variable X are assumed to be normally distributed for each value of variable Y, and vice versa.  
This assumption was tested by examining scatter plots for each of variables against HbA1c levels 
and against SDSCA scores and determined to be met(Polit, 2010c).   
Each of the models analyzed used scores from a different tool (PAM, PICS, or FPI) as the 
independent variable. Each of the three tools had a total of 6 models per tool to analyze all of the 
dependent variables. The dependent variables included HbA1c levels and the five self-care 
scores (GDS, SDS, exercise, blood glucose testing, and foot care) from the SDSCA.  As with 
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RQ1, a logistic regression model was used when analyzing smoking (yes/no) as an outcome 
variable.  
Research question 3. Do patients who see nurse practitioners for management of Type 2 
diabetes experience higher levels of engagement in self-care behaviors and more therapeutic 
HbA1c levels compared to patients who see a physician?  To answer this question, an ANCOVA 
analysis was completed.  There were a total of six ANCOVA models.   The first model used 
HbA1c levels as the dependent variable, and the other five models used the SDSCA scores as the 
dependent variables.  A logistic regression model was again used when analyzing smoking 
(yes/no) as an outcome variable.  
The data was screened to ensure the assumptions for ANCOVA were met. The first and 
second assumptions were related to data level. The covariates of type of medication used by the 
patient is categorical data and the length of time each patient has been diagnosed as having Type 
2 diabetes is continuous ratio-level data. The HbA1c levels and the SDSCA scores are also ratio 
data. The type of health care provider, being a nurse practitioner or a physician, was coded as 
nominal data because the independent variable in ANCOVA is always nominal (Polit, 2010a).     
The third assumption required that there was random selection of subjects, and 
participation was on a volunteer basis.  The fourth assumption required that the dependent 
variable be normally distributed (Polit, 2010a).  This was verified by examining the scatterplots.  
The fifth assumption uses the Shapiro-Wilk test to verify that there is homogeneity of variance. 
The sixth assumption is that the relationship between the dependent variable and covariates is 
linear. This was verified the using the Levene’s test. The seventh assumption is that relationships 
between all pairs of covariates were linear, which was verified by examining the scatterplots. 
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The eighth of homoscedasticity and ninth assumption of homogeneity of regression across 
groups were also tested and met.  
 The assumptions for logistic regression were verified for the analysis related to the 
dichotomous dependent variable of smoking.   The first assumption requires that the dependent 
variable be measured on a dichotomous scale.  The second assumption requires that one more of 
the independent variables be on a continuous or categorical scale.  The third assumption requires 
that there be independent observations and the dependent variable be mutually exclusive and 
have exhaustive categories.  The fourth assumption requires that there be a linear relationship 
between any continuous independent variables and the logit transformation of the dependent 
variable (Polit, 2010d).   
Research question 4.  Is there a difference in levels of patient activation, participation in 
decision-making, and facilitation of patient involvement in care when a nurse practitioner treats 
a patient compared to a physician? To answer this question, an ANCOVA analysis was 
completed.  There were three ANCOVA models, using the PAM, PICS and FPI scores as the 
dependent variable.   
The data was screened to ensure the assumptions for ANCOVA are met. The first and 
second assumptions are related to data level. Covariates are usually continuous interval or ratio 
level variables. The third assumption requires that there is random selection of subjects.  The 
fourth assumption requires that the dependent variable be normally distributed.  The fifth 
assumption is that there is homogeneity of variance. The sixth assumption is that the relationship 
between the dependent variable and covariates is linear. The seventh assumption is that 
relationships between all pairs of covariates are linear. The eighth and final assumption is that 
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there is homogeneity of regression across groups (Polit, 2010a). These assumptions were verified 
through examination of the data in SPSS. 
Results 
Demographics. Tables 1 and 2 present the demographic information related to this study. 
The mean age was 58.48 (standard deviation [SD] =11.44).  The majority of the patients were 
over 50 years of age (75.9%), female (63.4%), and white (87.9%).  The majority of patients 
graduated from high school or have a high school equivalent (66.3%) and are currently 
unemployed (56.1%). Half of the patients came from the clinic in Ohio and were all of the nurse 
practitioner patients, with the exception of two.  Related to their diagnosis of type 2 diabetes 
(Table 2), the majority of patients had been diagnosed 5 years or less and also had maintained the 
relationship with their health care provider for 5 years or less (70.7%). The majority of patients 
were taking oral medications (60%) related to their type 2 diabetes. Table 1 presents the 
demographic data for the entire sample and for the participants in each health care provider 
group.  
Table 1 Demographics Table for Sex, Race, and Education (N=82) 
 
Demographic 
Characteristic  
Total (N=83) 
n (%) 
Nurse Practitioner 
Patients (n=43) 
n (%) 
Physician Patients 
(n=39) 
n (%) 
Sex    
     Male 30 (36.6%) 13 (30.2%) 17 (43.6%) 
     Female 52 (63.4%) 30 (69.8%) 22 (56.4%) 
Average Age (years) 58.48 
(SD=11.44) 
54.02 (SD=9.46) 63.39 (SD=11.53) 
Race    
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     White 72 (87.8% 38 (88.4%) 34 (87.2%) 
     African 
American/Black 
7 (8.5%) 4 (9.3%) 3 (7.7%) 
     Other 3 (3.7%) 1 (2.3%) 2 (5.1%) 
Education     
     Did Not Complete 
High     
     School 
5 (6.0%) 1 (2.3%) 4 (10.3%) 
     High School Diploma 
or  
     Equivalent 
55 (67%) 33 (76.8%) 22 (56.4%) 
     Associate/Trade/Tech 16 (19.5%) 8 (18.6%) 8 (20.5%) 
     Bachelor’s Degree or  
     Higher 
6 (7.5%) 1 (2.3%) 5 (12.8%) 
Employment Status    
     Employed 33 (40.2%) 19 (44.2%) 14 (35.9%) 
     Unemployed/Unable to  
     Work/Retired 
46 (56.1%) 22 (51.2%) 24 (61.5%) 
     Other 3 (3.7%) 2 (4.6%) 1 (2.6%) 
Marital Status    
     Single/Widowed 23 (28%) 14 (32.6%) 9 (23.1%) 
     Married 30 (36.5%) 11 (25.5%) 19 (48.7%) 
     Divorced 29 (35.5%) 18 (41.9%) 11 (28.2%) 
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Table 2. Data Related to Type 2 Diabetes Diagnosis 
(N=82) 
 
Type of Health Care Provider 
 
n (%) 
     Physician 
 
39 (48.2%) 
     Nurse Practitioner 43 (51.8%) 
 
Location 
 
 
     A 
 
18 (22%) 
     B  
 
12 (14.6%) 
     C 
 
6 (7.3%) 
     D 
 
41 (51.8%) 
     E 5 (6.1%) 
 
Medication 
 
 
     None 
 
3 (3.7%) 
     Oral Medication 
 
49 (60%) 
     Insulin 4 (4.9%) 
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     Both Oral Medication and Insulin 26 (31.4%) 
 
Length of Diagnosis 
 
 
     Up to 5 years 
 
37 (45.1%) 
     6-10 years 
 
21 (25.6%) 
     11-15 years 
 
8 (9.8%) 
     16-20 years 
 
7 (8.5%) 
     More than 20 years 9 (11%) 
 
Length of Relationship with Health 
Care Provider 
 
 
     1-5 years 
 
58 (70.7%) 
     6-10 years 
 
5 (6.1%) 
     More than 10 years 
 
19 (23.2%) 
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Results for research question 1. Based on the CCM, what are the effects of Delivery 
System Design and Clinical Information Systems, together with patient perceptions of Decision 
Support, Self-Management Support, and Community Resources on HbA1c levels and 
participation in self-care behaviors for patients with Type 2 diabetes?  The Patient Assessment 
of Care for Chronic Conditions (PACIC) was used to gather information related to delivery 
system design, clinical information systems, decision support, self-management support, and 
community resources.  The PACIC was found to be a significantly associated with General Diet 
Score (GDS) (p = .202), Specific Diet Score (SDS) (p = .027), Exercise (p = .032), and Blood 
Glucose Testing (p = .046), when controlling for the covariates of age, sex, race, education, 
marital status, employment, length of diagnosis, type of health care provider, length of 
relationship with health care provider, and medication usage. Hemoglobin A1c values (p = .849) 
and foot care (p = .390) were not found to have a significant association with the CCM variables 
as measured by the PACIC.  The dichotomous variable of smoking was tested using logistic 
regression. Smoking status was not found to have a significant association with the CCM 
variables as measured by the PACIC.    Table 3 presents the data for research question 1.  
Table 3.  Multiple Regression Models for PACIC and Self-Care Behaviors (N=82) 
 
Outcome 
Variable 
 
B SE (B) Standardized Beta t-value p-value 
Hemoglobin 
A1c Levels 
 
-.002 .010 -.022 -.191 .849 
 
General Diet 
Score 
.025 .011 .266 2.371 .020 
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Specific Diet 
Score 
 
-.024 .011 -.258 -2.252 .027 
Exercise 
 
.027 .012 .253 2.191 .032 
Blood 
Glucose 
Testing 
 
.033 .016 .231 2.030 .046 
Foot Care 
 
.014 .016 .105 .864 .390 
Note. PACIC= Patient Assessment of Care for Chronic Conditions tool. 
Results for research question 2.  Among Type 2 diabetic patients, do levels of patient 
activation (PAM), participation in decision-making for treatment planning (PICS), and 
facilitation of patient involvement in care (FPI) affect HbA1c levels and patients’ performance of 
self-care behaviors? Patient Activation was found to be significantly associated with General 
Diet Score (GDS) (p = .023) and Foot Care (p = .006), but was not a statistically significantly 
associated with HbA1c levels (p = .260), Specific Diet Score (p = .182), Exercise (p = .440), or 
Blood Glucose Testing (p = .191).  In the General Diet Score (GDS) model with the PAM, sex 
and gender were found to be associated with GDS (p= .031 and p= .029, respectively). In the 
Foot Care model with the PAM, level of education was found to be significantly associated with 
foot care (p= .038).  Facilitation of patient involvement (FPI) and Perceived Involvement in Care 
(PICS) were both found to be a significantly associated with Blood Glucose Testing (p = .030 
and p = .046, respectively), but not HbA1c levels, General Diet Score, Specific Diet Score, 
Exercise, or Foot Care, all p > .05. In the blood glucose testing model with the PICS, type of 
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health care provider was found to be significantly associated with blood glucose testing 
(p=.028).  Tables 4-7 present the data for research question two, controlling for age, sex, race, 
education, marital status, employment, length of diagnosis, type of health care provider, and 
length of relationship with health care provider. The dichotomous variable of smoking was tested 
using logistic regression. Smoking status was not found to have a significant association with the 
FPI nor the PICS.     
Table 4. Multiple Regression Table for Patient Activation and General Diet Score (GDS) 
(N=82) 
Variable B SE (B) Standardized Beta t-value p-value 
PAM .090 .039 .260 2.319 .023 
Age .500 .265 .251 1.884 .064 
Sex -.951 .431 -.256 -2.207 .031 
Race -.107 .617 -.020 -.174 .862 
Education .129 .230 .063 .560 .577 
Marital status .131 .196 .074 .667 .507 
Employment 
status 
 
-.027 .294 -.012 -.092 .927 
Length of 
diagnosis 
 
-.354 .159 -.270 -2.232 .029 
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Type of 
health care 
provider 
 
.622 .520 .174 1.196 .236 
Length of 
relationship 
with health 
care provider 
 
.123 .285 .058 .431 .668 
Note. PAM= Patient Activation Measure. 
 
Table 5.  Multiple Regression Table for Patient and Predicting Foot Care (N=82) 
 
Variable B SE (B) Standardized Beta t-value p-value 
 
 
PAM 
 
 
.157 
 
.055 
 
.330 
 
2.842 
 
.006 
Age .174 .376 .064 .462 .645 
 
Sex -.468 .612 -.092 -.765 .447 
 
Race -.167 .875 -.022 -.191 .849 
 
Education .689 .326 .248 2.116 .038 
 
Marital status .069 .279 .029 .248 .805 
 
Employment 
status 
-.033 .417 -.010 -.078 .938 
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Length of 
diagnosis 
 
.294 .225 .164 1.306 .196 
Type of 
health care 
provider 
 
-.069 .738 -.014 -.094 .926 
Length of 
relationship 
with health 
care provider 
 
-.468 .405 -.161 -1.157 .251 
Note. PAM= Patient Activation Measure. 
 
Table 6.  Multiple Regression Table for Facilitation of Patient Involvement and Blood 
Glucose Testing (N=82) 
 
Variable 
 
B SE (B) Standardized Beta t-value p-value 
FPI .172 .078 .238 2.208 .030 
 
Age .318 .398 .108 .798 .428 
 
Sex -.386 .631 -.070 -.612 .543 
 
Race .636 .922 .079 .690 .493 
 
Education -.350 .342 -.116 -1.023 .310 
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Marital status .347 .295 .133 1.176 .243 
 
Employment 
status 
 
.421 .440 .122 .955 .343 
Length of 
diagnosis 
 
.308 .233 .158 1.321 .191 
Type of 
health care 
provider 
 
1.463 .777 .276 1.884 .064 
Length of 
time with 
health care 
provider 
 
-.201 .426 -.064 -.473 .638 
Note. FPI= Facilitation of Patient Involvement scale. 
 
Table 7.  Multiple Regression Table for Perceived Involvement in Care and Blood Glucose 
Testing (N=82) 
 
Variable 
 
B SE 
(B) 
Standardized 
Beta 
t-
value 
p-
value 
PICS .254 .125 .234 2.033 .046 
 
Age .204 .399 .069 .512 .610 
 
Sex -.348 .635 -.063 -.548 .585 
 
Race .565 .928 .070 .609 .545 
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Education -.371 .345 -.123 -1.076 .286 
 
Marital status .316 .299 .121 1.056 .295 
 
Employment status 
 
.099 .463 .029 .214 .831 
 
Length of diagnosis 
 
.292 .234 .150 1.247 .216 
Type of health care provider 
 
1.757 .785 .331 2.238 .028 
Length of relationship with health care 
provider 
 
-.181 .427 -.058 -.423 .674 
Note. PICS = Perceived Involvement in Care Scale 
Results for research question 3.  Do patients who see nurse practitioners for 
management of Type 2 diabetes experience higher levels of engagement in self-care behaviors 
and more therapeutic HbA1c levels compared to patients who see a physician? When running an 
ANOVA examining outcome behaviors among patients seeing nurse practitioners compared to 
patients seeing physicians, nurse practitioners were found to be a significantly associated with 
increased days per week of patients checking their blood glucose levels (p = .014).  Type of 
health care provider was also found to be a significantly associated with smoking (p < .01). 
However, after controlling for the covariates of age, sex, race, education, marital status, 
employment, length of diagnosis, and length of relationship with health care provider, the 
statistical significance for both checking blood glucose levels (p = .100) and smoking (p = .066) 
were no longer significant.  There were no other statistically significant associations found when 
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analyzing the data with and without the covariates for HbA1c values (p = .128), GDS (p = .927), 
SDS (p = .687), exercise (p = .878), and foot care (p = .376).  
Results for research question 4.  Is there a difference in levels of patient activation 
(PAM), participation in decision-making (PICS), and facilitation of patient involvement in care 
(FPI) when a nurse practitioner treats a patient compared to a physician? There were no 
statistically significant differences found for any of the dependent variables (patient activation (p 
= .422), participation in decision-making (p = .338), and facilitation of patient involvement in 
care (p = .175) between nurse practitioner patients and physician patients when controlling for 
the covariates of age, sex, race, education, marital status, employment, length of diagnosis, and 
length of relationship with health care provider.   
Discussion 
 In this study, the CCM was used as a foundation to examine elements of the CCM and 
their relationship to the outcome variables of HbA1c levels and self-care behaviors.  This study 
showed that the PACIC was significantly associated with General Diet Score (GDS), Specific 
Diet Score (SDS), Exercise, and Blood Glucose Testing.  Patient Activation was found to be 
associated with General Diet Score (GDS) and Foot Care.  Facilitation of patient involvement 
(FPI) and Perceived Involvement in Care (PICS) were both found to be associated with Blood 
Glucose Testing. 
In the first research question examining the impact of delivery system design and clinical 
information systems, decision support, self-management support, and community resources on 
HbA1c levels and participation in self-care behaviors, the only statistically significant outcomes 
associated with the PACIC, which represented the components of the CCM, were the self-
 130 
 
reported, self-care behaviors of general diet, specific diet, exercise, and blood glucose testing. In 
previous studies examining delivery system design within the context of the CCM, patient 
outcomes improved, specifically HbA1c levels, Foot Care, and Smoking Cessation, diet, and 
exercise, when the CCM was implemented as a guiding structure in primary care settings among 
patients with a chronic condition  (Ades et al., 2013; Nuno, Coleman, Bengoa, & Sauto, 2012; 
Peterson et al., 2014; Rathert, Wyrwich, & Boren, 2012; Stellefson et al., 2013; Thota et al., 
2012). While general diet, specific diet, exercise, and blood glucose testing are important self-
care behaviors, it would be important to further explore why HbA1c values, which were 
objectively measured data, were not also significantly associated with elements of the CCM.   
In the second research question examining the effect of patient activation, participation in 
decision-making for treatment planning, and facilitation of patient involvement on HbA1c levels 
and patients’ performance of self-care behaviors, patient activation was found to be a predictor 
of general diet and foot care. Facilitation of patient involvement and participation in decision-
making were predictive of blood glucose testing.  Again, no predictive relationship was found 
with HbA1c values.  Other studies looking at patient activation showed improvement of HbA1c 
levels, and significant associations with exercise, foot care, decreases in health care costs, and 
more positive interactions with health care providers as reported by patients (Hibbard & Greene, 
2013; Mosen et al., 2007; Rask et al., 2009; Remmers et al., 2009), showing some similar 
findings to the results of this study. Recent studies implementing facilitation of patient 
involvement and shared decision making among patients with type 2 diabetes have been 
implemented with a focus on improving HbA1c values, however, noting that with the complexity 
of a chronic disease, such as type 2 diabetes, there are many factors that contribute to the overall 
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outcomes of the patients (Inzucchi et al., 2015; Inzucchi et al., 2102; Joseph-Williams, Elwyn, & 
Edwards, 2014).   
Looking at the third and fourth research questions comparing nurse practitioners and 
physicians, none of the findings were statistically significant. The third research question was 
examining the type of health care provider and the predictive relationship with HbA1c values 
and participation in self-care behaviors.  However, again, there was no relationship with HbA1c 
levels. In the last research question examining differences in patient activation, participation in 
decision-making, and facilitation of patient involvement in care when a nurse practitioner treats a 
patient compared to a physician, there were no significant predictors for any of the outcome 
variables. Varied data exist related to patient outcomes of nurse practitioners and physicians.  
While there tends to be a general consensus that patients are more satisfied with care provided by 
nurse practitioners among general patient populations, data related to patient outcomes are more 
inconsistent (Chang et al., 2007; C. Everett et al., 2013; C. M. Everett et al., 2013; Kuo et al., 
2015; Stanik-Hutt et al., 2013; ter Bogt et al., 2011).  Other studies examining patients with type 
2 diabetes found patient satisfaction and/or patient outcomes in nurse practitioner groups to be 
very similar to those seeing physicians (Kuo et al., 2015; ter Bogt et al., 2011).  There are data to 
show that nurses and nurse practitioners can help to improve patient outcomes through various 
interventions and programs in conjunction with physicians, among patients with diabetes; 
however, many studies have found that nurse practitioners provide care for less complex patients 
than physicians, and little data exist to show a significant difference in patient outcomes for 
patients strictly seeing nurse practitioners instead of physicians (Chang et al., 2007; C. Everett et 
al., 2013; C. M. Everett et al., 2013; Hoffman et al., 2005; Kuo et al., 2015; Litaker et al., 2003; 
Renders et al., 2001; Taylor et al., 2003; ter Bogt et al., 2011).  When looking at care provided 
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by a nurse practitioner compared to a physician, there were no significant findings related to 
improvements in HbA1c levels and self-care behaviors, nor any significant differences in patient 
activation, participation in decision-making, and facilitation of patient involvement. This study 
did not compare patient satisfaction ratings between participants seeing nurse practitioners or 
physicians. In contrast to the results of this study, many other studies that examine generalized 
patient populations present data that shows patients are more satisfied with care and outcomes 
are improved when being treated by nurse practitioners (Chang et al., 2007; Condosta, 2012; 
Eisenstat et al., 2013; C. Everett et al., 2013; C. M. Everett et al., 2013; Fain & Melkus, 1994; 
Kinnersley et al., 2000; Roblin et al., 2004; Rudy et al., 1998; Salisbury & Tettersell, 1998; 
Stanik-Hutt et al., 2013; ter Bogt et al., 2011; Venning et al., 2000).  Being that this study had a 
relatively low sample size, and relatively low number of health care providers, this could explain 
the contrary results to what is published for other studies.    
Of notable importance, having no statistical significance is also important for research 
questions three and four because it demonstrates that, in this particular study, there was no 
difference in the standards and variables that were measured comparing nurse practitioners and 
physicians.  The patients who were cared for by both types of providers experienced similar 
outcomes with regard to self-care behaviors, HbA1c, levels of patient activation, participation in 
decision-making, and facilitation of patient involvement in care. Therefore, this is an important 
finding supporting the notion that care received by NP patients and MD patients is not different.  
Limitations 
 There were some limitations with this study. First, the sample size was smaller than 
desired, as a sample size of 112 participants would have been necessary to ensure the study had a 
power of .80. The goal of 112 patients was not met; the entire sample size was 82 patients after 
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two years of data collection; however, some statistically significant results were detected through 
the data analysis. The majority of the sample was White, female, had completed high school or 
had a high school equivalency, and were unemployed, therefore the sample was not very diverse, 
and findings are only generalizable to patients with these characteristics. Second, the locations 
did not to provide a variety of patients demographically.  Almost all of the nurse practitioner 
patients were seen in only one of the five locations, which was a clinic for the underserved 
population of the area. When looking at the overall number of patients on record with type 2 
diabetes (approximately 29 million people) (Gardner, 2016), this sample size may not be 
representation of all patients who have been diagnosed with type 2 diabetes.  
 Design limitations also were factors in this study. Data collection was very time 
consuming, as it required one researcher to individually meet with each participant. Because of 
the Health Insurance Portability and Accountability Act (HIPAA), recruiting patients was 
difficult. The staff at the primary care offices was not permitted to let the researcher know in 
advance if potential participants would be in the office on that day.  The researcher would take 
turns visiting offices, hoping to connect with participants.  The researcher would arrive at one of 
the five offices and potentially not see a patient the entire day, thus another reason data 
collection took such a long period of time.  The study also used a variety of tools which were 
perceived to be too time consuming by some of the participants. Completing the tools was also 
an issue for those participants who had issues with vision, reading comprehension, and difficulty 
writing.  For these participants, the researcher would read the questions aloud to the participant 
and have the participant verbalize their answer. If the participant could not write, due to arthritis 
or other issues, the researcher would circle the chosen responses in front of the participant as 
they responded to the questions.  
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For the FPI tool, the Cronbach’s alpha for this study was .303.  After reviewing the 
responses from this particular tool, it appears many of the participants did not carefully read 
some of the questions or may not have understood some of the questions. Many patients put the 
same answer for questions that were worded oppositely of a previous question. Participants were 
reminded to read the questions carefully and the researcher verbalized to the participants that 
some questions may look similar but were actually worded oppositely of the previous question. 
Despite this direction, many participants did not distinguish between the two questions. This 
makes the findings of this particular tool less reliable and less valid because after visually 
inspecting each participant’s forms, this potential error was noted quite frequently.   
There were a total of six forms that needed to be completed by each participant. The FPI 
tool was placed fourth in the stack of forms. At this point, survey fatigue may have become an 
issue for these participants. The number of surveys and length of time to complete all of the 
paperwork may have become overwhelming for participants.  
Future Research 
While some significant predictors were found among the various research questions, none 
of them were found to have a relationship with HbA1c levels. Being that the HbA1c levels are 
the standard by which control of diabetes is measured (American Diabetes Association, 2015; 
Casagrande et al., 2013), it was somewhat surprising to not find any relationships among the 
variables and HbA1c levels. Based on the data analysis, no matter how high participants rated 
themselves in the areas of patient activation, facilitation of patient involvement, and participation 
in decision making, there were not notable improvements in HbA1c values. This can lead future 
research to examine the qualitative aspects of the patients’ personal views of these variables. 
Qualitative studies may also examine what participation means to patients, self-care barriers and 
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challenges, and personal definitions of diet recommendations based on current American 
Diabetes Association recommendations for patients.  While a patient may feel that he or she was 
highly activated and involved in their care,  the patient may be have been lacking the education 
or other means to truly carry out the behaviors needed to affect HbA1c.  Future research could 
look at interventions to enhance or increase how the health care provider involves the patient in 
his or her care and enhancing how well the patient is actually involved in that care in order to 
positively influence HbA1c levels. 
The PACIC and PAM were found to be predictors of the General Diet Score (GDS). 
Future studies could have diet as an outcome measure focusing on interventions that enhance or 
improve patient activation, as measured by the PAM and PACIC. For the PACIC, interventions 
that looking at decision support, follow-up, problem solving, and goal setting would be 
appropriate when looking at diet as an outcome measure.  The self-care behaviors are important 
components in individual patient management and control of type 2 diabetes (Booth et al., 2013; 
Haas et al., 2013; Rise et al., 2013). When patients carry out the appropriate self-care behaviors, 
often HbA1c values improve (Booth et al., 2013; Haas et al., 2013; Rise et al., 2013).  If the data 
show a predictive relationship with these self-care behaviors, which if carried out on a regular 
basis help improve diabetes control, then examining why HbA1c values were not significantly 
affected is an important next step.  
Based on the data analysis, it would be important to examine if the patients’ defining 
factors of self-care behaviors matched the American Diabetes Association (ADA) guidelines and 
recommendations.    For example, if a patient reports following a diet and eating the appropriate 
amounts of fruits and vegetables per week, what does that translate into from a food diary 
perspective, and is their diet developed using appropriate dietary recommendations? Looking at 
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the ADA dietary recommendations for patients with diabetes, patients should be educated in 
many areas in addition to fruits, vegetables, proteins, and fats. These recommendations include, 
but are not limited to, looking at eating patterns, fructose, trans fat, alcohol, omega-3 fatty acids, 
and noncaloric sweeteners (Evert et al., 2013).  In terms of exercise, what is the quantity and 
quality of the exercise they are reporting? The recent ADA recommendation discuss the 
incorporation of both aerobic and resistance exercise, as well as including flexibility and balance 
(Colberg et al., 2016).   Research looking at the details of self-reported food intake and exercise 
participation may be helpful considering the detailed recommendations that are now available 
(Colberg et al., 2016; Evert et al., 2013).  It would be important to look into this further to find 
out at what point the self-care variables are able to predict HbA1c levels. Research objectively 
examining self-care behaviors in comparison to HbA1c values will provide valuable data in 
terms of what patients are actually doing versus what they are reporting.  
It would be beneficial to continue this research to gain a larger patient population to 
evaluate whether the non-significant results changed as the sample size increased. It would also 
be beneficial to gather a more diverse population, as type II diabetes affects many races and 
ethnicities.  Future research to find connections and relationships among self-care behaviors and 
HbA1c values would also help to determine at what point self-care behaviors become predictive 
of HbA1c values.   
Conclusion 
 In conclusion, the results of this study were valuable in helping to address some of the 
many questions related to HbA1c values and self-care behaviors for patients with type 2 
diabetes. Using the CCM as a framework for this study was appropriate as the CCM has been 
used in various other studies focusing on the management of Type 2 diabetes (Bodenheimer et 
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al., 2002b; Dancer & Courtney, 2010; Frei et al., 2014; Koh et al., 2013; National Institutes of 
Health and the Centers for Disease Control and Prevention, 2011; Parchman, Michael L,MD, 
MPH et al., 2007; Peterson et al., 2014; Robert Wood Johnson Foundation, 2016a; Siminerio et 
al., 2006; Siminerio et al., 2004; Smith et al., 2008; Stellefson et al., 2013), and it provided a 
comprehensive view of variables that may impact self-care and control of Type 2 diabetes.  
While this study did not have any significant findings related to variables that were associated 
with HbA1c values, there were some significant factors associated with self-care behaviors, 
specifically GDS, SDS, exercise, blood glucose testing, and foot care. It is important to 
acknowledge that while there were not any statistically significant results related to differences 
among nurse practitioners and physicians, that finding is significance because it demonstrated no 
differences in care between nurse practitioners and physicians.   There is still much to be learned 
about variations in types of health care providers, and examining ways to provide care to patients 
to ensure optimal outcomes for those who have been diagnosed with type 2 diabetes.  There are 
many avenues for future research based on the results of this study, including looking at the 
quality of self-care behaviors compared to self-reported frequency to find ways of improving 
HbA1c levels in patients with type 2 diabetes.  
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Appendix A 
Demographics Form 
 
1. Name:____________________________________________________ 
 
2. Age:_______________ 
 
Please circle the selection that is your answer for the following questions. 
3. Sex:  Male  Female 
 
4. Race:  
 
White  African American/Black  Asian 
 
Alaska Native/American Indian   Native Hawaiian/ Other Pacific Islander  
 
Other: ______________________ 
 
5. Level of education completed: 
 
Did not complete high school   High school graduate/Diploma/ GED 
 
Trade/Technical/Vocational Training  Associate Degree 
 
Bachelor’s Degree    Master’s Degree 
 
Professional Degree    Doctoral Degree 
 
 175 
 
6. Marital Status:  
 
Single/Never Married      Married/Domestic Partner  
 
Divorced   Widowed   Separated 
 
7. Employment status:   
 
Employed  Unemployed  Homemaker 
 
Student   Military   Retired Unable to work 
 
8. How long have you been diagnosed with type 2 diabetes? _____________________ 
 
9. Do you take medication for type 2 diabetes? 
No Medication   Oral medication/Pills 
Insulin/Shots   Both oral medication/pills AND insulin/shots 
 
10. What type of practitioner are you seeing for this visit: 
 
  Physician  Nurse Practitioner 
 
Questions About the Practitioner You Are Seeing TODAY 
 
Length of time that you have been seeing this 
practitioner:____________________________________________________ 
Number of visits to practitioner within the last 12 
months:_________________________________ 
Were you asked to make follow-up appointment?   Yes  No 
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Were you referred to any other services related to diabetes? Yes  No 
If YES, who were you referred to: 
 
 Endocrinologist  Dietician Diabetes Educator 
  
 Podiatrist  Optometrist/Ophthalmologist  
 
 Other: _____________________________________ 
 
Were you given a printed out report of any results or goals of treatment? Yes No 
 
Did you discuss goals of treatment?  Yes  No 
 
Questions About the OTHER Practitioners You Have Seen 
Have you seen any other this practitioners at this office:  Yes  No 
 
If answering YES to question 12, please list other practitioners you have seen in THIS OFFICE:  
 
___________________________________________________________________________ 
 
Have you had visits to other care providers within last 12 months related to diabetes:    
 
Yes   No  
 
    If you answered YES to question 16, please circle the reasons you visited these other 
practitioners 
Endocrinologist  Dietician Diabetes Educator 
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 Podiatrist  Optometrist/Ophthalmologist  
 
 Other: _____________________________________ 
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Appendix B 
Patient Activation Measure 
Below are some statements that people sometimes make when they talk about their health.  
Please indicate how much you agree or disagree with each statement as it applies to you 
personally by circling your answer. Your answers should be what is true for you and not just 
what you think others want you to say. 
If the statement does not apply to you, circle N/A. 
 
1. When all is said and done, I am the person who is responsible for taking care of my 
health 
 
Disagree Strongly  Disagree   Agree  Agree Strongly 
 N/A 
 
2. Taking an active role in my own health care is the most important thing that affects my 
health 
 
Disagree Strongly  Disagree   Agree   Agree Strongly 
 N/A 
 
3. I am confident I can help prevent or reduce problems associated with my health 
  
Disagree Strongly  Disagree   Agree   Agree Strongly 
 N/A 
 
4. I know what each of my prescribed medications do 
 
Disagree Strongly  Disagree   Agree   Agree Strongly 
 N/A 
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5. I am confident that I can tell whether I need to go to the doctor/nurse practitioner or  
   whether I can take care of a health problem myself 
 
Disagree Strongly  Disagree   Agree   Agree Strongly 
 N/A 
 
6. I am confident that I can tell a doctor/nurse practitioner concerns I have even when he 
    or she does not ask 
 
Disagree Strongly  Disagree   Agree   Agree Strongly 
 N/A 
 
7. I am confident that I can follow through on medical treatments I may need to do at home 
 
Disagree Strongly  Disagree  Agree  Agree Strongly 
 N/A 
 
8. I understand my health problems and what causes them 
 
Disagree Strongly  Disagree  Agree  Agree Strongly 
 N/A 
 
9. I know what treatments are available for my health problems 
 
Disagree Strongly  Disagree  Agree  Agree Strongly 
 N/A 
 
10. I have been able to maintain (keep up with) lifestyle changes, like eating right or 
exercising 
 
Disagree Strongly  Disagree  Agree  Agree Strongly 
 N/A 
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11. I know how to prevent problems with my health 
 
Disagree Strongly  Disagree  Agree  Agree Strongly 
 N/A 
 
12. I am confident I can figure out solutions when new problems arise with my health 
 
Disagree Strongly  Disagree  Agree  Agree Strongly 
 N/A 
 
13. I am confident that I can maintain lifestyle changes, like eating right and exercising, 
     even during times of stress 
 
Disagree Strongly  Disagree  Agree  Agree Strongly 
 N/A 
 
 
©2017 Insignia Health.  Patient Activation Measure® (PAM®).  All rights reserved. 
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Appendix C 
Facilitation of Patient Involvement Scale (Martin et al., 2001) 
Directions: Please indicate how often your physician or nurse practitioner typically 
does the following things, using these responses:  
(1) none of the time 
(2) a little of the time 
(3) some of the time 
(4) a good bit of the time 
(5) most of the time 
(6) all of the time  
 
1. My doctor gives me all the information that I need to make the decisions that are right for me. 
2. My doctor ignores my opinion about treatment options. 
3. When prescribing a new medication, my doctor asks if I have any questions about the 
    medication(s) and possible side effects. 
4. My doctor discourages my questions. 
5. My doctor explains all the treatment options to me so that I can make an informed choice. 
6. My doctor strongly encourages me to express all of my concerns about the prescribed 
    treatment. 
7. My doctor discourages me from expressing my personal opinion about my medical condition.  
8. My doctor’s office staff makes it hard for me to be involved in my own medical care. 
9. My doctor makes it difficult for me to communicate my concerns about treatment decisions. 
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Appendix D 
Perceived Involvement in Care Scale  
Available from: 
Lerman, C. E., Brody, D. S., Caputo, G. C., Smith, D. G., Lazaro, C. G., & Wolfson, H. G. 
(1990). Patients' perceived involvement in care scale: Relationship to attitudes about illness 
and medical care. Journal of General Internal Medicine, 5, 29-33. doi:10.1007/BF02602306 
 
 
  
Copyright 2004 The MacColl Center for Health Care Innovation, Group Health Cooperative. The Improving Chronic Illness Care program is 
supported by The Robert Wood Johnson Foundation, with direction and technical assistance provided by Group Health's MacColl Center for 
Health Care Innovation. For more information go to www.improvingchroniccare.org 
Assessment of Care for Chronic Conditions 
Staying healthy can be difficult when you have a chronic condition.  We would like to learn about the 
type of help with your condition you get from your health care team.  This might include your regular 
doctor, his or her nurse, or physician’s assistant who treats your illness.  Your answers will be kept 
confidential and will not be shared with your physician or clinic.  
Over the past 6 months, when I received care for my chronic conditions, I was: 
None of 
 the time 
A Little of 
the Time 
Some of 
the Time 
Most of 
the Time Always 
1. Asked for my ideas when we
made a treatment plan. 1 2 3 4 5 
2. Given choices about treatment to
think about. 1 2 3 4 5 
3. Asked to talk about any problems
with my medicines or their
effects. 1 2 3 4 5 
 4. Given a written list of things I
should do to improve my health. 1 2 3 4 5 
5. Satisfied that my care was well
organized. 1 2 3 4 5 
6. Shown how what I did to take
care of myself influenced my
condition. 1 2 3 4 5 
7. Asked to talk about my goals in
caring for my condition. 1 2 3 4 5 
8. Helped to set specific goals to
improve my eating or exercise. 1 2 3 4 5 
9. Given a copy of my treatment
plan. 1 2 3 4 5 
10. Encouraged to go to a specific
group or class to help me cope
with my chronic condition. 1 2 3 4 5 
11. Asked questions, either directly or
on a survey, about my health
habits. 1 2 3 4 5 
Appendix E
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supported by The Robert Wood Johnson Foundation, with direction and technical assistance provided by Group Health's MacColl Center for 
Health Care Innovation. For more information go to www.improvingchroniccare.org 
Over the past 6 months, when I received care for my chronic conditions, I was: 
None 
of the time 
A Little of 
the Time 
Some of 
the Time 
Most of 
the Time Always 
 12. Sure that my doctor or nurse
thought about my values, beliefs,
and traditions when they
recommended treatments to me. 1 2 3 4 5 
13. Helped to make a treatment plan
that I could carry out in my daily
life.
1 2 3 4 5 
14. Helped to plan ahead so I could
take care of my condition even in
hard times. 1 2 3 4 5 
15. Asked how my chronic condition
affects my life. 1 2 3 4 5 
 16. Contacted after a visit to see how
things were going. 1 2 3 4 5 
17. Encouraged to attend programs in
the community that could help
me. 1 2 3 4 5 
18. Referred to a dietitian, health
educator, or counselor. 1 2 3 4 5 
19. Told how my visits with other
types of doctors, like an eye
doctor or other specialist, helped
my treatment. 1 2 3 4 5 
20. Asked how my visits with other
doctors were going. 1 2 3 4 5 
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Appendix F  
Summary of Diabetes Self Care Activities 
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Appendix G  
Permission to Use Instruments 
Patient Activation Measure, Appendix B 
The PAM was purchased for doctoral dissertation use through the Insignia Health Website 
(Insignia Health LLC, 2012) 
Facilitation of Patient Involvement, Appendix C 
Permission to use the FPI scale was granted by Dr. Leslie Martin via email. 
 Dec 8, 2013 
Hi, 
Sorry for the delay; I rarely use this email address anymore (and you should have 
received an automatic email telling you that and giving you my new email address, which 
is lrmartin@llu.edu -- sorry that apparently didn't happen). In any case, you're welcome 
to use the FPI; simply cite the original article, that's all we ask. 
Best, 
Leslie 
Perceived Involvement in Care Scale, Appendix D 
Permission to use a copy of the PICS was granted by Dr. Lerman through email. 
Dec 1, 2013 
Hello 
The items are published in the paper. I know longer have a copy but you are welcome to 
use it 
Caryn Lerman Ph.D 
Department of Psychiatry and Annenberg Public Policy Center 
University of Pennsylvania 
Patient Assessment of Care for Chronic Conditions (PACIC), Appendix E 
The PACIC is available in the public domain and can be found on the Improving Chronic Illness 
Care website. http://www.improvingchroniccare.org/ 
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Summary of Diabetes Self-Care Activities (SDSCA), Appendix F 
A copy of the SDSCA was available in the public domain and permission for use was also 
provided by Dr. Toobert.  
Dec 2, 2013 
Dear  Courtney, 
You have our permission to use the Summary of Diabetes Self-Care Activities 
Questionnaire in your research project. The instrument is in the public domain, and 
permission is not required. (But you have it anyway). Attached is the 2000 Diabetes Care 
article with the SDSCA psychometric information. At the end of the article, there is an 
appendix with the questionnaire, and the scoring information. I have also attached a user-
friendly copy of the SDSCA instrument. 
Best of luck with your research 
Deborah 
 
 
 
 
 
 
 
 
 
 
 
To: Courtney Proie
From: Linda Goodfellow, IRB Chair
Subject: Protocol #2014/01/26 - Approval Notification
Date: 02/24/2014
The protocol An Examination of Factors Affecting Hemoglobin A1c Levels and Self-Care Behaviors among
Type 2 Diabetic Patients in Primary Care Settings has been approved by the IRB Chair under the rules for
expedited review on 02/24/2014.
University HIPAA Officer, Dr. Joan Kiel, has reviewed and approved the health information procedures as
HIPAA-compliant.
The consent forms are stamped with IRB approval and one year expiration date. You should use the stamped
forms as originals for copies that you distribute or display. I have also stamped the recruitment flier and it can be
accessed via Mentor.
The approval of your study is valid through 02/24/2015, by which time you must submit an annual report either
closing the protocol or requesting permission to continue the protocol for another year.  Please submit your
report by 01/26/2015 so that the IRB has time to review and approve your report if you wish to continue it for
another year.
If, prior to the annual review, you propose any changes in your procedure or consent process, you must
complete an amendment form of those changes and submit it to the IRB Chair for approval. Please wait for the
approval before implementing any changes to the original protocol. In addition, if any unanticipated problems or
adverse effects on subjects are discovered before the annual review, you must immediately report them to the
IRB Chair before proceeding with the study.
When the study is complete, please provide the IRB with a completed termination report.   Keep a copy of your
research records, other than those you have agreed to destroy for confidentiality, over a period of five years after
the study’s completion.
If you have any questions, feel free to contact me.
Linda Goodfellow, PhD, RN
IRB Chair
goodfellow@duq.edu
Appendix H
Approval from Duquesne University
188
 189 
 
Appendix I  
Approval from Allegheny Health Network
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Appendix J  
Approved Consent Form Duquesne University 
DUQUESNE UNIVERSITY 
600 FORBES AVENUE      PITTSBURGH, PA 15282 
 
 
 
 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
 
TITLE: An Examination of Factors Affecting Hemoglobin A1c 
Levels and Self-Care Behaviors among Type 2 Diabetic 
Patients in Primary Care Settings 
 
INVESTIGATOR:   Courtney D. Proie, PhD-C, MSN, RN 
     627 Quincy Lane 
     Wexford, PA 15090 
     412-508-5807 
 
ADVISOR:    Melanie Turk, PhD, MSN, RN 
     School of Nursing 
     518 Fisher Hall, 600 Forbes Ave. 
Pittsburgh, PA 15282 
     412-396-1817 
     
 
SOURCE OF SUPPORT: This study is being performed as partial fulfillment of the 
requirements for the doctoral degree in nursing at 
Duquesne University.   
 
PURPOSE: This is being done so we can learn how patients do with 
seeing a medical provider, how involved patients are in 
their own illness and care, if patients help make decisions 
related to their treatment, and if patients feel that their 
doctor or nurse practitioner is trying to involve them in the 
care process for patients with type 2 diabetes. This study 
also wants to learn about how patients are followed by their 
practitioners and referred to other services, programs, or 
practitioners related to the care of type 2 diabetes.  Lastly, 
this study wants to look at the differences in care for 
patients seen by nurse practitioners and physicians in the 
primary care setting.  
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 This research project seeks to examine how a patient’s 
involvement in the treatment of their type 2 diabetes can 
affect the overall blood sugar control and the ability to care 
for one’s self by participating in self-care behaviors 
specific to type 2 diabetes. You will be asked to complete 
questionnaire forms about involvement in your care and 
your perception of your practitioner’s willingness to 
include you in the decision-making process related to 
treatment of your type 2 diabetes. You will be given 
instructions on how to complete each questionnaire and a 
private area will be provided for your comfort. The 
questionnaires should take approximately 30 minutes to 
complete. By assessing your participation in daily self-care 
behaviors and your overall blood sugar control, in addition 
to reviewing the responses you provide on the 
questionnaires, the research study investigator will seek to 
find a relationship between all of these variables mentioned 
above.   
    
In addition to completing a series of questionnaires related 
to these topics, you will be asked to have one blood draw to 
obtain a hemoglobin A1c value if you have not had one 
done in the past 6 months. The hemoglobin A1c test is a 
blood test that gives a measure of your overall blood sugar 
levels for the previous 2-3 months. You are also being 
asked to give your consent to allow the investigator to 
obtain your most recent Hemoglobin A1c value from a 
research nurse who is an employee of the West Penn 
Allegheny Health System, part of the Allegheny Health 
Network.  
 
  These are the only requests that will be made of you. 
 
RISKS AND BENEFITS:  You may not gain any immediate benefit by taking part in 
this study.  A potential benefit that could be derived from 
this study relates to knowledge about the types of 
healthcare practitioners that patients may benefit from 
seeing.  In addition, possible benefits may include learning 
how practitioners facilitate the involvement of patients in 
their care and decision making, related to the management 
of type 2 diabetes. 
  
There are no risks greater than those encountered in 
everyday life. 
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COMPENSATION: To compensate you for your time, you will receive a $15 
Giant Eagle or Wal-Mart gift card when all the 
questionnaires are completed. 
Participation in the project will require no 
monetary cost to you. If you choose to take the 
questionnaires 
home rather than complete them at the office, a stamped 
envelope is provided for the return of the completed 
questionnaires within 7 days to the investigator. 
 
CONFIDENTIALITY: Your name will never appear on any survey or research 
instruments.  No identity will be made in the data analysis.  
All written materials and consent forms will be stored in a 
locked file in the researcher's home.  You will be identified 
on these research records by only a study ID number rather 
than your name, and the information linking these ID 
numbers with your identity will be kept separate from the 
research records.  Only the researchers listed on the first 
page of this form and the research nurse will be able to gain 
access to your records.  All information about your 
involvement in this study—including answers provided on 
the demographic form and questionnaires—will be handled 
in a confidential way.  Your responses will only appear in 
statistical data summaries.  All materials will be destroyed 
at the completion of the research. 
 
RIGHT TO WITHDRAW: You are under no obligation to participate in this study.  
You are free to withdraw your consent to participate at any 
time. There will be no impact on your care in the provider’s 
office should you choose not to participate or withdraw 
your consent to participate.  
 
SUMMARY OF RESULTS: A summary of the results of this research will be supplied 
to you, at no cost, upon request. 
 
VOLUNTARY CONSENT: I have read the above statements and understand what is 
being requested of me.  I also understand that my 
participation is voluntary and that I am free to withdraw my 
consent at any time, for any reason, without any 
consequence or impact in my care.  On these terms, I 
certify that I am willing to participate in this research 
project. 
 
 I understand that should I have any further questions about 
my participation in this study, I may call Courtney Proie, 
Investigator, at 412-508-5807, Dr. Melanie Turk, Advisor, 
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at 412-396-1817,   and Dr. Linda Goodfellow, Chair of the 
Duquesne University Institutional Review Board 412-396-
6548.   
 
 
_________________________________________    __________________  
Participant's Signature      Date 
 
 
_________________________________________ 
Participant’s Name (please print) 
 
 
_________________________________________    __________________ 
Researcher's Signature      Date 
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Appendix K  
Approved Consent Form at Allegheny Health Network Sites 
INFORMED CONSENT FORM AND AUTHORIZATION TO DISCLOSE PROTECTED 
HEALTH INFORMATION FOR A RESEARCH STUDY 
 
Title of research study (RC# 5886):  An Examination of Factors Affecting Hemoglobin A1c 
Levels and Self-Care Behaviors among Type 2 Diabetic Patients in Primary Care Settings 
 
Principal Investigator: Michele Prior, MSN, RN 
Co-investigator:  Courtney D. Proie, PhD-C, MSN, RN 
 
SPONSOR:         This study is being performed as partial fulfillment of the 
requirements for the doctoral degree in nursing at 
Duquesne University. 
 
PURPOSE:  This is being done so we can learn how patients do with 
seeing a medical provider, how involved patients are in 
their own illness and care, if patients help make decisions 
related to their treatment, and if patients feel that their 
doctor or nurse practitioner is trying to involve them in the 
care process for patients with type 2 diabetes. This study 
also wants to learn about how patients are followed by their 
practitioners and referred to other services, programs, or 
practitioners related to he care of type 2 diabetes. Lastly, 
this study wants to look at the differences in care for 
patients seen by nurse practitioners and physicians in the 
primary care setting. 
This research project seeks to examine how a patient’s 
involvement in the treatment of their type 2 diabetes can 
affect the overall blood sugar control and the ability to care 
for one’s self by participating in self-care behaviors 
specific to type 2 diabetes. You will be asked to complete 
questionnaire forms about involvement in your care and 
your perception of your practitioner’s willingness to 
include you in the decision-making process related to 
treatment of your type 2 diabetes. You will be 
given instructions on how to complete each questionnaire 
and a private area will be provided for your comfort. The 
questionnaires should take approximately 30 minutes to 
complete. By assessing your participation in daily self-care 
behaviors and your overall blood sugar control, in addition 
to reviewing the responses you provide on the 
questionnaires, the research study investigator will seek to 
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find a relationship between all of these variables mentioned 
above. 
In addition to completing a series of questionnaires related 
to these topics, you will be asked to have one blood draw to 
obtain a hemoglobin A1c value if you have not had one 
done in the past 6 months. The hemoglobin A1c test is a 
blood test that gives a measure of your overall blood sugar 
levels for the previous 2-3 months. You are also being 
asked to give your consent to allow 
the investigator to obtain your most recent Hemoglobin 
A1c value from a research nurse who is an employee of the 
West Penn Allegheny Health System, part of the Allegheny 
Health Network. 
These are the only requests that will be made of you. 
 
RISKS AND BENEFITS:  You may not gain any immediate benefit by taking part in 
this study. A potential benefit that could be derived from 
this study relates to knowledge about the types of 
healthcare practitioners that patients may benefit from 
seeing. In addition, possible benefits may include learning 
how practitioners facilitate the involvement of patients in 
their care and decision making, related to the management 
of type 2 diabetes. 
There are no risks greater than those encountered in 
everyday life. 
 
COMPENSATION:  To compensate you for your time, you will receive a $15 
Giant Eagle or Wal-Mart gift card when all the 
questionnaires are completed. 
Participation in the project will require no 
monetary cost to you. If you choose to take the 
questionnaires home rather than complete them at the 
office, a stamped envelope is provided for the return of the 
completed questionnaires within 7 days to the investigator. 
 
 
CONFIDENTIALITY:   Your name will never appear on any survey or research 
instruments. No identity will be made in the data analysis. 
All written materials and consent forms will be stored in a 
locked file in the researcher's home. You will be identified 
on these research records by only a study ID number rather 
than your name, and the information linking these ID 
numbers with your identity will be kept separate from the 
research records. Only the researchers listed on the first 
page of this form and the research nurse will be able to gain 
access to your records. All information about your 
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involvement in this study—including answers provided on 
the demographic form and questionnaires—will be handled 
in a confidential way. Your responses will only appear in 
statistical data summaries. All materials will be destroyed 
at the completion of the research. 
 
RIGHT TO WITHDRAW:  You are under no obligation to participate in this study. 
You are free to withdraw your consent to participate at any 
time. There will be no impact on your care in the provider’s 
office should you choose not to participate or withdraw 
your consent to participate. 
 
SUMMARY OF RESULTS:  A summary of the results of this research will be supplied 
to you, at no cost, upon request. 
 
VOLUNTARY CONSENT:  I have read the above statements and understand what is 
being requested of me. I also understand that my 
participation is voluntary and that I am free to withdraw my 
consent at any time, for any reason, without any 
consequence or impact in my care. 
On these terms, I certify that I am willing to participate in 
this research project. 
 
I understand that should I have any further questions about 
my participation in this study, I may contact Michele Prior, 
Primary Investigator at __________ or Courtney Proie, 
Co-Investigator, at __________, Allegheny Singer 
Research Institute __________or asri@wpahs.org, Dr. 
Melanie Turk, Advisor, at 412-396-1817, or Dr. Linda 
Goodfellow, Chair of then Duquesne University 
Institutional Review Board  
412-396-6548. 
 
What if I am injured while taking part in this study? 
If you are injured or made sick while taking part in this research study, emergency medical 
treatment will be provided at the usual charge.  No funds have been set aside by Allegheny 
Health Network or Allegheny-Singer Research Institute to pay you in case you are injured. You 
do not waive any of your legal rights to compensation, if any, by signing this form.   
 
Authorization to Use and Disclose Individually Identifiable Health 
Information for a Research Study 
 
Before you can take part in this research study, the Allegheny Health Network is required to 
obtain your authorization to use and/or disclose (release) your health information.  This section 
describes to you how, and to whom, your health information will be used and/or disclosed 
(shared) while you are participating in this research study.  It is important that you read this 
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carefully. Allegheny Health Network and its’ researchers are required by law to protect your 
health information.   
 
The following is a list of health information that will be used and/or disclosed: 
 Medical records 
 A1C lab results 
 Questionnaire results 
The following is a list of entities that may use and/or disclose your health information as 
part of this study: 
 
 Those who oversee the study will have access to your health information, including the 
following: 
 Allegheny Health Network (AHN) 
 Allegheny Singer Research Institute (ASRI) 
 AHN Compliance Office 
 The ASRI-WPAHS IRB 
 Your health information may also be shared with government agencies that have oversight 
of the study or to whom access is required under the law: 
 Department of Health and Human Services 
 The following persons and/or organizations outside of this institution may also use, 
disclose and receive you health information in connection with this study:  
 Co-Investigator: Courtney D. Proie, PhD-C, MSN, RN 
 
In order to participate in this study, you must agree to share your health information with the 
persons and organizations listed above. If these persons or organizations that you authorize to 
receive and/or use protected health information, are not health plans, covered health care 
providers or health care clearinghouses subject to federal health information privacy laws, they 
may further disclose the protected health information and it may no longer be protected by the 
federal health information privacy laws. 
 
Expiration of Authorization 
This authorization will not expire unless you revoke it in writing. You may revoke or end this 
authorization by writing to the Principal Investigator:  
 
Michele Prior, MSN, RN 
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C/O Allegheny General Hospital 
15th Floor South Tower  
320 East North Ave, 
Pittsburgh, Pa 15212 
 
If you revoke your authorization, you will also be removed from the study.  Revoking your 
authorization only affects the use and sharing of your health information after the written request 
is received.  Any health information obtained prior to receiving the written request may be used 
to maintain the integrity of the study. 
 
Authorization 
By signing this document (authorization), you authorize that your health information can be used 
and/or disclosed as described. 
 
If you choose to not sign this document, you will not be permitted to participate in this research 
study. 
 
 
Signature Block  
 
Your signature below indicates your permission to take part in this research and to the use and 
disclosure of your protected health information:  
   
Signature of subject  Date/Time 
  
Printed name of subject 
 
   
Investigator Signature   Date/Time 
  
Printed name of Investigator 
 
   
Signature of witness to signature  Date/Time 
  
Printed name of person witnessing signature 
 
 
 
 
 
